Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Alzheimer's Disease

  Free Subscription


Articles published in Alzheimers Dement

Retrieve available abstracts of 859 articles:
HTML format



Single Articles


    March 2024
  1. SONI N, Hohsfield LA, Tran KM, Kawauchi S, et al
    Genetic diversity promotes resilience in a mouse model of Alzheimer's disease.
    Alzheimers Dement. 2024 Mar 1. doi: 10.1002/alz.13753.
    PubMed     Abstract available


    February 2024
  2. RUTHIRAKUHAN M, Swardfager W, Xiong L, MacIntosh BJ, et al
    Investigating the impact of hypertension with and without diabetes on Alzheimer's disease risk: A clinico-pathological study.
    Alzheimers Dement. 2024 Feb 29. doi: 10.1002/alz.13717.
    PubMed     Abstract available


  3. NEWTON C, Pope M, Rua C, Henson R, et al
    Entorhinal-based path integration selectively predicts midlife risk of Alzheimer's disease.
    Alzheimers Dement. 2024 Feb 29. doi: 10.1002/alz.13733.
    PubMed     Abstract available


  4. MOHS RC, Beauregard D, Dwyer J, Gaudioso J, et al
    The Bio-Hermes Study: Biomarker database developed to investigate blood-based and digital biomarkers in community-based, diverse populations clinically screened for Alzheimer's disease.
    Alzheimers Dement. 2024 Feb 28. doi: 10.1002/alz.13722.
    PubMed     Abstract available


  5. SHIM KH, Kim D, Kang MJ, Pyun JM, et al
    Subsequent correlated changes in complement component 3 and amyloid beta oligomers in the blood of patients with Alzheimer's disease.
    Alzheimers Dement. 2024 Feb 27. doi: 10.1002/alz.13734.
    PubMed     Abstract available


  6. SASNER M, Onos KD, Territo PR, Sukoff Rizzo SJ, et al
    Meeting report of the fifth annual workshop on Principles and Techniques for Improving Preclinical to Clinical Translation in Alzheimer's Disease Research.
    Alzheimers Dement. 2024 Feb 24. doi: 10.1002/alz.13742.
    PubMed     Abstract available


  7. WANG G, Li Y, Xiong C, Benzinger TLS, et al
    Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease.
    Alzheimers Dement. 2024 Feb 23. doi: 10.1002/alz.13735.
    PubMed     Abstract available


  8. XICOTA L, Cosentino S, Vardarajan B, Mayeux R, et al
    Whole genome-wide sequence analysis of long-lived families (Long-Life Family Study) identifies MTUS2 gene associated with late-onset Alzheimer's disease.
    Alzheimers Dement. 2024 Feb 21. doi: 10.1002/alz.13718.
    PubMed     Abstract available


  9. WOLTERS FJ, Labrecque JA
    Potential impact of unblinding on observed treatment effects in Alzheimer's disease trials.
    Alzheimers Dement. 2024 Feb 21. doi: 10.1002/alz.13690.
    PubMed     Abstract available


  10. FERGUSON CM, Hildebrand S, Godinho BMDC, Buchwald J, et al
    Silencing Apoe with divalent-siRNAs improves amyloid burden and activates immune response pathways in Alzheimer's disease.
    Alzheimers Dement. 2024 Feb 20. doi: 10.1002/alz.13703.
    PubMed     Abstract available


  11. ORTEGA-CRUZ D, Bress KS, Gazula H, Rabano A, et al
    Three-dimensional histology reveals dissociable human hippocampal long-axis gradients of Alzheimer's pathology.
    Alzheimers Dement. 2024 Feb 18. doi: 10.1002/alz.13695.
    PubMed     Abstract available


  12. KUMAR A, Scarpa M, Nordberg A
    Tracing synaptic loss in Alzheimer's brain with SV2A PET-tracer UCB-J.
    Alzheimers Dement. 2024 Feb 16. doi: 10.1002/alz.13720.
    PubMed     Abstract available


  13. PILLAI JA, Bena J, Tousi B, Rothenberg K, et al
    Lewy body pathology modifies risk factors for cerebral amyloid angiopathy when comorbid with Alzheimer's disease pathology.
    Alzheimers Dement. 2024 Feb 14. doi: 10.1002/alz.13704.
    PubMed     Abstract available


  14. PADULA CB, Ball S, Wyman MF, Evans K, et al
    INviting Veterans InTo Enrollment in Alzheimer's Disease Research Centers (INVITE-ADRC): An NIA and VA-sponsored initiative to increase veteran participation in aging and dementia research.
    Alzheimers Dement. 2024 Feb 13. doi: 10.1002/alz.13725.
    PubMed     Abstract available


  15. LI Z, Liang D, Ebelt S, Gearing M, et al
    Differential DNA methylation in the brain as potential mediator of the association between traffic-related PM(2.5) and neuropathology markers of Alzheimer's disease.
    Alzheimers Dement. 2024 Feb 12. doi: 10.1002/alz.13650.
    PubMed     Abstract available


  16. BENZOW K, Karanjeet K, Oblak AL, Carter GW, et al
    Gene replacement-Alzheimer's disease (GR-AD): Modeling the genetics of human dementias in mice.
    Alzheimers Dement. 2024 Feb 11. doi: 10.1002/alz.13730.
    PubMed     Abstract available


  17. DIAZ-GALVAN P, Przybelski SA, Algeciras-Schimnich A, Figdore DJ, et al
    Plasma biomarkers of Alzheimer's disease in the continuum of dementia with Lewy bodies.
    Alzheimers Dement. 2024 Feb 8. doi: 10.1002/alz.13653.
    PubMed     Abstract available


  18. GONZALEZ-ORTIZ F, Karikari TK, Blennow K
    Analytical and clinical validation of Alzheimer's disease blood biomarkers with a focus on plasma p-tau217.
    Alzheimers Dement. 2024 Feb 8. doi: 10.1002/alz.13708.
    PubMed     Abstract available


  19. TAHA HB
    Early detection of subjective cognitive decline and Alzheimer's disease: Analytical validation of a newly developed pT217-tau assay.
    Alzheimers Dement. 2024 Feb 8. doi: 10.1002/alz.13707.
    PubMed    


  20. ABADIR P, Oh E, Chellappa R, Choudhry N, et al
    Artificial Intelligence and Technology Collaboratories: Innovating aging research and Alzheimer's care.
    Alzheimers Dement. 2024 Feb 7. doi: 10.1002/alz.13710.
    PubMed     Abstract available


  21. ZHONG H, Zhou X, Uhm H, Jiang Y, et al
    Using blood transcriptome analysis for Alzheimer's disease diagnosis and patient stratification.
    Alzheimers Dement. 2024 Feb 7. doi: 10.1002/alz.13691.
    PubMed     Abstract available


  22. BELLOMO G, Bayoumy S, Megaro A, Toja A, et al
    Fully automated measurement of plasma Abeta42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts.
    Alzheimers Dement. 2024 Feb 7. doi: 10.1002/alz.13687.
    PubMed     Abstract available


  23. BELLOMO G, Toja A, Paolini Paoletti F, Ma Y, et al
    Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay.
    Alzheimers Dement. 2024 Feb 7. doi: 10.1002/alz.13658.
    PubMed     Abstract available


  24. GRIFFIN JM, Kim K, Finnie DM, Lapid MI, et al
    Developing and describing a typology of lucid episodes among people with Alzheimer's disease and related dementias.
    Alzheimers Dement. 2024 Feb 2. doi: 10.1002/alz.13667.
    PubMed     Abstract available


  25. SHAABAN CE, Lin HS, Terry M, Ren D, et al
    COVID-19 pandemic's relationship with enrollment at US Alzheimer's Disease Research Centers.
    Alzheimers Dement. 2024 Feb 1. doi: 10.1002/alz.13706.
    PubMed     Abstract available


  26. ROSSANO SM, Johnson AS, Smith A, Ziaggi G, et al
    Microglia measured by TSPO PET are associated with Alzheimer's disease pathology and mediate key steps in a disease progression model.
    Alzheimers Dement. 2024 Feb 1. doi: 10.1002/alz.13699.
    PubMed     Abstract available



  27. Alzheimer's Association and ASNR announce recipients of imaging grants.
    Alzheimers Dement. 2024;20:1476-1477.
    PubMed    


  28. CLARK AL, Thomas KR, Ortega N, Haley AP, et al
    Empirically derived psychosocial-behavioral phenotypes in Black/African American and Hispanic/Latino older adults enrolled in HABS-HD: Associations with AD biomarkers and cognitive outcomes.
    Alzheimers Dement. 2024;20:1360-1373.
    PubMed     Abstract available


  29. EISSMAN JM, Archer DB, Mukherjee S, Lee ML, et al
    Sex-specific genetic architecture of late-life memory performance.
    Alzheimers Dement. 2024;20:1250-1267.
    PubMed     Abstract available


  30. SLEE MG, Rainey-Smith SR, Villemagne VL, Doecke JD, et al
    Physical activity and brain amyloid beta: A longitudinal analysis of cognitively unimpaired older adults.
    Alzheimers Dement. 2024;20:1350-1359.
    PubMed     Abstract available


  31. COGSWELL PM, Lundt ES, Therneau TM, Wiste HJ, et al
    Modeling the temporal evolution of plasma p-tau in relation to amyloid beta and tau PET.
    Alzheimers Dement. 2024;20:1225-1238.
    PubMed     Abstract available


  32. BUTTS B, Huang H, Hu WT, Kehoe PG, et al
    sPDGFRbeta and neuroinflammation are associated with AD biomarkers and differ by race: The ASCEND Study.
    Alzheimers Dement. 2024;20:1175-1189.
    PubMed     Abstract available


  33. CHEN H, Dunk MM, Wang B, Zhao M, et al
    Associations of the Mediterranean-DASH Intervention for Neurodegenerative Delay diet with brain structural markers and their changes.
    Alzheimers Dement. 2024;20:1190-1200.
    PubMed     Abstract available


  34. WOO MS, Tissot C, Lantero-Rodriguez J, Snellman A, et al
    Plasma pTau-217 and N-terminal tau (NTA) enhance sensitivity to identify tau PET positivity in amyloid-beta positive individuals.
    Alzheimers Dement. 2024;20:1166-1174.
    PubMed     Abstract available


  35. ACKLEY SF, Wang J, Chen R, Power MC, et al
    Estimated effects of amyloid reduction on cognitive change: A Bayesian update across a range of priors.
    Alzheimers Dement. 2024;20:1149-1155.
    PubMed     Abstract available


  36. SANFORD SAI, Miller LVC, Vaysburd M, Keeling S, et al
    The type-I interferon response potentiates seeded tau aggregation and exacerbates tau pathology.
    Alzheimers Dement. 2024;20:1013-1025.
    PubMed     Abstract available


  37. GERMAN-CASTELAN L, Shanks HRC, Gros R, Saito T, et al
    Sex-dependent cholinergic effects on amyloid pathology: A translational study.
    Alzheimers Dement. 2024;20:995-1012.
    PubMed     Abstract available


  38. SCHWEITZER N, Li J, Thurston RC, Lopresti B, et al
    Sex-dependent alterations in hippocampal connectivity are linked to cerebrovascular and amyloid pathologies in normal aging.
    Alzheimers Dement. 2024;20:914-924.
    PubMed     Abstract available


  39. AARONSON A, Ashford MT, Jin C, Bride J, et al
    Brain Health Registry Study Partner Portal: Novel infrastructure for digital, dyadic data collection.
    Alzheimers Dement. 2024;20:846-857.
    PubMed     Abstract available


  40. MARINO C, Perez-Corredor P, O'Hare M, Heuer A, et al
    APOE Christchurch-mimetic therapeutic antibody reduces APOE-mediated toxicity and tau phosphorylation.
    Alzheimers Dement. 2024;20:819-836.
    PubMed     Abstract available


  41. TATE AE, Bouteloup V, van Maurik IS, Jean D, et al
    Predicting sojourn times across dementia disease stages, institutionalization, and mortality.
    Alzheimers Dement. 2024;20:809-818.
    PubMed     Abstract available


    January 2024
  42. DAMSGAARD L, Janbek J, Laursen TM, Hogh P, et al
    Mapping morbidity 10 years prior to a diagnosis of young onset Alzheimer's disease.
    Alzheimers Dement. 2024 Jan 31. doi: 10.1002/alz.13681.
    PubMed     Abstract available



  43. Withdrawal: Glycine transporter 1 (GlyT1) is a novel therapeutic target for Alzheimer's disease.
    Alzheimers Dement. 2024 Jan 31. doi: 10.1002/alz.13724.
    PubMed     Abstract available


  44. ALGECIRAS-SCHIMNICH A, Bornhorst JA
    Importance of cerebrospinal fluid (CSF) collection protocol for the accurate diagnosis of Alzheimer's disease when using CSF biomarkers.
    Alzheimers Dement. 2024 Jan 30. doi: 10.1002/alz.13721.
    PubMed    


  45. HUBER H, Blennow K, Zetterberg H, Boada M, et al
    Biomarkers of Alzheimer's disease and neurodegeneration in dried blood spots-A new collection method for remote settings.
    Alzheimers Dement. 2024 Jan 29. doi: 10.1002/alz.13697.
    PubMed     Abstract available


  46. GOMEZ-ARBOLEDAS A, Fonseca MI, Kramar E, Chu SH, et al
    C5aR1 signaling promotes region- and age-dependent synaptic pruning in models of Alzheimer's disease.
    Alzheimers Dement. 2024 Jan 26. doi: 10.1002/alz.13682.
    PubMed     Abstract available


  47. RUBINSTEIN T, Brickman AM, Cheng B, Burkett S, et al
    Periodontitis and brain magnetic resonance imaging markers of Alzheimer's disease and cognitive aging.
    Alzheimers Dement. 2024 Jan 26. doi: 10.1002/alz.13683.
    PubMed     Abstract available


  48. DEECKE L, Homann J, Goldecktble D, Ohlei O, et al
    No increase of CD8+ TEMRA cells in the blood of healthy adults at high genetic risk of Alzheimer's disease.
    Alzheimers Dement. 2024 Jan 25. doi: 10.1002/alz.13709.
    PubMed    


  49. XU H, Bayless TM, Ostbye T, Dupre ME, et al
    Care sequences leading to the diagnosis of Alzheimer's disease and related dementias: An analysis of electronic health records.
    Alzheimers Dement. 2024 Jan 25. doi: 10.1002/alz.13669.
    PubMed     Abstract available


  50. LANDAU SM, Lee J, Murphy A, Ward TJ, et al
    Individuals with Alzheimer's disease and low tau burden: Characteristics and implications.
    Alzheimers Dement. 2024 Jan 19. doi: 10.1002/alz.13609.
    PubMed     Abstract available


  51. TSOY E, La Joie R, VandeVrede L, Rojas JC, et al
    Scalable plasma and digital cognitive markers for diagnosis and prognosis of Alzheimer's disease and related dementias.
    Alzheimers Dement. 2024 Jan 15. doi: 10.1002/alz.13686.
    PubMed     Abstract available


  52. POMARA N, Imbimbo BP
    Do anti-Abeta monoclonal antibodies lower brain plaques in Alzheimer patients through microglia activation?
    Alzheimers Dement. 2024 Jan 15. doi: 10.1002/alz.13684.
    PubMed    


  53. HATA Y, Nakase M, Ichimata S, Yoshida K, et al
    Neuropathology of patients with preclinical or early clinical Alzheimer's disease with pathogenic PSEN1_p. L392V: Comparison of advanced siblings.
    Alzheimers Dement. 2024 Jan 12. doi: 10.1002/alz.13675.
    PubMed     Abstract available


  54. SUCHY-DICEY AM, Longstreth WT Jr, Rhoads K, Umans J, et al
    Plasma biomarkers of Alzheimer's disease and related dementias in American Indians: The Strong Heart Study.
    Alzheimers Dement. 2024 Jan 12. doi: 10.1002/alz.13664.
    PubMed     Abstract available


  55. HO PC, Yu WH, Tee BL, Lee WP, et al
    Asian Cohort for Alzheimer's Disease (ACAD) pilot study on genetic and non-genetic risk factors for Alzheimer's disease among Asian Americans and Canadians.
    Alzheimers Dement. 2024 Jan 12. doi: 10.1002/alz.13611.
    PubMed     Abstract available


  56. OWENS HA, Thorburn LE, Walsby E, Moon OR, et al
    Alzheimer's disease-associated P460L variant of EphA1 dysregulates receptor activity and blood-brain barrier function.
    Alzheimers Dement. 2024 Jan 7. doi: 10.1002/alz.13603.
    PubMed     Abstract available


  57. WANG P, Lynn A, Miskimen K, Song YE, et al
    Genome-wide association studies identify novel loci in rapidly progressive Alzheimer's disease.
    Alzheimers Dement. 2024 Jan 7. doi: 10.1002/alz.13655.
    PubMed     Abstract available


  58. BUTO PT, Wang J, La Joie R, Zimmerman SC, et al
    Genetic risk score for Alzheimer's disease predicts brain volume differences in mid and late life in UK biobank participants.
    Alzheimers Dement. 2024 Jan 6. doi: 10.1002/alz.13610.
    PubMed     Abstract available


  59. GU Y, Honig LS, Kang MS, Bahl A, et al
    Risk of Alzheimer's disease is associated with longitudinal changes in plasma biomarkers in the multi-ethnic Washington Heights-Hamilton Heights-Inwood Columbia Aging Project (WHICAP) cohort.
    Alzheimers Dement. 2024 Jan 6. doi: 10.1002/alz.13652.
    PubMed     Abstract available


  60. JIANG Y, Uhm H, Ip FC, Ouyang L, et al
    A blood-based multi-pathway biomarker assay for early detection and staging of Alzheimer's disease across ethnic groups.
    Alzheimers Dement. 2024 Jan 6. doi: 10.1002/alz.13676.
    PubMed     Abstract available


  61. SRIKRISHNA M, Ashton NJ, Moscoso A, Pereira JB, et al
    CT-based volumetric measures obtained through deep learning: Association with biomarkers of neurodegeneration.
    Alzheimers Dement. 2024;20:629-640.
    PubMed     Abstract available


  62. JAIN L, Khrestian M, Formica S, Tuason ED, et al
    ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium.
    Alzheimers Dement. 2024;20:549-562.
    PubMed     Abstract available


  63. LOPES KP, Yu L, Shen X, Qiu Y, et al
    Associations of cortical SPP1 and ITGAX with cognition and common neuropathologies in older adults.
    Alzheimers Dement. 2024;20:525-537.
    PubMed     Abstract available


  64. MADSEN LS, Kjeldsen PL, Ismail R, Parbo P, et al
    Capillary dysfunction in healthy elderly APOE epsilon4 carriers with raised brain Abeta deposition.
    Alzheimers Dement. 2024;20:459-471.
    PubMed     Abstract available


  65. LIU W, Yu L, Deng Q, Li Y, et al
    Toward digitally screening and profiling AD: A GAMLSS approach of MemTrax in China.
    Alzheimers Dement. 2024;20:399-409.
    PubMed     Abstract available


  66. ZAMMIT MD, Betthauser TJ, McVea AK, Laymon CM, et al
    Characterizing the emergence of amyloid and tau burden in Down syndrome.
    Alzheimers Dement. 2024;20:388-398.
    PubMed     Abstract available


  67. WANG X, Sundermann EE, Buckley RF, Banks SJ, et al
    Sex differences in the association between tau PET and cognitive performance in a non-Hispanic White cohort with preclinical AD.
    Alzheimers Dement. 2024;20:25-33.
    PubMed     Abstract available


  68. SALONER R, VandeVrede L, Asken BM, Paolillo EW, et al
    Plasma phosphorylated tau-217 exhibits sex-specific prognostication of cognitive decline and brain atrophy in cognitively unimpaired adults.
    Alzheimers Dement. 2024;20:376-387.
    PubMed     Abstract available


  69. WALKIEWICZ G, Ronisz A, Van Ginderdeuren R, Lemmens S, et al
    Primary retinal tauopathy: A tauopathy with a distinct molecular pattern.
    Alzheimers Dement. 2024;20:330-340.
    PubMed     Abstract available


  70. PEZZOLI S, Giorgio J, Martersteck A, Dobyns L, et al
    Successful cognitive aging is associated with thicker anterior cingulate cortex and lower tau deposition compared to typical aging.
    Alzheimers Dement. 2024;20:341-355.
    PubMed     Abstract available


  71. GAUTHREAUX K, Kukull WA, Nelson KB, Mock C, et al
    Different cohort, disparate results: Selection bias is a key factor in autopsy cohorts.
    Alzheimers Dement. 2024;20:266-277.
    PubMed     Abstract available


  72. TITCOMB TJ, Richey P, Casanova R, Phillips LS, et al
    Association of type 2 diabetes mellitus with dementia-related and non-dementia-related mortality among postmenopausal women: A secondary competing risks analysis of the women's health initiative.
    Alzheimers Dement. 2024;20:234-242.
    PubMed     Abstract available


  73. BOCCALINI C, Ribaldi F, Hristovska I, Arnone A, et al
    The impact of tau deposition and hypometabolism on cognitive impairment and longitudinal cognitive decline.
    Alzheimers Dement. 2024;20:221-233.
    PubMed     Abstract available


  74. VAN DER HEIDE FCT, Khawaja A, Berendschot TTJM, Littlejohns TJ, et al
    Associations of inner retinal layers with risk of incident dementia: An individual participant data analysis of four prospective cohort studies.
    Alzheimers Dement. 2024;20:211-220.
    PubMed     Abstract available


  75. HARDY CJD, Taylor-Rubin C, Taylor B, Harding E, et al
    Symptom-led staging for semantic and non-fluent/agrammatic variants of primary progressive aphasia.
    Alzheimers Dement. 2024;20:195-210.
    PubMed     Abstract available


  76. WANG X, St George RJ, Bindoff AD, Noyce AJ, et al
    Estimating presymptomatic episodic memory impairment using simple hand movement tests: A cross-sectional study of a large sample of older adults.
    Alzheimers Dement. 2024;20:173-182.
    PubMed     Abstract available


  77. CAMINITI SP, De Francesco S, Tondo G, Galli A, et al
    FDG-PET markers of heterogeneity and different risk of progression in amnestic MCI.
    Alzheimers Dement. 2024;20:159-172.
    PubMed     Abstract available


  78. DENG J, Sun B, Kavcic V, Liu M, et al
    Novel methodology for detection and prediction of mild cognitive impairment using resting-state EEG.
    Alzheimers Dement. 2024;20:145-158.
    PubMed     Abstract available


    December 2023
  79. LU Y, Pike JR, Hoogeveen RC, Walker KA, et al
    Liver integrity and the risk of Alzheimer's disease and related dementias.
    Alzheimers Dement. 2023 Dec 28. doi: 10.1002/alz.13601.
    PubMed     Abstract available


  80. DARRICAU M, Dou C, Kinet R, Zhu T, et al
    Tau seeds from Alzheimer's disease brains trigger tau spread in macaques while oligomeric-Abeta mediates pathology maturation.
    Alzheimers Dement. 2023 Dec 26. doi: 10.1002/alz.13604.
    PubMed     Abstract available


  81. ABIOSE O, Rutledge J, Moran-Losada P, Belloy ME, et al
    Post-translational modifications linked to preclinical Alzheimer's disease-related pathological and cognitive changes.
    Alzheimers Dement. 2023 Dec 25. doi: 10.1002/alz.13576.
    PubMed     Abstract available



  82. Correction to "Strain hypothesis and additional evidence of the GluN3A deficiency? mediated pathogenesis of Alzheimer's disease".
    Alzheimers Dement. 2023 Dec 21. doi: 10.1002/alz.13549.
    PubMed    


  83. WANG X, Bakulski KM, Karvonen-Gutierrez CA, Park SK, et al
    Blood-based biomarkers for Alzheimer's disease and cognitive function from mid- to late life.
    Alzheimers Dement. 2023 Dec 21. doi: 10.1002/alz.13583.
    PubMed     Abstract available


  84. ASLANYAN V, Mack WJ, Ortega NE, Nasrallah IM, et al
    Cerebrovascular reactivity in Alzheimer's disease signature regions is associated with mild cognitive impairment in adults with hypertension.
    Alzheimers Dement. 2023 Dec 18. doi: 10.1002/alz.13572.
    PubMed     Abstract available


  85. CRANE PK, Groot C, Ossenkoppele R, Mukherjee S, et al
    Cognitively defined Alzheimer's dementia subgroups have distinct atrophy patterns.
    Alzheimers Dement. 2023 Dec 13. doi: 10.1002/alz.13567.
    PubMed     Abstract available


  86. DOUROS A, Ante Z, Fallone CA, Azoulay L, et al
    Clinically apparent Helicobacter pylori infection and the risk of incident Alzheimer's disease: A population-based nested case-control study.
    Alzheimers Dement. 2023 Dec 13. doi: 10.1002/alz.13561.
    PubMed     Abstract available


  87. VILOR-TEJEDOR N, Genius P, Rodriguez-Fernandez B, Minguillon C, et al
    Genetic characterization of the ALFA study: Uncovering genetic profiles in the Alzheimer's continuum.
    Alzheimers Dement. 2023 Dec 13. doi: 10.1002/alz.13537.
    PubMed     Abstract available


  88. DEVANARAYAN V, Ye Y, Charil A, Andreozzi E, et al
    Predicting clinical progression trajectories of early Alzheimer's disease patients.
    Alzheimers Dement. 2023 Dec 13. doi: 10.1002/alz.13565.
    PubMed     Abstract available


  89. MORGAN DG, Lamb BT
    Transgenic amyloid precursor protein mouse models of amyloidosis. Incomplete models for Alzheimer's disease but effective predictors of anti-amyloid therapies.
    Alzheimers Dement. 2023 Dec 12. doi: 10.1002/alz.13566.
    PubMed     Abstract available


  90. CONNIFF KR, Grill JD, Gillen DL
    Retention of American Indian and Alaska Native participants in the National Alzheimer's Coordinating Center Uniform Data Set.
    Alzheimers Dement. 2023 Dec 5. doi: 10.1002/alz.13573.
    PubMed     Abstract available


  91. AMANO T, Halvorsen CJ, Kim S, Reynolds A, et al
    An outcome-wide analysis of the effects of diagnostic labeling of Alzheimer's disease and related dementias on social relationships.
    Alzheimers Dement. 2023 Dec 5. doi: 10.1002/alz.13574.
    PubMed     Abstract available


  92. LYU X, Duong MT, Xie L, de Flores R, et al
    Tau-neurodegeneration mismatch reveals vulnerability and resilience to comorbidities in Alzheimer's continuum.
    Alzheimers Dement. 2023 Dec 5. doi: 10.1002/alz.13559.
    PubMed     Abstract available


  93. BELLIER JP, Cai Y, Alam SM, Wiederhold T, et al
    Uncovering elevated tau TPP motif phosphorylation in the brain of Alzheimer's disease patients.
    Alzheimers Dement. 2023 Dec 2. doi: 10.1002/alz.13557.
    PubMed     Abstract available


  94. LE BORGNE J, Amouyel P, Andreassen O, Frikke-Schmidt R, et al
    Association of MGMT and BIN1 genes with Alzheimer's disease risk across sex and APOE epsilon4 status.
    Alzheimers Dement. 2023 Dec 2. doi: 10.1002/alz.13550.
    PubMed    


  95. REN Y, Li Y, Tian N, Liu R, et al
    Multimorbidity, cognitive phenotypes, and Alzheimer's disease plasma biomarkers in older adults: A population-based study.
    Alzheimers Dement. 2023 Dec 2. doi: 10.1002/alz.13519.
    PubMed     Abstract available


  96. BETTENCOURT C, Skene N, Bandres-Ciga S, Anderson E, et al
    Artificial intelligence for dementia genetics and omics.
    Alzheimers Dement. 2023;19:5905-5921.
    PubMed     Abstract available


  97. BORCHERT RJ, Azevedo T, Badhwar A, Bernal J, et al
    Artificial intelligence for diagnostic and prognostic neuroimaging in dementia: A systematic review.
    Alzheimers Dement. 2023;19:5885-5904.
    PubMed     Abstract available


  98. STERN AM, Van Pelt KL, Liu L, Anderson AK, et al
    Plasma NT1-tau and Abeta(42) correlate with age and cognitive function in two large Down syndrome cohorts.
    Alzheimers Dement. 2023;19:5755-5764.
    PubMed     Abstract available


  99. LEE YG, Jeon S, Kang SW, Ye BS, et al
    Effects of amyloid beta and dopaminergic depletion on perfusion and clinical symptoms.
    Alzheimers Dement. 2023;19:5719-5729.
    PubMed     Abstract available


  100. GRASSET L, Planche V, Bouteloup V, Azouani C, et al
    Physical activity, biomarkers of brain pathologies and dementia risk: Results from the Memento clinical cohort.
    Alzheimers Dement. 2023;19:5700-5718.
    PubMed     Abstract available


  101. GERICKE C, Kirabali T, Flury R, Mallone A, et al
    Early beta-amyloid accumulation in the brain is associated with peripheral T cell alterations.
    Alzheimers Dement. 2023;19:5642-5662.
    PubMed     Abstract available


  102. NGUYEN HO PT, van Arendonk J, Steketee RME, van Rooij FJA, et al
    Predicting amyloid-beta pathology in the general population.
    Alzheimers Dement. 2023;19:5506-5517.
    PubMed     Abstract available


  103. TOSUN D, Thropp P, Southekal S, Spottiswoode B, et al
    Profiling and predicting distinct tau progression patterns: An unsupervised data-driven approach to flortaucipir positron emission tomography.
    Alzheimers Dement. 2023;19:5605-5619.
    PubMed     Abstract available


  104. FRANZEN S, Nuytemans K, Bourdage R, Caramelli P, et al
    Gaps in clinical research in frontotemporal dementia: A call for diversity and disparities-focused research.
    Alzheimers Dement. 2023;19:5817-5836.
    PubMed     Abstract available


  105. JAHREIS K, Bruge A, Borsdorf S, Muller FE, et al
    Amisulpride as a potential disease-modifying drug in the treatment of tauopathies.
    Alzheimers Dement. 2023;19:5482-5497.
    PubMed     Abstract available


  106. KIM KY, Ha J, Lee JY, Kim E, et al
    Weight loss and risk of dementia in individuals with versus without obesity.
    Alzheimers Dement. 2023;19:5471-5481.
    PubMed     Abstract available


  107. STANKEVICIUTE L, Falcon C, Operto G, Garcia M, et al
    Differential effects of sleep on brain structure and metabolism at the preclinical stages of AD.
    Alzheimers Dement. 2023;19:5371-5386.
    PubMed     Abstract available


  108. LANTERO-RODRIGUEZ J, Tissot C, Snellman A, Servaes S, et al
    Plasma and CSF concentrations of N-terminal tau fragments associate with in vivo neurofibrillary tangle burden.
    Alzheimers Dement. 2023;19:5343-5354.
    PubMed     Abstract available


    November 2023
  109. CHUMIN EJ, Burton CP, Silvola R, Miner EW, et al
    Brain metabolic network covariance and aging in a mouse model of Alzheimer's disease.
    Alzheimers Dement. 2023 Nov 30. doi: 10.1002/alz.13538.
    PubMed     Abstract available


  110. FOLEY KE, Winder Z, Sudduth TL, Martin BJ, et al
    Alzheimer's disease and inflammatory biomarkers positively correlate in plasma in the UK-ADRC cohort.
    Alzheimers Dement. 2023 Nov 27. doi: 10.1002/alz.13485.
    PubMed     Abstract available


  111. DALMASSO MC, de Rojas I, Olivar N, Muchnik C, et al
    The first genome-wide association study in the Argentinian and Chilean populations identifies shared genetics with Europeans in Alzheimer's disease.
    Alzheimers Dement. 2023 Nov 20. doi: 10.1002/alz.13522.
    PubMed     Abstract available


  112. HOU Y, Caldwell JZK, Lathia JD, Leverenz JB, et al
    Microglial immunometabolism endophenotypes contribute to sex difference in Alzheimer's disease.
    Alzheimers Dement. 2023 Nov 20. doi: 10.1002/alz.13546.
    PubMed     Abstract available


  113. BRUM WS, Ashton NJ, Simren J, di Molfetta G, et al
    Biological variation estimates of Alzheimer's disease plasma biomarkers in healthy individuals.
    Alzheimers Dement. 2023 Nov 20. doi: 10.1002/alz.13518.
    PubMed     Abstract available


  114. ARCHER DB, Eissman JM, Mukherjee S, Lee ML, et al
    Longitudinal change in memory performance as a strong endophenotype for Alzheimer's disease.
    Alzheimers Dement. 2023 Nov 20. doi: 10.1002/alz.13508.
    PubMed     Abstract available


  115. GONZALEZ-ORTIZ F, Ferreira PCL, Gonzalez-Escalante A, Montoliu-Gaya L, et al
    A novel ultrasensitive assay for plasma p-tau217: Performance in individuals with subjective cognitive decline and early Alzheimer's disease.
    Alzheimers Dement. 2023 Nov 17. doi: 10.1002/alz.13525.
    PubMed     Abstract available


  116. POWELL WR, Vilen L, Zuelsdorff M, Goutman SA, et al
    Association between military service and Alzheimer's disease neuropathology at autopsy.
    Alzheimers Dement. 2023 Nov 15. doi: 10.1002/alz.13520.
    PubMed     Abstract available


  117. RISSMAN RA, Langford O, Raman R, Donohue MC, et al
    Plasma Abeta42/Abeta40 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease.
    Alzheimers Dement. 2023 Nov 6. doi: 10.1002/alz.13542.
    PubMed     Abstract available


  118. ALBER J, Bouwman F, den Haan J, Rissman RA, et al
    Retina pathology as a target for biomarkers for Alzheimer's disease: Current status, ophthalmopathological background, challenges, and future directions.
    Alzheimers Dement. 2023 Nov 2. doi: 10.1002/alz.13529.
    PubMed     Abstract available


  119. CANEPA E, Parodi-Rullan R, Vazquez-Torres R, Gamallo-Lana B, et al
    FDA-approved carbonic anhydrase inhibitors reduce amyloid beta pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness.
    Alzheimers Dement. 2023;19:5048-5073.
    PubMed     Abstract available


  120. HAUSMANN A, Chiabotti PS, Nasuti M, Rouaud O, et al
    Don't forget primary progressive aphasia for anti-amyloid drugs: An estimation of eligible patients from the Lausanne Memory Center registry.
    Alzheimers Dement. 2023;19:5303-5304.
    PubMed     Abstract available


  121. JIANG X, Hu X, Daamen M, Wang X, et al
    Altered limbic functional connectivity in individuals with subjective cognitive decline: Converging and diverging findings across Chinese and German cohorts.
    Alzheimers Dement. 2023;19:4922-4934.
    PubMed     Abstract available


  122. OECKL P, Bluma M, Bucci M, Halbgebauer S, et al
    Blood beta-synuclein is related to amyloid PET positivity in memory clinic patients.
    Alzheimers Dement. 2023;19:4896-4907.
    PubMed     Abstract available


  123. MALEKI BALAJOO S, Eickhoff SB, Masouleh SK, Plachti A, et al
    Hippocampal metabolic subregions and networks: Behavioral, molecular, and pathological aging profiles.
    Alzheimers Dement. 2023;19:4787-4804.
    PubMed     Abstract available


  124. WILCOCK DM
    The longitudinal early-onset Alzheimer's disease study (LEADS): Advancing our understanding of Alzheimer's disease in individuals aged 40-64.
    Alzheimers Dement. 2023;19 Suppl 9:S7.
    PubMed    


  125. ORTEGA-CRUZ D, Iglesias JE, Rabano A, Strange BA, et al
    Hippocampal sclerosis of aging at post-mortem is evident on MRI more than a decade prior.
    Alzheimers Dement. 2023;19:5307-5315.
    PubMed     Abstract available


  126. FREEZE WM, Van Veluw SJ, Jansen WJ, Bennett DA, et al
    Locus coeruleus pathology is associated with cerebral microangiopathy at autopsy.
    Alzheimers Dement. 2023;19:5023-5035.
    PubMed     Abstract available


  127. ZHANG M, Ganz AB, Rohde S, Lorenz L, et al
    The correlation between neuropathology levels and cognitive performance in centenarians.
    Alzheimers Dement. 2023;19:5036-5047.
    PubMed     Abstract available


  128. CAI Y, Fan X, Zhao L, Liu W, et al
    Comparing machine learning-derived MRI-based and blood-based neurodegeneration biomarkers in predicting syndromal conversion in early AD.
    Alzheimers Dement. 2023;19:4987-4998.
    PubMed     Abstract available


  129. WEINER MW, Aaronson A, Eichenbaum J, Kwang W, et al
    Brain health registry updates: An online longitudinal neuroscience platform.
    Alzheimers Dement. 2023;19:4935-4951.
    PubMed     Abstract available


  130. SHI H, Koronyo Y, Fuchs DT, Sheyn J, et al
    Retinal arterial Abeta(40) deposition is linked with tight junction loss and cerebral amyloid angiopathy in MCI and AD patients.
    Alzheimers Dement. 2023;19:5185-5197.
    PubMed     Abstract available


    October 2023
  131. MUIR RT, Ismail Z, Black SE, Smith EE, et al
    Comparative methods for quantifying plasma biomarkers in Alzheimer's disease: Implications for the next frontier in cerebral amyloid angiopathy diagnostics.
    Alzheimers Dement. 2023 Oct 31. doi: 10.1002/alz.13510.
    PubMed     Abstract available


  132. KELLY L, Brown C, Michalik D, Hawkes CA, et al
    Clearance of interstitial fluid (ISF) and CSF (CLIC) group-part of Vascular Professional Interest Area (PIA), updates in 2022-2023. Cerebrovascular disease and the failure of elimination of Amyloid-beta from the brain and retina with age and Alzheimer
    Alzheimers Dement. 2023 Oct 28. doi: 10.1002/alz.13512.
    PubMed     Abstract available


  133. PANG M, Gabelle A, Saha-Chaudhuri P, Huijbers W, et al
    Precision medicine analysis of heterogeneity in individual-level treatment response to amyloid beta removal in early Alzheimer's disease.
    Alzheimers Dement. 2023 Oct 26. doi: 10.1002/alz.13431.
    PubMed     Abstract available


  134. FERRETTI MT, Ding H, Au R, Liu C, et al
    Maximizing utility of neuropsychological measures in sex-specific predictive models of incident Alzheimer's disease in the Framingham Heart Study.
    Alzheimers Dement. 2023 Oct 26. doi: 10.1002/alz.13500.
    PubMed     Abstract available


  135. GREENFEST-ALLEN E, Valladares O, Kuksa PP, Gangadharan P, et al
    NIAGADS Alzheimer's GenomicsDB: A resource for exploring Alzheimer's disease genetic and genomic knowledge.
    Alzheimers Dement. 2023 Oct 26. doi: 10.1002/alz.13509.
    PubMed     Abstract available


  136. GONZALEZ-ORTIZ F, Karikari TK, Bentivenga GM, Baiardi S, et al
    Levels of plasma brain-derived tau and p-tau181 in Alzheimer's disease and rapidly progressive dementias.
    Alzheimers Dement. 2023 Oct 19. doi: 10.1002/alz.13516.
    PubMed     Abstract available


  137. XU Y, Sun Z, Jonaitis E, Deming Y, et al
    Apolipoprotein E moderates the association between non-APOE polygenic risk score for Alzheimer's disease and aging on preclinical cognitive function.
    Alzheimers Dement. 2023 Oct 19. doi: 10.1002/alz.13515.
    PubMed     Abstract available


  138. BREEN C, Papale LA, Clark LR, Bergmann PE, et al
    Whole genome methylation sequencing in blood identifies extensive differential DNA methylation in late-onset dementia due to Alzheimer's disease.
    Alzheimers Dement. 2023 Oct 19. doi: 10.1002/alz.13514.
    PubMed     Abstract available


  139. GORIJALA P, Aslam MM, Dang LT, Xicota L, et al
    Alzheimer's polygenic risk scores are associated with cognitive phenotypes in Down syndrome.
    Alzheimers Dement. 2023 Oct 19. doi: 10.1002/alz.13506.
    PubMed     Abstract available


  140. WEI YJ, Winterstein AG, Schmidt S, Fillingim RB, et al
    Pain intensity, physical function, and depressive symptoms associated with discontinuing long-term opioid therapy in older adults with Alzheimer's disease and related dementias.
    Alzheimers Dement. 2023 Oct 19. doi: 10.1002/alz.13489.
    PubMed     Abstract available


  141. TOUROUTOGLOU A, Katsumi Y, Brickhouse M, Zaitsev A, et al
    The Sporadic Early-onset Alzheimer's Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early-onset Alzheimer's Disease Study (LEADS) Cohort.
    Alzheimers Dement. 2023 Oct 18. doi: 10.1002/alz.13466.
    PubMed     Abstract available


  142. LANGELLA S, Lopera F, Baena A, Fox-Fuller JT, et al
    Depressive symptoms and hippocampal volume in autosomal dominant Alzheimer's disease.
    Alzheimers Dement. 2023 Oct 14. doi: 10.1002/alz.13501.
    PubMed     Abstract available


  143. SCOYNI F, Giudice L, Vaananen MA, Downes N, et al
    Alzheimer's disease-induced phagocytic microglia express a specific profile of coding and non-coding RNAs.
    Alzheimers Dement. 2023 Oct 12. doi: 10.1002/alz.13502.
    PubMed     Abstract available


  144. LI P, Gao L, Dashti HS, Hu K, et al
    Authors' response to: A Mendelian randomization study of Alzheimer's disease and daytime napping.
    Alzheimers Dement. 2023 Oct 12. doi: 10.1002/alz.13504.
    PubMed    


  145. RAN S, Lin X, Liu B
    A Mendelian randomization study of Alzheimer's disease and daytime napping.
    Alzheimers Dement. 2023 Oct 12. doi: 10.1002/alz.13505.
    PubMed    


  146. FERRANTE FJ, Migeot J, Birba A, Amoruso L, et al
    Multivariate word properties in fluency tasks reveal markers of Alzheimer's dementia.
    Alzheimers Dement. 2023 Oct 12. doi: 10.1002/alz.13472.
    PubMed     Abstract available


  147. GAIKWAD S, Senapati S, Haque MA, Kayed R, et al
    Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: Evidence from clinical and preclinical studies.
    Alzheimers Dement. 2023 Oct 9. doi: 10.1002/alz.13490.
    PubMed     Abstract available


  148. WANG J, Sims KD, Ackley SF, Chen R, et al
    Association of cancer history with structural brain aging markers of Alzheimer's disease and related dementias risk.
    Alzheimers Dement. 2023 Oct 9. doi: 10.1002/alz.13497.
    PubMed     Abstract available


  149. NUDELMAN KNH, Jackson T, Rumbaugh M, Eloyan A, et al
    Pathogenic variants in the Longitudinal Early-onset Alzheimer's Disease Study cohort.
    Alzheimers Dement. 2023 Oct 6. doi: 10.1002/alz.13482.
    PubMed     Abstract available



  150. AAIC 2023: Discoveries propel Alzheimer's diagnosis and clinical care.
    Alzheimers Dement. 2023 Oct 3. doi: 10.1002/alz.13487.
    PubMed    


  151. BEYDOUN HA, Beydoun MA, Meirelles O, Erickson LD, et al
    Cardiovascular health, infection burden, and incident dementia in the UK Biobank.
    Alzheimers Dement. 2023;19:4475-4487.
    PubMed     Abstract available


  152. GONZALEZ-ORTIZ F, Dias A, Turton M, Magalhaes R, et al
    Preanalytical stability of plasma/serum brain-derived tau.
    Alzheimers Dement. 2023;19:4764-4770.
    PubMed     Abstract available


  153. KWON HS, Kim JY, Koh SH, Choi SH, et al
    Predicting cognitive stage transition using p-tau181, Centiloid, and other measures.
    Alzheimers Dement. 2023;19:4641-4650.
    PubMed     Abstract available


  154. WANG M, Sajobi TT, Hogan DB, Ganesh A, et al
    Expert elicitation of risk factors for progression to dementia in individuals with mild cognitive impairment.
    Alzheimers Dement. 2023;19:4542-4548.
    PubMed     Abstract available


  155. FERREIRA PCL, Therriault J, Tissot C, Ferrari-Souza JP, et al
    Plasma p-tau231 and p-tau217 inform on tau tangles aggregation in cognitively impaired individuals.
    Alzheimers Dement. 2023;19:4463-4474.
    PubMed     Abstract available


  156. LITKOWSKI EM, Logue MW, Zhang R, Charest BR, et al
    Mendelian randomization study of diabetes and dementia in the Million Veteran Program.
    Alzheimers Dement. 2023;19:4367-4376.
    PubMed     Abstract available


  157. SAMUELSSON J, Marseglia A, Lindberg O, Westman E, et al
    Associations between dietary patterns and dementia-related neuroimaging markers.
    Alzheimers Dement. 2023;19:4629-4640.
    PubMed     Abstract available


    September 2023
  158. WALKER JM, Orr ME, Orr TC, Thorn EL, et al
    Spatial proteomics of hippocampal subfield-specific pathology in Alzheimer's disease and primary age-related tauopathy.
    Alzheimers Dement. 2023 Sep 30. doi: 10.1002/alz.13484.
    PubMed     Abstract available


  159. ERASLAN BOZ H, Kocoglu K, Akkoyun M, Tufekci IY, et al
    Visual search in Alzheimer's disease and amnestic mild cognitive impairment: An eye-tracking study.
    Alzheimers Dement. 2023 Sep 29. doi: 10.1002/alz.13478.
    PubMed     Abstract available


  160. ALBALA B, Appelmans E, Burress R, De Santi S, et al
    The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partners Scientific Board (PPSB).
    Alzheimers Dement. 2023 Sep 29. doi: 10.1002/alz.13483.
    PubMed     Abstract available


  161. HEUER SE, Keezer KJ, Hewes AA, Onos KD, et al
    Control of hippocampal synaptic plasticity by microglia-dendrite interactions depends on genetic context in mouse models of Alzheimer's disease.
    Alzheimers Dement. 2023 Sep 27. doi: 10.1002/alz.13440.
    PubMed     Abstract available


  162. WAGEMANN O, Li Y, Hassenstab J, Aschenbrenner AJ, et al
    Investigation of sex differences in mutation carriers of the Dominantly Inherited Alzheimer Network.
    Alzheimers Dement. 2023 Sep 23. doi: 10.1002/alz.13460.
    PubMed     Abstract available


  163. MORRISON C, Dadar M, Collins DL
    Sex differences in risk factors, burden, and outcomes of cerebrovascular disease in Alzheimer's disease populations.
    Alzheimers Dement. 2023 Sep 21. doi: 10.1002/alz.13452.
    PubMed     Abstract available


  164. BONOMI S, Gupta MR, Schindler SE
    Inadequate reimbursement for lumbar puncture is a potential barrier to accessing new Alzheimer's disease treatments.
    Alzheimers Dement. 2023 Sep 18. doi: 10.1002/alz.13473.
    PubMed    


  165. VEITCH DP, Weiner MW, Miller M, Aisen PS, et al
    The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022.
    Alzheimers Dement. 2023 Sep 12. doi: 10.1002/alz.13449.
    PubMed     Abstract available


  166. GAUGLER JE, Borson S, Epps F, Shih RA, et al
    The intersection of social determinants of health and family care of people living with Alzheimer's disease and related dementias: A public health opportunity.
    Alzheimers Dement. 2023 Sep 12. doi: 10.1002/alz.13437.
    PubMed     Abstract available


  167. CHEN K, Gupta R, Martin-Avila A, Cui M, et al
    Anesthesia-induced hippocampal-cortical hyperactivity and tau hyperphosphorylation impair remote memory retrieval in Alzheimer's disease.
    Alzheimers Dement. 2023 Sep 11. doi: 10.1002/alz.13464.
    PubMed     Abstract available


  168. BLENNOW K, Galasko D, Perneczky R, Quevenco FC, et al
    The potential clinical value of plasma biomarkers in Alzheimer's disease.
    Alzheimers Dement. 2023 Sep 11. doi: 10.1002/alz.13455.
    PubMed     Abstract available


  169. CHO H, Mundada NS, Apostolova LG, Carrillo MC, et al
    Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS).
    Alzheimers Dement. 2023 Sep 10. doi: 10.1002/alz.13453.
    PubMed     Abstract available


  170. PELKMANS W, Shekari M, Brugulat-Serrat A, Sanchez-Benavides G, et al
    Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer's disease progression.
    Alzheimers Dement. 2023 Sep 10. doi: 10.1002/alz.13450.
    PubMed     Abstract available


  171. ASKEN BM, Wang WE, McFarland K, Arias F, et al
    Plasma Alzheimer's biomarkers and brain amyloid in Hispanic and non-Hispanic older adults.
    Alzheimers Dement. 2023 Sep 6. doi: 10.1002/alz.13456.
    PubMed     Abstract available


  172. TOSUN D, Yardibi O, Benzinger TLS, Kukull WA, et al
    Identifying individuals with non-Alzheimer's disease co-pathologies: A precision medicine approach to clinical trials in sporadic Alzheimer's disease.
    Alzheimers Dement. 2023 Sep 4. doi: 10.1002/alz.13447.
    PubMed     Abstract available


  173. WOOD KA, Han F, Ko YA, Wharton WW, et al
    Is the association between cognitive disease progression and atrial fibrillation modified by sex?
    Alzheimers Dement. 2023;19:4163-4173.
    PubMed     Abstract available


  174. LU J, Liang F, Bai P, Liu C, et al
    Blood tau-PT217 contributes to the anesthesia/surgery-induced delirium-like behavior in aged mice.
    Alzheimers Dement. 2023;19:4110-4126.
    PubMed     Abstract available


  175. WEAVER DF
    Amyloid-beta is a cytokine.
    Alzheimers Dement. 2023;19:4237-4247.
    PubMed     Abstract available


  176. ROBINSON T, Klinger H, Buckley R, Deters KD, et al
    Subjective cognitive decline across ethnoracial groups in the A4 study.
    Alzheimers Dement. 2023;19:4084-4093.
    PubMed     Abstract available


  177. QIANG YX, Deng YT, Zhang YR, Wang HF, et al
    Associations of blood cell indices and anemia with risk of incident dementia: A prospective cohort study of 313,448 participants.
    Alzheimers Dement. 2023;19:3965-3976.
    PubMed     Abstract available


  178. MATTKE S, Batie D, Chodosh J, Felten K, et al
    Expanding the use of brief cognitive assessments to detect suspected early-stage cognitive impairment in primary care.
    Alzheimers Dement. 2023;19:4252-4259.
    PubMed     Abstract available


  179. OH H, White EM, Muench U, Santostefano C, et al
    Advanced practice clinician care and end-of-life outcomes for community- and nursing home-dwelling Medicare beneficiaries with dementia.
    Alzheimers Dement. 2023;19:3946-3964.
    PubMed     Abstract available


  180. BURGDORF JG, Mroz TM, Reckrey JM, Barron Y, et al
    Prevalence and predictors of incident ADRD diagnosis following a Medicare home health episode.
    Alzheimers Dement. 2023;19:3936-3945.
    PubMed     Abstract available


  181. NASSAN M, Daghlas I, Piras IS, Rogalski E, et al
    Evaluating the association between genetically proxied ACE inhibition and dementias.
    Alzheimers Dement. 2023;19:3894-3901.
    PubMed     Abstract available


  182. JUTKOWITZ E, Pizzi LT, Shewmaker P, Alarid-Escudero F, et al
    Cost effectiveness of non-drug interventions that reduce nursing home admissions for people living with dementia.
    Alzheimers Dement. 2023;19:3867-3893.
    PubMed     Abstract available


  183. SINGH NA, Martin PR, Graff-Radford J, Machulda MM, et al
    APOE epsilon4 influences within and between network functional connectivity in posterior cortical atrophy and logopenic progressive aphasia.
    Alzheimers Dement. 2023;19:3858-3866.
    PubMed     Abstract available


  184. COCHRAN JN, Acosta-Uribe J, Esposito BT, Madrigal L, et al
    Genetic associations with age at dementia onset in the PSEN1 E280A Colombian kindred.
    Alzheimers Dement. 2023;19:3835-3847.
    PubMed     Abstract available


  185. BELLAVER B, Puig-Pijoan A, Ferrari-Souza JP, Leffa DT, et al
    Blood-brain barrier integrity impacts the use of plasma amyloid-beta as a proxy of brain amyloid-beta pathology.
    Alzheimers Dement. 2023;19:3815-3825.
    PubMed     Abstract available


  186. BAXTER LC, Limback-Stokin M, Patten KJ, Arreola AC, et al
    Hippocampal connectivity and memory decline in cognitively intact APOE epsilon4 carriers.
    Alzheimers Dement. 2023;19:3806-3814.
    PubMed     Abstract available


    August 2023
  187. WINCHESTER LM, Harshfield EL, Shi L, Badhwar A, et al
    Artificial intelligence for biomarker discovery in Alzheimer's disease and dementia.
    Alzheimers Dement. 2023 Aug 31. doi: 10.1002/alz.13390.
    PubMed     Abstract available


  188. BUSHNELL J, Hammers DB, Aisen P, Dage JL, et al
    Influence of amyloid and diagnostic syndrome on non-traditional memory scores in early-onset Alzheimer's disease.
    Alzheimers Dement. 2023 Aug 31. doi: 10.1002/alz.13434.
    PubMed     Abstract available


  189. HARTLEY SL, Handen B, Tudorascu D, Lee L, et al
    AT(N) biomarker profiles and Alzheimer's disease symptomology in Down syndrome.
    Alzheimers Dement. 2023 Aug 28. doi: 10.1002/alz.13446.
    PubMed     Abstract available


  190. GILLESPIE NA, Elman JA, McKenzie RE, Tu XM, et al
    The heritability of blood-based biomarkers related to risk of Alzheimer's disease in a population-based sample of early old-age men.
    Alzheimers Dement. 2023 Aug 25. doi: 10.1002/alz.13407.
    PubMed     Abstract available


  191. PULVER RL, Kronberg E, Medenblik LM, Kheyfets VO, et al
    Mapping sleep's oscillatory events as a biomarker of Alzheimer's disease.
    Alzheimers Dement. 2023 Aug 23. doi: 10.1002/alz.13420.
    PubMed     Abstract available


  192. ECHEVARRIA-COOPER SL, Ho EH, Gershon RC, Weintraub S, et al
    Evaluation of the NIH Toolbox Odor Identification Test across normal cognition, amnestic mild cognitive impairment, and dementia due to Alzheimer's disease.
    Alzheimers Dement. 2023 Aug 21. doi: 10.1002/alz.13426.
    PubMed     Abstract available


  193. MIRANDA A, Rubovits E, Mudar R, Leung V, et al
    Where are caregivers in the clinical trial? Evaluation of caregiver responsibilities in Alzheimer's disease and related dementias clinical trials.
    Alzheimers Dement. 2023 Aug 18. doi: 10.1002/alz.13418.
    PubMed     Abstract available


  194. TEJEDA M, Farrell J, Zhu C, Wetzler L, et al
    DNA from multiple viral species is associated with Alzheimer's disease risk.
    Alzheimers Dement. 2023 Aug 14. doi: 10.1002/alz.13414.
    PubMed     Abstract available


  195. STRAIN JF, Phuah CL, Adeyemo B, Cheng K, et al
    White matter hyperintensity longitudinal morphometric analysis in association with Alzheimer disease.
    Alzheimers Dement. 2023 Aug 10. doi: 10.1002/alz.13377.
    PubMed     Abstract available


  196. PYUN JM, Park YH, Wang J, Bennett DA, et al
    Transcriptional risk scores in Alzheimer's disease: From pathology to cognition.
    Alzheimers Dement. 2023 Aug 10. doi: 10.1002/alz.13406.
    PubMed     Abstract available


  197. TIAN Q, Bilgel M, Walker KA, Moghekar AR, et al
    Skeletal muscle mitochondrial function predicts cognitive impairment and is associated with biomarkers of Alzheimer's disease and neurodegeneration.
    Alzheimers Dement. 2023 Aug 2. doi: 10.1002/alz.13388.
    PubMed     Abstract available


  198. PILOTTO A, Bongianni M, Tirloni C, Galli A, et al
    CSF alpha-synuclein aggregates by seed amplification and clinical presentation of AD.
    Alzheimers Dement. 2023;19:3754-3759.
    PubMed     Abstract available


  199. KOPEC RE, Chasman DI, Okereke OI, Sesso HD, et al
    Re-remembering the influence of randomized beta-carotene on cognitive decline.
    Alzheimers Dement. 2023;19:3718-3721.
    PubMed     Abstract available


  200. LOIZOS M, Zhu CW, Akrivos J, Sewell M, et al
    Evaluating memory testing to distinguish dementia severity among White, Black, and Spanish-speaking individuals in the Uniform Data Set (UDS).
    Alzheimers Dement. 2023;19:3625-3634.
    PubMed     Abstract available


  201. ESTEPP TG, Charnigo RJ, Abner EL, Jicha GA, et al
    Associations of potential ADRD plasma biomarkers in cognitively normal volunteers.
    Alzheimers Dement. 2023;19:3593-3601.
    PubMed     Abstract available


  202. BABULAL GM, Zhu Y, Trani JF
    Racial and ethnic differences in neuropsychiatric symptoms and progression to incident cognitive impairment among community-dwelling participants.
    Alzheimers Dement. 2023;19:3635-3643.
    PubMed     Abstract available


  203. WOLZAK K, Vermunt L, Campo MD, Jorge-Oliva M, et al
    Protein disulfide isomerases as CSF biomarkers for the neuronal response to tau pathology.
    Alzheimers Dement. 2023;19:3563-3574.
    PubMed     Abstract available


  204. NISENBAUM L, Martone R, Chen T, Rajagovindan R, et al
    CSF biomarker concordance with amyloid PET in Phase 3 studies of aducanumab.
    Alzheimers Dement. 2023;19:3379-3388.
    PubMed     Abstract available


  205. SNYDER A, Grant H, Chou A, Lindbergh CA, et al
    Immune cell counts in cerebrospinal fluid predict cognitive function in aging and neurodegenerative disease.
    Alzheimers Dement. 2023;19:3339-3349.
    PubMed     Abstract available


    July 2023
  206. WANG ZB, Tan L, Gao PY, Ma YH, et al
    Associations of the A/T/N profiles in PET, CSF, and plasma biomarkers with Alzheimer's disease neuropathology at autopsy.
    Alzheimers Dement. 2023 Jul 28. doi: 10.1002/alz.13413.
    PubMed     Abstract available


  207. VAN DER SCHAAR J, Visser LNC, Ket JCF, Groot C, et al
    Impact of sharing Alzheimer's disease biomarkers with individuals without dementia: A systematic review and meta-analysis of empirical data.
    Alzheimers Dement. 2023 Jul 26. doi: 10.1002/alz.13410.
    PubMed     Abstract available


  208. NEMES S, Logan PE, Manchella MK, Mundada NS, et al
    Sex and APOE epsilon4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's disease.
    Alzheimers Dement. 2023 Jul 26. doi: 10.1002/alz.13403.
    PubMed     Abstract available


  209. LIAO Y, Wang Y, Tao QQ, Yang C, et al
    CALHM2 V136G polymorphism reduces astrocytic ATP release and is associated with depressive symptoms and Alzheimer's disease risk.
    Alzheimers Dement. 2023 Jul 26. doi: 10.1002/alz.13366.
    PubMed     Abstract available


  210. BROOKE B, Lidan Z, Scherazad K, Jane AK, et al
    Sex and gender differences in risk scores for dementia and Alzheimer's disease among cisgender, transgender, and non-binary adults.
    Alzheimers Dement. 2023 Jul 26. doi: 10.1002/alz.13317.
    PubMed     Abstract available


  211. DAGE JL, Eloyan A, Thangarajah M, Hammers DB, et al
    Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease Study.
    Alzheimers Dement. 2023 Jul 25. doi: 10.1002/alz.13399.
    PubMed     Abstract available


  212. ELOYAN A, Thangarajah M, An N, Borowski BJ, et al
    White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS).
    Alzheimers Dement. 2023 Jul 25. doi: 10.1002/alz.13402.
    PubMed     Abstract available


  213. SINTINI I, Graff-Radford J, Schwarz CG, Machulda MM, et al
    Longitudinal rates of atrophy and tau accumulation differ between the visual and language variants of atypical Alzheimer's disease.
    Alzheimers Dement. 2023 Jul 23. doi: 10.1002/alz.13396.
    PubMed     Abstract available


  214. YU SP, Jiang M, Berglund K, Wei L, et al
    Strain hypothesis and additional evidence of the GluN3A deficiency-mediated pathogenesis of Alzheimer's disease.
    Alzheimers Dement. 2023 Jul 23. doi: 10.1002/alz.13374.
    PubMed     Abstract available


  215. GOLLAN TH, Garcia DL, Stasenko A, Murillo M, et al
    The MINT Sprint 2.0: A picture naming test for detection of naming impairments in Alzheimer's disease and in preclinical AD.
    Alzheimers Dement. 2023 Jul 19. doi: 10.1002/alz.13381.
    PubMed     Abstract available


  216. DAS S, Li Z, Wachter A, Alla S, et al
    Distinct transcriptomic responses to Abeta plaques, neurofibrillary tangles, and APOE in Alzheimer's disease.
    Alzheimers Dement. 2023 Jul 17. doi: 10.1002/alz.13387.
    PubMed     Abstract available


  217. DHANA K, Beck T, Desai P, Wilson RS, et al
    Prevalence of Alzheimer's disease dementia in the 50 US states and 3142 counties: A population estimate using the 2020 bridged-race postcensal from the National Center for Health Statistics.
    Alzheimers Dement. 2023 Jul 17. doi: 10.1002/alz.13081.
    PubMed     Abstract available


  218. RAHMAN-FILIPIAK A, Bolton C, Grill JD, Rostamzadeh A, et al
    Biomarker disclosure protocols in prodromal Alzheimer's disease clinical trials.
    Alzheimers Dement. 2023 Jul 14. doi: 10.1002/alz.13380.
    PubMed     Abstract available


  219. SLEIMAN PM, Qu HQ, Connolly JJ, Mentch F, et al
    Trans-ethnic genomic informed risk assessment for Alzheimer's disease: An International Hundred K+ Cohorts Consortium study.
    Alzheimers Dement. 2023 Jul 14. doi: 10.1002/alz.13378.
    PubMed     Abstract available


  220. GARNIER-CRUSSARD A, Chetelat G
    White matter hyperintensities in Alzheimer's disease: Beyond (but not instead of) the vascular contribution.
    Alzheimers Dement. 2023 Jul 12. doi: 10.1002/alz.13372.
    PubMed    


  221. BRICKMAN AM, Rizvi B
    White matter hyperintensities and Alzheimer's disease: An alternative view of an alternative hypothesis.
    Alzheimers Dement. 2023 Jul 12. doi: 10.1002/alz.13371.
    PubMed    


  222. KRISHNAMURTHY S, Rollin FG
    We must be clear that the root cause of racial disparities in Alzheimer's disease is racism.
    Alzheimers Dement. 2023 Jul 12. doi: 10.1002/alz.13389.
    PubMed    


  223. VINZE S, Chodosh J, Lee M, Wright J, et al
    The national public health response to Alzheimer's disease and related dementias: Origins, evolution, and recommendations to improve early detection.
    Alzheimers Dement. 2023 Jul 12. doi: 10.1002/alz.13376.
    PubMed     Abstract available


  224. CHOUDHURY P, Zhang N, Adler CH, Chen K, et al
    Longitudinal motor decline in dementia with Lewy bodies, Parkinson disease dementia, and Alzheimer's dementia in a community autopsy cohort.
    Alzheimers Dement. 2023 Jul 8. doi: 10.1002/alz.13357.
    PubMed     Abstract available


  225. BAE J, Logan PE, Acri DJ, Bharthur A, et al
    A simulative deep learning model of SNP interactions on chromosome 19 for predicting Alzheimer's disease risk and rates of disease progression.
    Alzheimers Dement. 2023 Jul 6. doi: 10.1002/alz.13319.
    PubMed     Abstract available


  226. WANG K, Tang W, Hao X, Zhao J, et al
    Ultra-processed food consumption and risk of dementia and Alzheimer's disease: Long-term results from the Framingham Offspring Study.
    Alzheimers Dement. 2023 Jul 3. doi: 10.1002/alz.13351.
    PubMed     Abstract available


  227. DONAGHY PC, Carrarini C, Ferreira D, Habich A, et al
    Research diagnostic criteria for mild cognitive impairment with Lewy bodies: A systematic review and meta-analysis.
    Alzheimers Dement. 2023;19:3186-3202.
    PubMed     Abstract available


  228. WALKER JM, Goette W, Farrell K, Iida MA, et al
    The relationship between hippocampal amyloid beta burden and spatial distribution of neurofibrillary degeneration.
    Alzheimers Dement. 2023;19:3158-3170.
    PubMed     Abstract available


  229. VASILJEVIC E, Koscik RL, Jonaitis E, Betthauser T, et al
    Cognitive trajectories diverge by genetic risk in a preclinical longitudinal cohort.
    Alzheimers Dement. 2023;19:3108-3118.
    PubMed     Abstract available


  230. ORTEGA-CRUZ D, Uceda-Heras A, Iglesias JE, Zea-Sevilla MA, et al
    A novel histological staging of hippocampal sclerosis that is evident in gray matter loss in vivo.
    Alzheimers Dement. 2023;19:3028-3040.
    PubMed     Abstract available


  231. LAUKKA EJ, Ekstrom I, Larsson M, Grande G, et al
    Markers of olfactory dysfunction and progression to dementia: A 12-year population-based study.
    Alzheimers Dement. 2023;19:3019-3027.
    PubMed     Abstract available


  232. PHONGPREECHA T, Cholerton B, Bukhari S, Chang AL, et al
    Prediction of neuropathologic lesions from clinical data.
    Alzheimers Dement. 2023;19:3005-3018.
    PubMed     Abstract available


  233. LEUZY A, Mattsson-Carlgren N, Cullen NC, Stomrud E, et al
    Robustness of CSF Abeta42/40 and Abeta42/P-tau181 measured using fully automated immunoassays to detect AD-related outcomes.
    Alzheimers Dement. 2023;19:2994-3004.
    PubMed     Abstract available


  234. SALVADO G, Larsson V, Cody KA, Cullen NC, et al
    Optimal combinations of CSF biomarkers for predicting cognitive decline and clinical conversion in cognitively unimpaired participants and mild cognitive impairment patients: A multi-cohort study.
    Alzheimers Dement. 2023;19:2943-2955.
    PubMed     Abstract available


  235. PILLAI JA, Bena J, Maly EF, Leverenz JB, et al
    Initial non-amnestic symptoms relate to faster rate of functional and cognitive decline compared to amnestic symptoms in neuropathologically confirmed dementias.
    Alzheimers Dement. 2023;19:2956-2965.
    PubMed     Abstract available


  236. DUBBELMAN MA, Sikkes SAM, Ebenau JL, van Leeuwenstijn MSSA, et al
    Changes in self- and study partner-perceived cognitive functioning in relation to amyloid status and future clinical progression: Findings from the SCIENCe project.
    Alzheimers Dement. 2023;19:2933-2942.
    PubMed     Abstract available


  237. PERNA L, Mons U, Stocker H, Beyer L, et al
    High cholesterol levels change the association of biomarkers of neurodegenerative diseases with dementia risk: Findings from a population-based cohort.
    Alzheimers Dement. 2023;19:2913-2922.
    PubMed     Abstract available


  238. RAJBANSHI B, Guruacharya A, Mandell JW, Bloom GS, et al
    Localization, induction, and cellular effects of tau phosphorylated at threonine 217.
    Alzheimers Dement. 2023;19:2874-2887.
    PubMed     Abstract available


  239. ZHANG M, Ganz AB, Rohde S, Rozemuller AJM, et al
    Resilience and resistance to the accumulation of amyloid plaques and neurofibrillary tangles in centenarians: An age-continuous perspective.
    Alzheimers Dement. 2023;19:2831-2841.
    PubMed     Abstract available


  240. GOMEZ-TORTOSA E, Baradaran-Heravi Y, Dillen L, Choudhury NR, et al
    TRIM25 mutation (p.C168*), coding for an E3 ubiquitin ligase, is a cause of early-onset autosomal dominant dementia with amyloid load and parkinsonism.
    Alzheimers Dement. 2023;19:2805-2815.
    PubMed     Abstract available


  241. WANG S, Wang J, Dove A, Guo J, et al
    Association of impaired kidney function with dementia and brain pathologies: A community-based cohort study.
    Alzheimers Dement. 2023;19:2765-2773.
    PubMed     Abstract available


    June 2023
  242. RAY NR, Ayodele T, Jean-Francois M, Baez P, et al
    The Early-Onset Alzheimer's Disease Whole-Genome Sequencing Project: Study design and methodology.
    Alzheimers Dement. 2023 Jun 30. doi: 10.1002/alz.13370.
    PubMed     Abstract available


  243. GRIFFIN P, Apostolova L, Dickerson BC, Rabinovici G, et al
    Developments in understanding early onset Alzheimer's disease.
    Alzheimers Dement. 2023 Jun 30. doi: 10.1002/alz.13353.
    PubMed     Abstract available


  244. MARQUINE MJ, Parks A, Perales-Puchalt J, Gonzalez DA, et al
    Demographically-adjusted normative data among Latinos for the version 3 of the Alzheimer's Disease Centers' Neuropsychological Test Battery in the Uniform Data Set.
    Alzheimers Dement. 2023 Jun 25. doi: 10.1002/alz.13313.
    PubMed     Abstract available


  245. BOLLACK A, Pemberton HG, Collij LE, Markiewicz P, et al
    Longitudinal amyloid and tau PET imaging in Alzheimer's disease: A systematic review of methodologies and factors affecting quantification.
    Alzheimers Dement. 2023 Jun 12. doi: 10.1002/alz.13158.
    PubMed     Abstract available


  246. YAKOUB Y, Ashton NJ, Strikwerda-Brown C, Montoliu-Gaya L, et al
    Longitudinal blood biomarker trajectories in preclinical Alzheimer's disease.
    Alzheimers Dement. 2023 Jun 9. doi: 10.1002/alz.13318.
    PubMed     Abstract available


  247. POLSINELLI AJ, Wonderlin RJ, Hammers DB, Garcia AP, et al
    Baseline neuropsychiatric symptoms and psychotropic medication use midway through data collection of the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort.
    Alzheimers Dement. 2023 Jun 9. doi: 10.1002/alz.13344.
    PubMed     Abstract available


  248. LATHE R, Schultek NM, Balin BJ, Ehrlich GD, et al
    Establishment of a consensus protocol to explore the brain pathobiome in patients with mild cognitive impairment and Alzheimer's disease: Research outline and call for collaboration: Research outline and call for collaboration.
    Alzheimers Dement. 2023 Jun 7. doi: 10.1002/alz.13076.
    PubMed     Abstract available


  249. VILA-CASTELAR C, Chen Y, Langella S, Lopera F, et al
    Sex differences in blood biomarkers and cognitive performance in individuals with autosomal dominant Alzheimer's disease.
    Alzheimers Dement. 2023 Jun 6. doi: 10.1002/alz.13314.
    PubMed     Abstract available


  250. MATTKE S, Loh WK, Yuen KH, Yoong J, et al
    Preparedness of China's health care system to provide access to a disease-modifying Alzheimer's treatment.
    Alzheimers Dement. 2023 Jun 6. doi: 10.1002/alz.13348.
    PubMed     Abstract available


  251. KNAPSKOG AB, Aksnes M, Edwin TH, Ueland PM, et al
    Higher concentrations of kynurenic acid in CSF are associated with the slower clinical progression of Alzheimer's disease.
    Alzheimers Dement. 2023 Jun 2. doi: 10.1002/alz.13162.
    PubMed     Abstract available


  252. KRONIMUS Y, Albus A, Hasenberg M, Walkenfort B, et al
    Fc N-glycosylation of autoreactive Abeta antibodies as a blood-based biomarker for Alzheimer's disease.
    Alzheimers Dement. 2023 Jun 1. doi: 10.1002/alz.13124.
    PubMed     Abstract available


  253. LI D, Farrell JJ, Mez J, Martin ER, et al
    Novel loci for Alzheimer's disease identified by a genome-wide association study in Ashkenazi Jews.
    Alzheimers Dement. 2023 Jun 1. doi: 10.1002/alz.13117.
    PubMed     Abstract available


  254. COLEMAN ME, Roessler MEH, Peng S, Roth AR, et al
    Social enrichment on the job: Complex work with people improves episodic memory, promotes brain reserve, and reduces the risk of dementia.
    Alzheimers Dement. 2023;19:2655-2665.
    PubMed     Abstract available


  255. KLOSKE CM, Barnum CJ, Batista AF, Bradshaw EM, et al
    APOE and immunity: Research highlights.
    Alzheimers Dement. 2023;19:2677-2696.
    PubMed     Abstract available


  256. THANAPORNSANGSUTH P, Booncharoen K, Luechaipanit W, Supharatpariyakorn T, et al
    Prospective evaluation of plasma phosphorylated tau in a real-life memory clinic in Thailand.
    Alzheimers Dement. 2023;19:2745-2749.
    PubMed     Abstract available


  257. HRAST B, Khachatryan E, Suput D, Van Hulle MM, et al
    Effects of risk factors on longitudinal changes in brain structure and function in the progression of AD.
    Alzheimers Dement. 2023;19:2666-2676.
    PubMed     Abstract available


  258. LEHMANN S, Schraen-Maschke S, Vidal JS, Allinquant B, et al
    Plasma Abeta42/Abeta40 ratio is independent of renal function.
    Alzheimers Dement. 2023;19:2737-2739.
    PubMed    


  259. PETERSEN RC, Aisen PS, Andrews JS, Atri A, et al
    Expectations and clinical meaningfulness of randomized controlled trials.
    Alzheimers Dement. 2023;19:2730-2736.
    PubMed     Abstract available


  260. KING D, Holt K, Toombs J, He X, et al
    Synaptic resilience is associated with maintained cognition during ageing.
    Alzheimers Dement. 2023;19:2560-2574.
    PubMed     Abstract available


  261. THORWALD MA, Silva J, Head E, Finch CE, et al
    Amyloid futures in the expanding pathology of brain aging and dementia.
    Alzheimers Dement. 2023;19:2605-2617.
    PubMed     Abstract available


  262. SMITH R, Cullen NC, Pichet Binette A, Leuzy A, et al
    Tau-PET is superior to phospho-tau when predicting cognitive decline in symptomatic AD patients.
    Alzheimers Dement. 2023;19:2497-2507.
    PubMed     Abstract available


  263. NICHOLS E, Brickman AM, Casaletto KB, Dams-O'Connor K, et al
    AD and non-AD mediators of the pathway between the APOE genotype and cognition.
    Alzheimers Dement. 2023;19:2508-2519.
    PubMed     Abstract available


  264. ADHIKARI UK, Khan R, Mikhael M, Balez R, et al
    Therapeutic anti-amyloid beta antibodies cause neuronal disturbances.
    Alzheimers Dement. 2023;19:2479-2496.
    PubMed     Abstract available


  265. LAN G, Li A, Liu Z, Ma S, et al
    Presynaptic membrane protein dysfunction occurs prior to neurodegeneration and predicts faster cognitive decline.
    Alzheimers Dement. 2023;19:2408-2419.
    PubMed     Abstract available


  266. COLLIJ LE, Salvado G, de Wilde A, Altomare D, et al
    Quantification of [(18) F]florbetaben amyloid-PET imaging in a mixed memory clinic population: The ABIDE project.
    Alzheimers Dement. 2023;19:2397-2407.
    PubMed     Abstract available


  267. LUSK JB, Ford C, Clark AG, Greiner MA, et al
    Racial/ethnic disparities in dementia incidence, outcomes, and health-care utilization.
    Alzheimers Dement. 2023;19:2376-2388.
    PubMed     Abstract available


  268. GONCALVES RA, Sudo FK, Lourenco MV, Drummond C, et al
    Cerebrospinal fluid irisin and lipoxin A4 are reduced in elderly Brazilian individuals with depression: Insight into shared mechanisms between depression and dementia.
    Alzheimers Dement. 2023;19:2595-2604.
    PubMed     Abstract available


  269. SADAGHIANI S, Trotman W, Lim SA, Chung E, et al
    Associations of phosphorylated tau pathology with whole-hemisphere ex vivo morphometry in 7 tesla MRI.
    Alzheimers Dement. 2023;19:2355-2364.
    PubMed     Abstract available


  270. LESPINASSE J, Chene G, Mangin JF, Dubois B, et al
    Associations among hypertension, dementia biomarkers, and cognition: The MEMENTO cohort.
    Alzheimers Dement. 2023;19:2332-2342.
    PubMed     Abstract available


  271. SUCHY-DICEY A, Su Y, Buchwald DS, Manson SM, et al
    Volume atrophy in medial temporal cortex and verbal memory scores in American Indians: Data from the Strong Heart Study.
    Alzheimers Dement. 2023;19:2298-2306.
    PubMed     Abstract available


    May 2023
  272. HAMMERS DB, Eloyan A, Taurone A, Thangarajah M, et al
    Profiling baseline performance on the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collection.
    Alzheimers Dement. 2023 May 31. doi: 10.1002/alz.13160.
    PubMed     Abstract available


  273. LUTZ MW, Chiba-Falek O
    Bioinformatics pipeline to guide post-GWAS studies in Alzheimer's: A new catalogue of disease candidate short structural variants.
    Alzheimers Dement. 2023 May 30. doi: 10.1002/alz.13168.
    PubMed     Abstract available


  274. HAMMERS DB, Nemes S, Diedrich T, Eloyan A, et al
    Learning slopes in early-onset Alzheimer's disease.
    Alzheimers Dement. 2023 May 27. doi: 10.1002/alz.13159.
    PubMed     Abstract available


  275. HUBER H, Ashton NJ, Schieren A, Montoliu-Gaya L, et al
    Levels of Alzheimer's disease blood biomarkers are altered after food intake-A pilot intervention study in healthy adults.
    Alzheimers Dement. 2023 May 27. doi: 10.1002/alz.13163.
    PubMed     Abstract available


  276. SAITO Y, Kamagata K, Uchida W, Takabayashi K, et al
    The partial volume effect of choroid plexus in pathogenesis of Alzheimer's disease.
    Alzheimers Dement. 2023 May 26. doi: 10.1002/alz.13123.
    PubMed    


  277. STERN AM
    Anti-dementia bias and Medicare regulation of Alzheimer's disease care.
    Alzheimers Dement. 2023 May 24. doi: 10.1002/alz.13166.
    PubMed    


  278. WIESE LAK, Gibson A, Guest MA, Nelson AR, et al
    Global rural health disparities in Alzheimer's disease and related dementias: State of the science.
    Alzheimers Dement. 2023 May 23. doi: 10.1002/alz.13104.
    PubMed     Abstract available


  279. WANG J, Chen M, Masters CL, Wang YJ, et al
    Translating blood biomarkers into clinical practice for Alzheimer's disease: Challenges and perspectives.
    Alzheimers Dement. 2023 May 23. doi: 10.1002/alz.13116.
    PubMed     Abstract available


  280. PANYARD DJ, McKetney J, Deming YK, Morrow AR, et al
    Large-scale proteome and metabolome analysis of CSF implicates altered glucose and carbon metabolism and succinylcarnitine in Alzheimer's disease.
    Alzheimers Dement. 2023 May 22. doi: 10.1002/alz.13130.
    PubMed     Abstract available


  281. BILGEL M, An Y, Walker KA, Moghekar AR, et al
    Longitudinal changes in Alzheimer's-related plasma biomarkers and brain amyloid.
    Alzheimers Dement. 2023 May 22. doi: 10.1002/alz.13157.
    PubMed     Abstract available


  282. BYFIELD G, Starks TD, Luther R, Edwards CL, et al
    Leveraging African American family connectors for Alzheimer's disease genomic studies.
    Alzheimers Dement. 2023 May 22. doi: 10.1002/alz.13106.
    PubMed     Abstract available


  283. BODART-SANTOS V, Pinheiro LS, da Silva-Junior AJ, Froza RL, et al
    Alzheimer's disease brain-derived extracellular vesicles reveal altered synapse-related proteome and induce cognitive impairment in mice.
    Alzheimers Dement. 2023 May 19. doi: 10.1002/alz.13134.
    PubMed     Abstract available


  284. PEROVNIK M, Tang CC, Namias M, Eidelberg D, et al
    Longitudinal changes in metabolic network activity in early Alzheimer's disease.
    Alzheimers Dement. 2023 May 19. doi: 10.1002/alz.13137.
    PubMed     Abstract available


  285. LI M, Li Y, Schindler SE, Yen D, et al
    Design and feasibility of an Alzheimer's disease blood test study in a diverse community-based population.
    Alzheimers Dement. 2023 May 19. doi: 10.1002/alz.13125.
    PubMed     Abstract available


  286. KARMARKAR AM, Roy I, Rivera-Hernandez M, Shaibi S, et al
    Examining the role of race and quality of home health agencies in delayed initiation of home health services for individuals with Alzheimer's disease and related dementias (ADRD).
    Alzheimers Dement. 2023 May 19. doi: 10.1002/alz.13139.
    PubMed     Abstract available


  287. EVANS CD, Sparks J, Andersen SW, Brooks DA, et al
    APOE epsilon4's impact on response to amyloid therapies in early symptomatic Alzheimer's disease: Analyses from multiple clinical trials.
    Alzheimers Dement. 2023 May 19. doi: 10.1002/alz.13128.
    PubMed     Abstract available


  288. LANGBAUM JB, Maloney E, Hennessy M, Harkins K, et al
    How intention to join an Alzheimer's participant recruitment registry differs by race, ethnicity, sex, and family history: Results from a national survey of US adults.
    Alzheimers Dement. 2023 May 19. doi: 10.1002/alz.13126.
    PubMed     Abstract available


  289. TUMURBAATAR B, Fracassi A, Scaduto P, Guptarak J, et al
    Preserved autophagy in cognitively intact non-demented individuals with Alzheimer's neuropathology.
    Alzheimers Dement. 2023 May 16. doi: 10.1002/alz.13074.
    PubMed     Abstract available


  290. CHUNG J, Sahelijo N, Maruyama T, Hu J, et al
    Alzheimer's disease heterogeneity explained by polygenic risk scores derived from brain transcriptomic profiles.
    Alzheimers Dement. 2023 May 11. doi: 10.1002/alz.13069.
    PubMed     Abstract available


  291. SHULMAN D, Dubnov S, Zorbaz T, Madrer N, et al
    Sex-specific declines in cholinergic-targeting tRNA fragments in the nucleus accumbens in Alzheimer's disease.
    Alzheimers Dement. 2023 May 9. doi: 10.1002/alz.13095.
    PubMed     Abstract available


  292. D'ALESSANDRO A, Lukens JR, Zimring JC
    The role of PIMT in Alzheimer's disease pathogenesis: A novel hypothesis.
    Alzheimers Dement. 2023 May 8. doi: 10.1002/alz.13115.
    PubMed     Abstract available


  293. QUINNEY SK, Murugesh K, Oblak A, Onos KD, et al
    STOP-AD portal: Selecting the optimal pharmaceutical for preclinical drug testing in Alzheimer's disease.
    Alzheimers Dement. 2023 May 8. doi: 10.1002/alz.13108.
    PubMed     Abstract available


  294. MILLER MR, Lee YF, Kastanenka KV
    Calcium sensor Yellow Cameleon 3.6 as a tool to support the calcium hypothesis of Alzheimer's disease.
    Alzheimers Dement. 2023 May 8. doi: 10.1002/alz.13111.
    PubMed     Abstract available


  295. WEBBER EK, Fivaz M, Stutzmann GE, Griffioen G, et al
    Cytosolic calcium: Judge, jury and executioner of neurodegeneration in Alzheimer's disease and beyond.
    Alzheimers Dement. 2023 May 3. doi: 10.1002/alz.13065.
    PubMed     Abstract available


  296. REAS ET, Shadrin A, Frei O, Motazedi E, et al
    Improved multimodal prediction of progression from MCI to Alzheimer's disease combining genetics with quantitative brain MRI and cognitive measures.
    Alzheimers Dement. 2023 May 2. doi: 10.1002/alz.13112.
    PubMed     Abstract available


  297. VASUNILASHORN SM, Lunardi N, Newman JC, Crosby G, et al
    Preclinical and translational models for delirium: Recommendations for future research from the NIDUS delirium network.
    Alzheimers Dement. 2023;19:2150-2174.
    PubMed     Abstract available


  298. DALY T
    Amyloid PET-assisted diagnosis and improved outcomes: Biomarkering or biomarketing?
    Alzheimers Dement. 2023;19:2211.
    PubMed    


  299. POLSINELLI AJ, Lane KA, Manchella MK, Logan PE, et al
    APOE epsilon4 is associated with earlier symptom onset in LOAD but later symptom onset in EOAD.
    Alzheimers Dement. 2023;19:2212-2217.
    PubMed     Abstract available


  300. WOLFF JL, DesRoches CM, Amjad H, Burgdorf JG, et al
    Catalyzing dementia care through the learning health system and consumer health information technology.
    Alzheimers Dement. 2023;19:2197-2207.
    PubMed     Abstract available


  301. JONSDOTTIR MK, Harrison J, Hannesdottir KI
    The ambivalence toward neuropsychology in dementia research, diagnosis, and drug development: Myths and misconceptions.
    Alzheimers Dement. 2023;19:2175-2181.
    PubMed     Abstract available


  302. KISBY GE, Oakes H, Beckett D, Spencer PS, et al
    MGMT, a risk factor for both genetic and environmental forms of dementia.
    Alzheimers Dement. 2023;19:2208-2210.
    PubMed     Abstract available


  303. VAN MAURIK IS, Broulikova HM, Mank A, Bakker ED, et al
    A more precise diagnosis by means of amyloid PET contributes to delayed institutionalization, lower mortality, and reduced care costs in a tertiary memory clinic setting.
    Alzheimers Dement. 2023;19:2006-2013.
    PubMed     Abstract available


  304. POLSTERL S, Wachinger C
    Identification of causal effects of neuroanatomy on cognitive decline requires modeling unobserved confounders.
    Alzheimers Dement. 2023;19:1994-2005.
    PubMed     Abstract available


  305. ASHTON NJ, Puig-Pijoan A, Mila-Aloma M, Fernandez-Lebrero A, et al
    Plasma and CSF biomarkers in a memory clinic: Head-to-head comparison of phosphorylated tau immunoassays.
    Alzheimers Dement. 2023;19:1913-1924.
    PubMed     Abstract available


  306. WORTHA SM, Frenzel S, Bahls M, Habes M, et al
    Association of spermidine plasma levels with brain aging in a population-based study.
    Alzheimers Dement. 2023;19:1832-1840.
    PubMed     Abstract available


  307. SWADDIWUDHIPONG N, Whiteside DJ, Hezemans FH, Street D, et al
    Pre-diagnostic cognitive and functional impairment in multiple sporadic neurodegenerative diseases.
    Alzheimers Dement. 2023;19:1752-1763.
    PubMed     Abstract available


  308. KLEINEIDAM L, Wagner M, Guski J, Wolfsgruber S, et al
    Disentangling the relationship of subjective cognitive decline and depressive symptoms in the development of cognitive decline and dementia.
    Alzheimers Dement. 2023;19:2056-2068.
    PubMed     Abstract available


    April 2023
  309. DINESH D, Shao Q, Palnati M, McDannold S, et al
    The epidemiology of mild cognitive impairment, Alzheimer's disease and related dementia in U.S. veterans.
    Alzheimers Dement. 2023 Apr 28. doi: 10.1002/alz.13071.
    PubMed     Abstract available


  310. MGAIETH F, Baksh RA, Startin CM, Hamburg S, et al
    Exploring semantic verbal fluency patterns and their relationship to age and Alzheimer's disease in adults with Down syndrome.
    Alzheimers Dement. 2023 Apr 28. doi: 10.1002/alz.13097.
    PubMed     Abstract available


  311. XIAO C, Pappas I, Aksman LM, O'Bryant SE, et al
    Comparison of genetic and health risk factors for mild cognitive impairment and Alzheimer's disease between Hispanic and non-Hispanic white participants.
    Alzheimers Dement. 2023 Apr 27. doi: 10.1002/alz.13110.
    PubMed     Abstract available


  312. ADHIKARI S, Qiao Y, Singer M, Sagare A, et al
    Retinotopic degeneration of the retina and optic tracts in autosomal dominant Alzheimer's disease.
    Alzheimers Dement. 2023 Apr 27. doi: 10.1002/alz.13100.
    PubMed     Abstract available


  313. OECKL P, Janelidze S, Halbgebauer S, Stomrud E, et al
    Higher plasma beta-synuclein indicates early synaptic degeneration in Alzheimer's disease.
    Alzheimers Dement. 2023 Apr 27. doi: 10.1002/alz.13103.
    PubMed     Abstract available


  314. XU Y, Aung HL, Bateman RJ, Brooks WS, et al
    Higher systolic blood pressure in early-mid adulthood is associated with poorer cognitive performance in those with a dominantly inherited Alzheimer's disease mutation but not in non-carriers. Results from the DIAN study.
    Alzheimers Dement. 2023 Apr 23. doi: 10.1002/alz.13082.
    PubMed     Abstract available


  315. IMBIMBO BP, Watling M, Imbimbo C, Nistico R, et al
    Plasma ATN(I) classification and precision pharmacology in Alzheimer's disease.
    Alzheimers Dement. 2023 Apr 20. doi: 10.1002/alz.13084.
    PubMed     Abstract available


  316. THERRIAULT J, Servaes S, Tissot C, Rahmouni N, et al
    Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's disease.
    Alzheimers Dement. 2023 Apr 20. doi: 10.1002/alz.13026.
    PubMed     Abstract available


  317. ADKINS-JACKSON PB, George KM, Besser LM, Hyun J, et al
    The structural and social determinants of Alzheimer's disease related dementias.
    Alzheimers Dement. 2023 Apr 19. doi: 10.1002/alz.13027.
    PubMed     Abstract available


  318. KUMAR A, Su Y, Sharma M, Singh S, et al
    MicroRNA expression in extracellular vesicles as a novel blood-based biomarker for Alzheimer's disease.
    Alzheimers Dement. 2023 Apr 18. doi: 10.1002/alz.13055.
    PubMed     Abstract available


  319. SASNER M, Territo PR, Sukoff Rizzo SJ
    Meeting report of the annual workshop on Principles and Techniques for Improving Preclinical to Clinical Translation in Alzheimer's Disease research.
    Alzheimers Dement. 2023 Apr 18. doi: 10.1002/alz.13093.
    PubMed     Abstract available


  320. SAMUELS JD, Moore KA, Ennerfelt HE, Johnson AM, et al
    The Alzheimer's disease risk factor INPP5D restricts neuroprotective microglial responses in amyloid beta-mediated pathology.
    Alzheimers Dement. 2023 Apr 15. doi: 10.1002/alz.13089.
    PubMed     Abstract available


  321. MORENO M, Kline CR, Lanigan K, Kallmyer B, et al
    Personal meaningfulness of potential FDA-approved treatments: Perspectives of individuals living with Alzheimer's disease.
    Alzheimers Dement. 2023 Apr 14. doi: 10.1002/alz.13079.
    PubMed     Abstract available


  322. BAI H, Naj AC, Benchek P, Dumitrescu L, et al
    A haptoglobin (HP) structural variant alters the effect of APOE alleles on Alzheimer's disease.
    Alzheimers Dement. 2023 Apr 12. doi: 10.1002/alz.13050.
    PubMed     Abstract available


  323. ZHOU RZ, Vetrano DL, Grande G, Duell F, et al
    A glycan epitope correlates with tau in serum and predicts progression to Alzheimer's disease in combination with APOE4 allele status.
    Alzheimers Dement. 2023 Apr 12. doi: 10.1002/alz.13024.
    PubMed     Abstract available


  324. VIDELA L, Benejam B, Carmona-Iragui M, Barroeta I, et al
    Cross-sectional versus longitudinal cognitive assessments for the diagnosis of symptomatic Alzheimer's disease in adults with Down syndrome.
    Alzheimers Dement. 2023 Apr 11. doi: 10.1002/alz.13073.
    PubMed     Abstract available


  325. CELIS K, Moreno MDMM, Rajabli F, Whitehead P, et al
    Ancestry-related differences in chromatin accessibility and gene expression of APOE epsilon4 are associated with Alzheimer's disease risk.
    Alzheimers Dement. 2023 Apr 10. doi: 10.1002/alz.13075.
    PubMed     Abstract available


  326. HUANG CW, Rust NC, Wu HF, Yin A, et al
    Low glucose induced Alzheimer's disease-like biochemical changes in human induced pluripotent stem cell-derived neurons is due to dysregulated O-GlcNAcylation.
    Alzheimers Dement. 2023 Apr 10. doi: 10.1002/alz.13058.
    PubMed     Abstract available


  327. GARNIER-CRUSSARD A, Cotton F, Krolak-Salmon P, Chetelat G, et al
    White matter hyperintensities in Alzheimer's disease: Beyond vascular contribution.
    Alzheimers Dement. 2023 Apr 7. doi: 10.1002/alz.13057.
    PubMed     Abstract available


  328. CHATTERJEE M, Ozdemir S, Kunadt M, Koel-Simmelink M, et al
    C1q is increased in cerebrospinal fluid-derived extracellular vesicles in Alzheimer's disease: A multi-cohort proteomics and immuno-assay validation study.
    Alzheimers Dement. 2023 Apr 6. doi: 10.1002/alz.13066.
    PubMed     Abstract available


  329. ROZALEM ARANHA M, Iulita MF, Montal V, Pegueroles J, et al
    Basal forebrain atrophy along the Alzheimer's disease continuum in adults with Down syndrome.
    Alzheimers Dement. 2023 Apr 6. doi: 10.1002/alz.12999.
    PubMed     Abstract available


  330. DILMORE AH, Martino C, Neth BJ, West KA, et al
    Effects of a ketogenic and low-fat diet on the human metabolome, microbiome, and foodome in adults at risk for Alzheimer's disease.
    Alzheimers Dement. 2023 Apr 5. doi: 10.1002/alz.13007.
    PubMed     Abstract available


  331. KUO K, Zhang YR, Chen SD, He XY, et al
    Associations of grip strength, walking pace, and the risk of incident dementia: A prospective cohort study of 340212 participants.
    Alzheimers Dement. 2023;19:1415-1427.
    PubMed     Abstract available


  332. GIBSON LL, Grinberg LT, Ffytche D, Leite REP, et al
    Neuropathological correlates of neuropsychiatric symptoms in dementia.
    Alzheimers Dement. 2023;19:1372-1382.
    PubMed     Abstract available


  333. RABE C, Bittner T, Jethwa A, Suridjan I, et al
    Clinical performance and robustness evaluation of plasma amyloid-beta(42/40) prescreening.
    Alzheimers Dement. 2023;19:1393-1402.
    PubMed     Abstract available


  334. OECKL P, Anderl-Straub S, Danek A, Diehl-Schmid J, et al
    Relationship of serum beta-synuclein with blood biomarkers and brain atrophy.
    Alzheimers Dement. 2023;19:1358-1371.
    PubMed     Abstract available


  335. OTTOY J, Ozzoude M, Zukotynski K, Adamo S, et al
    Vascular burden and cognition: Mediating roles of neurodegeneration and amyloid PET.
    Alzheimers Dement. 2023;19:1503-1517.
    PubMed     Abstract available


  336. PANG M, Zhu L, Gabelle A, Gafson AR, et al
    Effect of reduction in brain amyloid levels on change in cognitive and functional decline in randomized clinical trials: An instrumental variable meta-analysis.
    Alzheimers Dement. 2023;19:1292-1299.
    PubMed     Abstract available


  337. GROTHE MJ, Moscoso A, Silva-Rodriguez J, Lange C, et al
    Differential diagnosis of amnestic dementia patients based on an FDG-PET signature of autopsy-confirmed LATE-NC.
    Alzheimers Dement. 2023;19:1234-1244.
    PubMed     Abstract available


  338. PALMA-GUDIEL H, Yu L, Huo Z, Yang J, et al
    Fine-mapping and replication of EWAS loci harboring putative epigenetic alterations associated with AD neuropathology in a large collection of human brain tissue samples.
    Alzheimers Dement. 2023;19:1216-1226.
    PubMed     Abstract available


  339. PACYNA RR, Han SD, Wroblewski KE, McClintock MK, et al
    Rapid olfactory decline during aging predicts dementia and GMV loss in AD brain regions.
    Alzheimers Dement. 2023;19:1479-1490.
    PubMed     Abstract available


    March 2023
  340. CHEN XL, Fortes JM, Hu YT, van Iersel J, et al
    Sexually dimorphic age-related molecular differences in the entorhinal cortex of cognitively intact elderly: Relation to early Alzheimer's changes.
    Alzheimers Dement. 2023 Mar 24. doi: 10.1002/alz.13037.
    PubMed     Abstract available


  341. WEINER S, Sauer M, Brinkmalm G, Constantinescu J, et al
    SCRN1: A cerebrospinal fluid biomarker correlating with tau in Alzheimer's disease.
    Alzheimers Dement. 2023 Mar 22. doi: 10.1002/alz.13042.
    PubMed     Abstract available


  342. HOLDRIDGE KC, Yaari R, Hoban DB, Andersen S, et al
    Targeting amyloid beta in Alzheimer's disease: Meta-analysis of low-dose solanezumab in Alzheimer's disease with mild dementia studies.
    Alzheimers Dement. 2023 Mar 22. doi: 10.1002/alz.13031.
    PubMed     Abstract available


  343. CHENG Y, Zamrini E, Faselis C, Redd D, et al
    Cardiorespiratory fitness and risk of Alzheimer's disease and related dementias among American veterans.
    Alzheimers Dement. 2023 Mar 22. doi: 10.1002/alz.12998.
    PubMed     Abstract available


  344. CHAPPELLE SD, Gigliotti C, Leger GC, Peavy GM, et al
    Comparison of the telephone-Montreal Cognitive Assessment (T-MoCA) and Telephone Interview for Cognitive Status (TICS) as screening tests for early Alzheimer's disease.
    Alzheimers Dement. 2023 Mar 20. doi: 10.1002/alz.13039.
    PubMed     Abstract available


  345. KUSTERS CDJ, Paul KC, Romero T, Sinsheimer JS, et al
    Among men, androgens are associated with a decrease in Alzheimer's disease risk.
    Alzheimers Dement. 2023 Mar 20. doi: 10.1002/alz.13013.
    PubMed     Abstract available


  346. URAS I, Karayel-Basar M, Sahin B, Baykal AT, et al
    Detection of early proteomic alterations in 5xFAD Alzheimer's disease neonatal mouse model via MALDI-MSI.
    Alzheimers Dement. 2023 Mar 18. doi: 10.1002/alz.13008.
    PubMed     Abstract available


  347. WESTON PSJ, Coath W, Harris MJ, Malone IB, et al
    Cortical tau is associated with microstructural imaging biomarkers of neurite density and dendritic complexity in Alzheimer's disease.
    Alzheimers Dement. 2023 Mar 18. doi: 10.1002/alz.13011.
    PubMed     Abstract available


  348. SCHUMACHER J, Ray NJ, Hamilton CA, Bergamino M, et al
    Free water imaging of the cholinergic system in dementia with Lewy bodies and Alzheimer's disease.
    Alzheimers Dement. 2023 Mar 15. doi: 10.1002/alz.13034.
    PubMed     Abstract available



  349. 2023 Alzheimer's disease facts and figures.
    Alzheimers Dement. 2023 Mar 14. doi: 10.1002/alz.13016.
    PubMed     Abstract available


  350. MOURTZI N, Charisis S, Tsapanou A, Ntanasi E, et al
    Genetic propensity for cerebral amyloidosis and risk of mild cognitive impairment and Alzheimer's disease within a cognitive reserve framework.
    Alzheimers Dement. 2023 Mar 9. doi: 10.1002/alz.12980.
    PubMed     Abstract available


  351. FERREIRA PCL, Zhang Y, Snitz B, Chang CH, et al
    Plasma biomarkers identify older adults at risk of Alzheimer's disease and related dementias in a real-world population-based cohort.
    Alzheimers Dement. 2023 Mar 6. doi: 10.1002/alz.12986.
    PubMed     Abstract available


  352. MEYERS EA, Sexton C, Snyder HM, Carrillo MC, et al
    Impact of Alzheimer's association support and engagement in the AD/ADRD research community through the COVID-19 pandemic and beyond.
    Alzheimers Dement. 2023 Mar 5. doi: 10.1002/alz.13015.
    PubMed     Abstract available


    February 2023
  353. LIN PJ, Levine A, Rucker J, Chambers JD, et al
    Variation in Medicaid and commercial payer coverage of aducanumab for Alzheimer's disease.
    Alzheimers Dement. 2023 Feb 28. doi: 10.1002/alz.12965.
    PubMed     Abstract available


  354. LLIBRE-GUERRA JJ, Heavener A, Brucki SMD, Marante JPD, et al
    A call for clinical trial globalization in Alzheimer's disease and related dementia.
    Alzheimers Dement. 2023 Feb 25. doi: 10.1002/alz.12995.
    PubMed     Abstract available


  355. WANG ZB, Tan L, Wang HF, Chen SD, et al
    Differences between ante mortem Alzheimer's disease biomarkers in predicting neuropathology at autopsy.
    Alzheimers Dement. 2023 Feb 25. doi: 10.1002/alz.12997.
    PubMed     Abstract available


  356. ZHANG W, Wang HF, Kuo K, Wang L, et al
    Contribution of Alzheimer's disease pathology to biological and clinical progression: A longitudinal study across two cohorts.
    Alzheimers Dement. 2023 Feb 25. doi: 10.1002/alz.12992.
    PubMed     Abstract available


  357. YU L, Wang T, Wilson RS, Guo W, et al
    Predicting age at Alzheimer's dementia onset with the cognitive clock.
    Alzheimers Dement. 2023 Feb 24. doi: 10.1002/alz.13004.
    PubMed     Abstract available


  358. CARNA M, Onyango IG, Katina S, Holub D, et al
    Pathogenesis of Alzheimer's disease: Involvement of the choroid plexus.
    Alzheimers Dement. 2023 Feb 24. doi: 10.1002/alz.12970.
    PubMed     Abstract available


  359. LI M, Larsen PA
    Single-cell sequencing of entorhinal cortex reveals widespread disruption of neuropeptide networks in Alzheimer's disease.
    Alzheimers Dement. 2023 Feb 24. doi: 10.1002/alz.12979.
    PubMed     Abstract available


  360. LI Q, Yang X, Xu J, Guo Y, et al
    Early prediction of Alzheimer's disease and related dementias using real-world electronic health records.
    Alzheimers Dement. 2023 Feb 23. doi: 10.1002/alz.12967.
    PubMed     Abstract available


  361. WANG E, Wang M, Guo L, Fullard JF, et al
    Genome-wide methylomic regulation of multiscale gene networks in Alzheimer's disease.
    Alzheimers Dement. 2023 Feb 22. doi: 10.1002/alz.12969.
    PubMed     Abstract available


  362. CHARISIS S, Lin H, Ray R, Joehanes R, et al
    Obesity impacts the expression of Alzheimer's disease-related genes: The Framingham Heart Study.
    Alzheimers Dement. 2023 Feb 22. doi: 10.1002/alz.12954.
    PubMed     Abstract available


  363. SALONER R, Paolillo EW, Wojta KJ, Fonseca C, et al
    Sex-specific effects of SNAP-25 genotype on verbal memory and Alzheimer's disease biomarkers in clinically normal older adults.
    Alzheimers Dement. 2023 Feb 18. doi: 10.1002/alz.12989.
    PubMed     Abstract available


  364. PURI S, Hu J, Sun Z, Lin M, et al
    Identification of circRNAs linked to Alzheimer's disease and related dementias.
    Alzheimers Dement. 2023 Feb 16. doi: 10.1002/alz.12960.
    PubMed     Abstract available


  365. DEMING Y, Vasiljevic E, Morrow A, Miao J, et al
    Neuropathology-based APOE genetic risk score better quantifies Alzheimer's risk.
    Alzheimers Dement. 2023 Feb 16. doi: 10.1002/alz.12990.
    PubMed     Abstract available


  366. ULEMAN JF, Melis RJF, Ntanasi E, Scarmeas N, et al
    Simulating the multicausality of Alzheimer's disease with system dynamics.
    Alzheimers Dement. 2023 Feb 16. doi: 10.1002/alz.12923.
    PubMed     Abstract available


  367. SHI L, Xu J, Green R, Wretlind A, et al
    Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's disease.
    Alzheimers Dement. 2023 Feb 15. doi: 10.1002/alz.12961.
    PubMed     Abstract available


  368. ZOU X, Liao Y, Jiang C, Yuan Y, et al
    Brain perfusion, cognition, and plasma Alzheimer's biomarkers in moyamoya disease.
    Alzheimers Dement. 2023 Feb 10. doi: 10.1002/alz.12958.
    PubMed     Abstract available


  369. SOLFRIZZI V, Scafato E, Custodero C, Piazzolla G, et al
    Biopsychosocial frailty and mild cognitive impairment subtypes: Findings from the Italian project on the epidemiology of Alzheimer's disease (IPREA).
    Alzheimers Dement. 2023 Feb 9. doi: 10.1002/alz.12944.
    PubMed     Abstract available


  370. FALGAS N, Walsh CM, Yack L, Simon AJ, et al
    Alzheimer's disease phenotypes show different sleep architecture.
    Alzheimers Dement. 2023 Feb 7. doi: 10.1002/alz.12963.
    PubMed     Abstract available


  371. PLANCHE V, Mansencal B, Manjon JV, Tourdias T, et al
    Anatomical MRI staging of frontotemporal dementia variants: For the Frontotemporal Lobar Degeneration Neuroimaging Initiative and the National Alzheimer's Coordinating Center cohort: For the Frontotemporal Lobar Degeneration Neuroimaging Initiative an
    Alzheimers Dement. 2023 Feb 7. doi: 10.1002/alz.12975.
    PubMed     Abstract available


  372. ELLISON TS, Cappa SF, Garrett D, Georges J, et al
    Outcome measures for Alzheimer's disease: A global inter-societal Delphi consensus.
    Alzheimers Dement. 2023 Feb 7. doi: 10.1002/alz.12945.
    PubMed     Abstract available


  373. LI YJ, Nuytemans K, La JO, Jiang R, et al
    Identification of novel genes for age-at-onset of Alzheimer's disease by combining quantitative and survival trait analyses.
    Alzheimers Dement. 2023 Feb 4. doi: 10.1002/alz.12927.
    PubMed     Abstract available



  374. Apply now to the Alzheimer's Association Interdisciplinary Summer Research Institute.
    Alzheimers Dement. 2023 Feb 1. doi: 10.1002/alz.12973.
    PubMed    


  375. DEVANAND DP, Masurkar AV, Wisniewski T
    Vigorous, regular physical exercise may slow disease progression in Alzheimer's disease.
    Alzheimers Dement. 2023 Feb 1. doi: 10.1002/alz.12946.
    PubMed     Abstract available


  376. DONG Y, Li Y, Liu K, Han X, et al
    Anosmia, mild cognitive impairment, and biomarkers of brain aging in older adults.
    Alzheimers Dement. 2023;19:589-601.
    PubMed     Abstract available


  377. LLIBRE-GUERRA JJ, Li J, Qian Y, Llibre-Rodriguez JJ, et al
    Apolipoprotein E (APOE) genotype, dementia, and memory performance among Caribbean Hispanic versus US populations.
    Alzheimers Dement. 2023;19:602-610.
    PubMed     Abstract available


  378. RAMOS J, Caywood LJ, Prough MB, Clouse JE, et al
    Genetic variants in the SHISA6 gene are associated with delayed cognitive impairment in two family datasets.
    Alzheimers Dement. 2023;19:611-620.
    PubMed     Abstract available


  379. WEIJS RWJ, Shkredova DA, Brekelmans ACM, Thijssen DHJ, et al
    Longitudinal changes in cerebral blood flow and their relation with cognitive decline in patients with dementia: Current knowledge and future directions.
    Alzheimers Dement. 2023;19:532-548.
    PubMed     Abstract available


  380. SEMMENS EO, Leary CS, Fitzpatrick AL, Ilango SD, et al
    Air pollution and dementia in older adults in the Ginkgo Evaluation of Memory Study.
    Alzheimers Dement. 2023;19:549-559.
    PubMed     Abstract available


  381. LANDAU SM, Ward TJ, Murphy A, Iaccarino L, et al
    Quantification of amyloid beta and tau PET without a structural MRI.
    Alzheimers Dement. 2023;19:444-455.
    PubMed     Abstract available


  382. WANG L, Davis PB, Kaelber DC, Xu R, et al
    COVID-19 breakthrough infections and hospitalizations among vaccinated patients with dementia in the United States between December 2020 and August 2021.
    Alzheimers Dement. 2023;19:421-432.
    PubMed     Abstract available


    January 2023
  383. WANG X, Broce I, Qiu Y, Deters KD, et al
    A simple genetic stratification method for lower cost, more expedient clinical trials in early Alzheimer's disease: A preliminary study of tau PET and cognitive outcomes.
    Alzheimers Dement. 2023 Jan 26. doi: 10.1002/alz.12952.
    PubMed     Abstract available


  384. GRAHAM NSN, Cole JH, Bourke NJ, Schott JM, et al
    Distinct patterns of neurodegeneration after TBI and in Alzheimer's disease.
    Alzheimers Dement. 2023 Jan 25. doi: 10.1002/alz.12934.
    PubMed     Abstract available


  385. LIU H, Barthelemy NR, Ovod V, Bollinger JG, et al
    Acute sleep loss decreases CSF-to-blood clearance of Alzheimer's disease biomarkers.
    Alzheimers Dement. 2023 Jan 25. doi: 10.1002/alz.12930.
    PubMed     Abstract available


  386. ZAWAR I, Kapur J
    Does Alzheimer's disease with mesial temporal lobe epilepsy represent a distinct disease subtype?
    Alzheimers Dement. 2023 Jan 17. doi: 10.1002/alz.12943.
    PubMed     Abstract available


  387. EHRENBERG AJ, Kelberman MA, Liu KY, Dahl MJ, et al
    Priorities for research on neuromodulatory subcortical systems in Alzheimer's disease: Position paper from the NSS PIA of ISTAART.
    Alzheimers Dement. 2023 Jan 15. doi: 10.1002/alz.12937.
    PubMed     Abstract available


  388. XIONG C, McCue LM, Buckles V, Grant E, et al
    Cross-sectional and longitudinal comparisons of biomarkers and cognition among asymptomatic middle-aged individuals with a parental history of either autosomal dominant or late-onset Alzheimer's disease.
    Alzheimers Dement. 2023 Jan 14. doi: 10.1002/alz.12912.
    PubMed     Abstract available


  389. KRUSE C, Maier F, Spottke A, Bach JP, et al
    Apathy in patients with Alzheimer's disease is a cost-driving factor.
    Alzheimers Dement. 2023 Jan 2. doi: 10.1002/alz.12915.
    PubMed     Abstract available


  390. TOLEDO JB, Abdelnour C, Weil RS, Ferreira D, et al
    Dementia with Lewy bodies: Impact of co-pathologies and implications for clinical trial design.
    Alzheimers Dement. 2023;19:318-332.
    PubMed     Abstract available


  391. ROSEBOROUGH AD, Saad L, Goodman M, Cipriano LE, et al
    White matter hyperintensities and longitudinal cognitive decline in cognitively normal populations and across diagnostic categories: A meta-analysis, systematic review, and recommendations for future study harmonization.
    Alzheimers Dement. 2023;19:194-207.
    PubMed     Abstract available


    December 2022
  392. DAUAR MT, Labonte A, Picard C, Miron J, et al
    Characterization of the contactin 5 protein and its risk-associated polymorphic variant throughout the Alzheimer's disease spectrum.
    Alzheimers Dement. 2022 Dec 30. doi: 10.1002/alz.12868.
    PubMed     Abstract available


  393. VELIOGLU HA, Ayyildiz B, Ayyildiz S, Sutcubasi B, et al
    A structural and resting-state functional connectivity investigation of the pulvinar in elderly individuals and Alzheimer's disease patients.
    Alzheimers Dement. 2022 Dec 28. doi: 10.1002/alz.12850.
    PubMed     Abstract available


  394. CHATTERJEE P, Vermunt L, Gordon BA, Pedrini S, et al
    Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Abeta-PET, neurodegeneration, and cognition.
    Alzheimers Dement. 2022 Dec 28. doi: 10.1002/alz.12879.
    PubMed     Abstract available


  395. AGUILLON D, Langella S, Chen Y, Sanchez JS, et al
    Plasma p-tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's disease.
    Alzheimers Dement. 2022 Dec 26. doi: 10.1002/alz.12906.
    PubMed     Abstract available


  396. STRICKER NH, Twohy EL, Albertson SM, Karstens AJ, et al
    Mayo-PACC: A parsimonious preclinical Alzheimer's disease cognitive composite comprised of public-domain measures to facilitate clinical translation.
    Alzheimers Dement. 2022 Dec 24. doi: 10.1002/alz.12895.
    PubMed     Abstract available


  397. LOGUE MW, Miller MW, Sherva R, Zhang R, et al
    Alzheimer's disease and related dementias among aging veterans: Examining gene-by-environment interactions with post-traumatic stress disorder and traumatic brain injury.
    Alzheimers Dement. 2022 Dec 22. doi: 10.1002/alz.12870.
    PubMed     Abstract available


  398. HUSEBY CJ, Delvaux E, Brokaw DL, Coleman PD, et al
    Blood RNA transcripts reveal similar and differential alterations in fundamental cellular processes in Alzheimer's disease and other neurodegenerative diseases.
    Alzheimers Dement. 2022 Dec 21. doi: 10.1002/alz.12880.
    PubMed     Abstract available


  399. RAJABLI F, Tosto G, Hamilton-Nelson KL, Kunkle BW, et al
    Admixture mapping identifies novel Alzheimer's disease risk regions in African Americans.
    Alzheimers Dement. 2022 Dec 20. doi: 10.1002/alz.12865.
    PubMed     Abstract available


  400. LIN PB, Tsai AP, Soni D, Lee-Gosselin A, et al
    INPP5D deficiency attenuates amyloid pathology in a mouse model of Alzheimer's disease.
    Alzheimers Dement. 2022 Dec 16. doi: 10.1002/alz.12849.
    PubMed     Abstract available



  401. Alzheimer's Association names Dr. Joanne Pike its next chief executive officer.
    Alzheimers Dement. 2022 Dec 9. doi: 10.1002/alz.12911.
    PubMed    


  402. YASSINE HN, Self W, Kerman BE, Santoni G, et al
    Nutritional metabolism and cerebral bioenergetics in Alzheimer's disease and related dementias.
    Alzheimers Dement. 2022 Dec 8. doi: 10.1002/alz.12845.
    PubMed     Abstract available


  403. BALL DE, Mattke S, Frank L, Murray JF, et al
    A framework for addressing Alzheimer's disease: Without a frame, the work has no aim.
    Alzheimers Dement. 2022 Dec 8. doi: 10.1002/alz.12869.
    PubMed     Abstract available


  404. YU H, Wang M, Yang Q, Xu X, et al
    The electrophysiological and neuropathological profiles of cerebellum in APP(swe) /PS1(DeltaE9) mice: A hypothesis on the role of cerebellum in Alzheimer's disease.
    Alzheimers Dement. 2022 Dec 5. doi: 10.1002/alz.12853.
    PubMed     Abstract available


  405. KUCUKALI F, Neumann A, Van Dongen J, De Pooter T, et al
    Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits.
    Alzheimers Dement. 2022 Dec 4. doi: 10.1002/alz.12842.
    PubMed     Abstract available


  406. CARLOS AF, Tosakulwong N, Weigand SD, Senjem ML, et al
    TDP-43 pathology effect on volume and flortaucipir uptake in Alzheimer's disease.
    Alzheimers Dement. 2022 Dec 4. doi: 10.1002/alz.12878.
    PubMed     Abstract available


  407. MAZER NA, Hofmann C, Lott D, Gieschke R, et al
    Development of a quantitative semi-mechanistic model of Alzheimer's disease based on the amyloid/tau/neurodegeneration framework (the Q-ATN model).
    Alzheimers Dement. 2022 Dec 1. doi: 10.1002/alz.12877.
    PubMed     Abstract available


  408. SUSHKO VV, Sushko VV
    Use Acetazolamide in the Complex Therapy of Alzheimer's Disease.
    Alzheimers Dement. 2022;18 Suppl 9:e059982.
    PubMed     Abstract available


  409. HENDRIX SB, Nicodemus-Johnson J, Hogan NJ, Knowlton N, et al
    Not sexy enough: the uphill battle faced by non-traditional treatments in the U.S. despite having the most compelling AD results to date.
    Alzheimers Dement. 2022;18 Suppl 9:e068373.
    PubMed     Abstract available


  410. COSE DS
    An Innovative Approach to Empowering Care Partners Living with A Loved One Diagnosed with Younger-Onset Alzheimer's.
    Alzheimers Dement. 2022;18 Suppl 9:e061257.
    PubMed     Abstract available


  411. FIELDS BE, Boutilier JJ, Jolliff A, Elliott C, et al
    Does Caregiver Education Level Influence Confidence in Care Budgeting and Planning for Persons Living with Alzheimer's Disease or Related Dementias?
    Alzheimers Dement. 2022;18 Suppl 9:e068923.
    PubMed     Abstract available


  412. MACKOWICZ M, Yee J, Clark LR, Wanninger E, et al
    Dysphagia Evaluation in a Multidisciplinary VA Cognitive Care Clinic.
    Alzheimers Dement. 2022;18 Suppl 9:e063955.
    PubMed     Abstract available


  413. DIAZ-SANTOS M, Yanez JJ, Suarez PA
    Alzheimer's Disease in Bilingual Latinos: Clinical Decisions for Diagnosis and Treatment Planning.
    Alzheimers Dement. 2022;18 Suppl 9:e064253.
    PubMed     Abstract available


  414. BLEKOU P, Sakka P, Leonti AA, Megagianni S, et al
    The Greek Dementia Helpline: experience and impact.
    Alzheimers Dement. 2022;18 Suppl 9:e061186.
    PubMed     Abstract available


  415. VAN PHAN T, Praet J, Guarnieri R, Lowenthal E, et al
    An Educational Platform about Current and Future Paradigms of Neuroimaging in the Management of Alzheimer's Disease.
    Alzheimers Dement. 2022;18 Suppl 9:e065989.
    PubMed     Abstract available


  416. MCGURIN NE, McCarthy L, Arsenault L, Showalter E, et al
    Dementia Care Coordination: Evaluating a Program to Support Caregivers through Collaboration with the Alzheimer's Association and Health Care Partners.
    Alzheimers Dement. 2022;18 Suppl 9:e059900.
    PubMed     Abstract available


  417. REUBEN D, Panlilio M
    Effects of an Alzheimer's and Dementia Care Co-management Program on Quality, Clinical Outcomes, and Utilization.
    Alzheimers Dement. 2022;18 Suppl 9:e063939.
    PubMed     Abstract available


  418. JOYCE JL, Caes D, Chapman S, Gottesman RT, et al
    Screening for Memory Concerns at the Well-Woman Visit.
    Alzheimers Dement. 2022;18 Suppl 9:e067894.
    PubMed     Abstract available


  419. COSE DS
    Supporting Youth With A Parent Who Is Living Younger-Onset Alzheimer's: A Crucial Component In Integrated Care.
    Alzheimers Dement. 2022;18 Suppl 9:e062968.
    PubMed     Abstract available


  420. BLEKOU P, Sakka P, Zoi P, Kalligeros N, et al
    Tablet training at home for people with dementia and their caregivers during pandemic.
    Alzheimers Dement. 2022;18 Suppl 9:e065713.
    PubMed     Abstract available


  421. BORMANS K, Zwakhalen S
    Using children's drawings as implicit measurements in future Alzheimer's research for the detection and alteration of negative stereotyping.
    Alzheimers Dement. 2022;18 Suppl 9:e067593.
    PubMed     Abstract available


  422. SPENSLEY SB
    Identifying priorities and supporting ADRD researchers through Alzheimer's Disease Research Center Research Education Components.
    Alzheimers Dement. 2022;18 Suppl 9:e062410.
    PubMed     Abstract available


  423. SUPER N
    Scaling Comprehensive Dementia Care.
    Alzheimers Dement. 2022;18 Suppl 9:e063942.
    PubMed     Abstract available


  424. MIRABNAHRAZAM G, Ma D, Beaulac C, Lee S, et al
    Predicting Alzheimer's disease progression in healthy and MCI subjects using multi-modal deep learning approach.
    Alzheimers Dement. 2022;18 Suppl 2:e060949.
    PubMed     Abstract available


  425. HILSABECK RC, Keller JN, Henry ML, Toprac P, et al
    Multidisciplinary collaboration to develop a digital health solution for early detection of cognitive decline in primary care.
    Alzheimers Dement. 2022;18 Suppl 2:e067832.
    PubMed     Abstract available


  426. KOLANKO MA, Soreq E, Lai H, Barnaghi P, et al
    Clinically relevant monitoring of long-term night-time behaviour and physiology from the homes of people living with dementia.
    Alzheimers Dement. 2022;18 Suppl 2:e068241.
    PubMed     Abstract available


  427. WATERMEYER TJ, Butler J, Matterson E, Harper EG, et al
    A digital biomarker for remote self-assessment of Alzheimer's Diseases: development and validation.
    Alzheimers Dement. 2022;18 Suppl 2:e066066.
    PubMed     Abstract available


  428. BEATTIE ZT, Gothard S, Barnes LL, Calloway S, et al
    The Collaboration and Harmonization of Digital Biomarkers for Alzheimer's Research.
    Alzheimers Dement. 2022;18 Suppl 2:e067984.
    PubMed     Abstract available


  429. OHMAN F, Berron D, Skoog J, Bodin TH, et al
    Smartphone-based long-term delayed memory performance is associated with the Preclinical Alzheimer's Cognitive Composite and CSF levels of beta-amyloid.
    Alzheimers Dement. 2022;18 Suppl 2:e068015.
    PubMed     Abstract available


  430. SCHUSSLER S, Zuschnegg J, Paletta L, Russegger S, et al
    Experiences of people with Alzheimer's disease, relatives, and dementia trainers on the usability of a tablet-based dementia training.
    Alzheimers Dement. 2022;18 Suppl 2:e062097.
    PubMed     Abstract available


  431. MEYER T, Moro-Velazquez L, Motley S, Butala A, et al
    Automatic Extraction of Oculographic Signals as Digital Biomarkers for Alzheimer's Disease.
    Alzheimers Dement. 2022;18 Suppl 2:e066018.
    PubMed     Abstract available


  432. BABATOPE EY, Rodriguez ML, Garcia-Vazquez MS, Alvaro Ramirez-Acosta A, et al
    Recognizing human functional patterns in IADLs through hand detection and artificial intelligence.
    Alzheimers Dement. 2022;18 Suppl 2:e064212.
    PubMed     Abstract available


  433. FAVARO A, Motley S, Samus QM, Butala A, et al
    Artificial Intelligence Tools to Evaluate Language and Speech Patterns in Alzheimer's Disease.
    Alzheimers Dement. 2022;18 Suppl 2:e064913.
    PubMed     Abstract available


  434. RANSON JM, Khleifat AA, Lyall DM, Newby D, et al
    The Deep Dementia Phenotyping (DEMON) Network: A global platform for innovation using data science and artificial intelligence.
    Alzheimers Dement. 2022;18 Suppl 2:e067308.
    PubMed     Abstract available


  435. PARSAPOOR M
    Towards Fair ML-based Language Assessment Methods for Detecting Alzheimer's Disease.
    Alzheimers Dement. 2022;18 Suppl 2:e063426.
    PubMed     Abstract available


  436. ROSSINI PM, Miraglia F, Vecchio F
    Early dementia diagnosis, MCI-to-dementia risk prediction, and the role of machine learning methods for feature extraction from integrated biomarkers, in particular for EEG signal analysis.
    Alzheimers Dement. 2022;18:2699-2706.
    PubMed     Abstract available


  437. FOCKLER J, Ashford MT, Eichenbaum J, Howell T, et al
    Remote blood collection from older adults in the Brain Health Registry for plasma biomarker and genetic analysis.
    Alzheimers Dement. 2022;18:2627-2636.
    PubMed     Abstract available


  438. MOSCOSO A, Karikari TK, Grothe MJ, Ashton NJ, et al
    CSF biomarkers and plasma p-tau181 as predictors of longitudinal tau accumulation: Implications for clinical trial design.
    Alzheimers Dement. 2022;18:2614-2626.
    PubMed     Abstract available


  439. ZHU CW, Neugroschl J, Barnes LL, Sano M, et al
    Racial/ethnic disparities in initiation and persistent use of anti-dementia medications.
    Alzheimers Dement. 2022;18:2582-2592.
    PubMed     Abstract available


  440. HANON O, Vidal JS, Lehmann S, Bombois S, et al
    Plasma amyloid beta predicts conversion to dementia in subjects with mild cognitive impairment: The BALTAZAR study.
    Alzheimers Dement. 2022;18:2537-2550.
    PubMed     Abstract available


  441. WANG J, Dove A, Song R, Qi X, et al
    Poor pulmonary function is associated with mild cognitive impairment, its progression to dementia, and brain pathologies: A community-based cohort study.
    Alzheimers Dement. 2022;18:2551-2559.
    PubMed     Abstract available


  442. GODRICH D, Martin ER, Schellenberg G, Pericak-Vance MA, et al
    Neuropathological lesions and their contribution to dementia and cognitive impairment in a heterogeneous clinical population.
    Alzheimers Dement. 2022;18:2403-2412.
    PubMed     Abstract available


  443. SHAH J, Gao F, Li B, Ghisays V, et al
    Deep residual inception encoder-decoder network for amyloid PET harmonization.
    Alzheimers Dement. 2022;18:2448-2457.
    PubMed     Abstract available


  444. BHARTHUR SANJAY A, Patania A, Yan X, Svaldi D, et al
    Characterization of gene expression patterns in mild cognitive impairment using a transcriptomics approach and neuroimaging endophenotypes.
    Alzheimers Dement. 2022;18:2493-2508.
    PubMed     Abstract available


    November 2022
  445. GUEORGUIEVA I, Chua L, Willis BA, Sims JR, et al
    Disease progression model using the integrated Alzheimer's Disease Rating Scale.
    Alzheimers Dement. 2022 Nov 30. doi: 10.1002/alz.12876.
    PubMed     Abstract available


  446. CASTRANIO EL, Hasel P, Haure-Mirande JV, Ramirez Jimenez AV, et al
    Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer's disease.
    Alzheimers Dement. 2022 Nov 30. doi: 10.1002/alz.12821.
    PubMed     Abstract available


  447. FERRELL PB, Fillit H, Neumann PJ, Wall JK, et al
    Toward comprehensive value assessment for Alzheimer's disease innovations.
    Alzheimers Dement. 2022 Nov 25. doi: 10.1002/alz.12874.
    PubMed     Abstract available


  448. STEWARD A, Biel D, Brendel M, Dewenter A, et al
    Functional network segregation is associated with attenuated tau spreading in Alzheimer's disease.
    Alzheimers Dement. 2022 Nov 25. doi: 10.1002/alz.12867.
    PubMed     Abstract available


  449. DOHERTY JM, Murphy SA, Bayat S, Wisch JK, et al
    Adverse driving behaviors increase over time as a function of preclinical Alzheimer's disease biomarkers.
    Alzheimers Dement. 2022 Nov 23. doi: 10.1002/alz.12852.
    PubMed     Abstract available


  450. CAREY A, Fossati S
    Hypertension and hyperhomocysteinemia as modifiable risk factors for Alzheimer's disease and dementia: New evidence, potential therapeutic strategies, and biomarkers.
    Alzheimers Dement. 2022 Nov 19. doi: 10.1002/alz.12871.
    PubMed     Abstract available


  451. KARPOUZIAN-ROGERS T, Ho E, Novack M, Chinkers M, et al
    Baseline characterization of the ARMADA (Assessing Reliable Measurement in Alzheimer's Disease) study cohorts.
    Alzheimers Dement. 2022 Nov 17. doi: 10.1002/alz.12816.
    PubMed     Abstract available


  452. GOLDHARDT O, Freiberger R, Dreyer T, Wilner L, et al
    Herpes simplex virus alters Alzheimer's disease biomarkers - A hypothesis paper.
    Alzheimers Dement. 2022 Nov 17. doi: 10.1002/alz.12834.
    PubMed     Abstract available


  453. HUANG J, Stein TD, Wang Y, Ang TFA, et al
    Blood levels of MCP-1 modulate the genetic risks of Alzheimer's disease mediated by HLA-DRB1 and APOE for Alzheimer's disease.
    Alzheimers Dement. 2022 Nov 17. doi: 10.1002/alz.12851.
    PubMed     Abstract available


  454. POLSINELLI AJ, Logan PE, Lane KA, Manchella MK, et al
    APOE epsilon4 carrier status and sex differentiate rates of cognitive decline in early- and late-onset Alzheimer's disease.
    Alzheimers Dement. 2022 Nov 17. doi: 10.1002/alz.12831.
    PubMed     Abstract available


  455. PANG M, Zhu L, Gabelle A, Gafson AR, et al
    Toward the end of a controversy on the effect of reduction in brain amyloid levels on change in cognitive and functional decline in Alzheimer's disease-Reply to a letter.
    Alzheimers Dement. 2022 Nov 16. doi: 10.1002/alz.12864.
    PubMed    


  456. REIMAN EM, Pruzin JJ, Rios-Romenets S, Brown C, et al
    A public resource of baseline data from the Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial.
    Alzheimers Dement. 2022 Nov 14. doi: 10.1002/alz.12843.
    PubMed     Abstract available


  457. MINDT MR, Okonkwo O, Weiner MW, Veitch DP, et al
    Improving generalizability and study design of Alzheimer's disease cohort studies in the United States by including under-represented populations.
    Alzheimers Dement. 2022 Nov 13. doi: 10.1002/alz.12823.
    PubMed     Abstract available


  458. CHEN XQ, Zuo X, Becker A, Head E, et al
    Reduced synaptic proteins and SNARE complexes in Down syndrome with Alzheimer's disease and the Dp16 mouse Down syndrome model: Impact of APP gene dose.
    Alzheimers Dement. 2022 Nov 12. doi: 10.1002/alz.12835.
    PubMed     Abstract available


  459. HSHIEH TT, Gou RY, Jones RN, Leslie DL, et al
    One-year Medicare costs associated with delirium in older hospitalized patients with and without Alzheimer's disease dementia and related disorders.
    Alzheimers Dement. 2022 Nov 10. doi: 10.1002/alz.12826.
    PubMed     Abstract available


  460. HUANG X, Li Y, Fowler C, Doecke JD, et al
    Leukocyte surface biomarkers implicate deficits of innate immunity in sporadic Alzheimer's disease.
    Alzheimers Dement. 2022 Nov 9. doi: 10.1002/alz.12813.
    PubMed     Abstract available


  461. WU R, Tripathy S, Menon V, Yu L, et al
    Fragmentation of rest periods, astrocyte activation, and cognitive decline in older adults with and without Alzheimer's disease.
    Alzheimers Dement. 2022 Nov 6. doi: 10.1002/alz.12817.
    PubMed     Abstract available


  462. ZHANG P, Hou Y, Tu W, Campbell N, et al
    Population-based discovery and Mendelian randomization analysis identify telmisartan as a candidate medicine for Alzheimer's disease in African Americans.
    Alzheimers Dement. 2022 Nov 4. doi: 10.1002/alz.12819.
    PubMed     Abstract available



  463. Alzheimer's Association takes on leadership role in landmark Alzheimer's biomarker study.
    Alzheimers Dement. 2022 Nov 4. doi: 10.1002/alz.12873.
    PubMed    


  464. KYLE S, Youran T, Thomas W, Liuhua S, et al
    The effect of race and co-morbidities on Alzheimer's disease based on Medicare data.
    Alzheimers Dement. 2022 Nov 3. doi: 10.1002/alz.12838.
    PubMed     Abstract available


  465. GILLIS C, Montenigro P, Nejati M, Maserejian N, et al
    Estimating prevalence of early Alzheimer's disease in the United States, accounting for racial and ethnic diversity.
    Alzheimers Dement. 2022 Nov 2. doi: 10.1002/alz.12822.
    PubMed     Abstract available



  466. Improving community health-care systems' early detection of cognitive decline and dementia.
    Alzheimers Dement. 2022;18:2375-2381.
    PubMed     Abstract available


  467. TEMP AGM, Ly A, van Doorn J, Wagenmakers EJ, et al
    A Bayesian perspective on Biogen's aducanumab trial.
    Alzheimers Dement. 2022;18:2341-2351.
    PubMed     Abstract available


  468. LECCA D, Jung YJ, Scerba MT, Hwang I, et al
    Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis.
    Alzheimers Dement. 2022;18:2327-2340.
    PubMed     Abstract available


  469. HEGAZY SH, Thomassen JQ, Rasmussen IJ, Nordestgaard BG, et al
    C-reactive protein levels and risk of dementia-Observational and genetic studies of 111,242 individuals from the general population.
    Alzheimers Dement. 2022;18:2262-2271.
    PubMed     Abstract available


  470. BHASIN H, Agrawal RK
    Triploid genetic algorithm for convolutional neural network-based diagnosis of mild cognitive impairment.
    Alzheimers Dement. 2022;18:2283-2291.
    PubMed     Abstract available


  471. KULLER LH, Snitz BE, Hughes TM, Chang Y, et al
    Low untreated systolic blood pressure over 18 years is associated with survival free of dementia age 90.
    Alzheimers Dement. 2022;18:2176-2187.
    PubMed     Abstract available


  472. PADOVANI A, Canale A, Schiavon L, Masciocchi S, et al
    Is amyloid involved in acute neuroinflammation? A CSF analysis in encephalitis.
    Alzheimers Dement. 2022;18:2167-2175.
    PubMed     Abstract available


  473. BELLEVILLE S, Cloutier S, Mellah S, Willis S, et al
    Is more always better? Dose effect in a multidomain intervention in older adults at risk of dementia.
    Alzheimers Dement. 2022;18:2140-2150.
    PubMed     Abstract available


    October 2022
  474. HANDELS RLH, Green C, Gustavsson A, Herring WL, et al
    Cost-effectiveness models for Alzheimer's disease and related dementias: IPECAD modeling workshop cross-comparison challenge.
    Alzheimers Dement. 2022 Oct 25. doi: 10.1002/alz.12811.
    PubMed     Abstract available


  475. NOVOTNY BC, Fernandez MV, Wang C, Budde JP, et al
    Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer's disease brains.
    Alzheimers Dement. 2022 Oct 17. doi: 10.1002/alz.12800.
    PubMed     Abstract available


  476. NILSSON J, Cousins KAQ, Gobom J, Portelius E, et al
    Cerebrospinal fluid biomarker panel of synaptic dysfunction in Alzheimer's disease and other neurodegenerative disorders.
    Alzheimers Dement. 2022 Oct 14. doi: 10.1002/alz.12809.
    PubMed     Abstract available



  477. AAIC((R)) 2022: The promise of Alzheimer's research.
    Alzheimers Dement. 2022 Oct 12. doi: 10.1002/alz.12829.
    PubMed    


  478. HARERIMANA NV, Paliwali D, Romero-Molina C, Bennett DA, et al
    The role of mitochondrial genome abundance in Alzheimer's disease.
    Alzheimers Dement. 2022 Oct 12. doi: 10.1002/alz.12812.
    PubMed     Abstract available


  479. LIEBERMAN OJ, Lee S, Zabinski J
    Donepezil treatment is associated with improved outcomes in critically ill dementia patients via a reduction in delirium.
    Alzheimers Dement. 2022 Oct 11. doi: 10.1002/alz.12807.
    PubMed     Abstract available


  480. WEINER MW, Veitch DP, Miller MJ, Aisen PS, et al
    Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community-engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4.
    Alzheimers Dement. 2022 Oct 9. doi: 10.1002/alz.12797.
    PubMed     Abstract available


  481. STEPHAN BCM, Gaughan DM, Edland S, Gudnason V, et al
    Mid- and later-life risk factors for predicting neuropathological brain changes associated with Alzheimer's and vascular dementia: The Honolulu Asia Aging Study and the Age, Gene/Environment Susceptibility-Reykjavik Study.
    Alzheimers Dement. 2022 Oct 4. doi: 10.1002/alz.12762.
    PubMed     Abstract available


  482. NUYTEMANS K, Lipkin Vasquez M, Wang L, Van Booven D, et al
    Identifying differential regulatory control of APOE varepsilon4 on African versus European haplotypes as potential therapeutic targets.
    Alzheimers Dement. 2022;18:1930-1942.
    PubMed     Abstract available


  483. CORNELL PY, Zhang W, Smith L, Rahman M, et al
    Memory care reduces nursing home admissions among assisted-living residents with dementia.
    Alzheimers Dement. 2022;18:1880-1888.
    PubMed     Abstract available


  484. MARRIOTT RJ, Murray K, Flicker L, Hankey GJ, et al
    Lower serum testosterone concentrations are associated with a higher incidence of dementia in men: The UK Biobank prospective cohort study.
    Alzheimers Dement. 2022;18:1907-1918.
    PubMed     Abstract available


  485. PINK A, Krell-Roesch J, Syrjanen JA, Vassilaki M, et al
    A longitudinal investigation of Abeta, anxiety, depression, and mild cognitive impairment.
    Alzheimers Dement. 2022;18:1824-1831.
    PubMed     Abstract available


  486. JANSSEN O, Jansen WJ, Vos SJB, Boada M, et al
    Characteristics of subjective cognitive decline associated with amyloid positivity.
    Alzheimers Dement. 2022;18:1832-1845.
    PubMed     Abstract available


  487. SCHLIEP KC, Ju S, Foster NL, Smith KR, et al
    How good are medical and death records for identifying dementia?
    Alzheimers Dement. 2022;18:1812-1823.
    PubMed     Abstract available


  488. GAO Y, Felsky D, Reyes-Dumeyer D, Sariya S, et al
    Integration of GWAS and brain transcriptomic analyses in a multiethnic sample of 35,245 older adults identifies DCDC2 gene as predictor of episodic memory maintenance.
    Alzheimers Dement. 2022;18:1797-1811.
    PubMed     Abstract available


    September 2022
  489. HARTZ SM, Mozersky J, Schindler SE, Linnenbringer E, et al
    A flexible modeling approach for biomarker-based computation of absolute risk of Alzheimer's disease dementia.
    Alzheimers Dement. 2022 Sep 30. doi: 10.1002/alz.12781.
    PubMed     Abstract available


  490. SCHAEVERBEKE J, Tome SO, Ronisz A, Ospitalieri S, et al
    Neuronal loss of the nucleus basalis of Meynert in primary progressive aphasia is associated with Alzheimer's disease neuropathological changes.
    Alzheimers Dement. 2022 Sep 28. doi: 10.1002/alz.12794.
    PubMed     Abstract available


  491. KATABATHULA S, Davis PB, Xu R
    Comorbidity-driven multi-modal subtype analysis in mild cognitive impairment of Alzheimer's disease.
    Alzheimers Dement. 2022 Sep 27. doi: 10.1002/alz.12792.
    PubMed     Abstract available


  492. WEAVER DF
    Alzheimer's disease as an innate autoimmune disease (AD(2) ): A new molecular paradigm.
    Alzheimers Dement. 2022 Sep 27. doi: 10.1002/alz.12789.
    PubMed     Abstract available


  493. LIU KY, Thambisetty M, Howard R
    How can secondary dementia prevention trials of Alzheimer's disease be clinically meaningful?
    Alzheimers Dement. 2022 Sep 26. doi: 10.1002/alz.12788.
    PubMed     Abstract available


  494. PICHET BINETTE A, Janelidze S, Cullen N, Dage JL, et al
    Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance.
    Alzheimers Dement. 2022 Sep 24. doi: 10.1002/alz.12787.
    PubMed     Abstract available


  495. VETELEANU A, Pape S, Davies K, Kodosaki E, et al
    Complement dysregulation and Alzheimer's disease in Down syndrome.
    Alzheimers Dement. 2022 Sep 23. doi: 10.1002/alz.12799.
    PubMed     Abstract available


  496. YIN L, Zhou J, Li T, Wang X, et al
    Inhibition of the dopamine transporter promotes lysosome biogenesis and ameliorates Alzheimer's disease-like symptoms in mice.
    Alzheimers Dement. 2022 Sep 21. doi: 10.1002/alz.12776.
    PubMed     Abstract available


  497. DEPYPERE H, Vergallo A, Lemercier P, Lista S, et al
    Menopause hormone therapy significantly alters pathophysiological biomarkers of Alzheimer's disease.
    Alzheimers Dement. 2022 Sep 15. doi: 10.1002/alz.12759.
    PubMed     Abstract available



  498. Alzheimer's Association launches ALZ-NET: A long-term data collection and sharing network for new treatments.
    Alzheimers Dement. 2022 Sep 12. doi: 10.1002/alz.12782.
    PubMed    


  499. JUTTEN RJ, Papp KV, Hendrix S, Ellison N, et al
    Why a clinical trial is as good as its outcome measure: A framework for the selection and use of cognitive outcome measures for clinical trials of Alzheimer's disease.
    Alzheimers Dement. 2022 Sep 10. doi: 10.1002/alz.12773.
    PubMed     Abstract available


  500. DALY T
    The conundrum of the AD continuum.
    Alzheimers Dement. 2022 Sep 8. doi: 10.1002/alz.12783.
    PubMed    


  501. MATTKE S, Correa Dos Santos Filho O, Hanson M, Mateus EF, et al
    Preparedness of the Brazilian health-care system to provide access to a disease-modifying Alzheimer's disease treatment.
    Alzheimers Dement. 2022 Sep 5. doi: 10.1002/alz.12778.
    PubMed     Abstract available


  502. SKILLBACK T, Blennow K, Zetterberg H, Skoog J, et al
    Slowing gait speed precedes cognitive decline by several years.
    Alzheimers Dement. 2022;18:1667-1676.
    PubMed     Abstract available


    August 2022
  503. JIANG L, Li JC, Tang BS, Guo JF, et al
    Lack of bidirectional association between age-related macular degeneration and Alzheimer's disease: A Mendelian randomization study.
    Alzheimers Dement. 2022 Aug 25. doi: 10.1002/alz.12775.
    PubMed     Abstract available


  504. LUTZ MW, Khachaturian AS, Zetterberg H, Blennow K, et al
    Biomarkers of Alzheimer syndrome and related dementias: A&D author's guide.
    Alzheimers Dement. 2022 Aug 25. doi: 10.1002/alz.12772.
    PubMed    


  505. FRIKKE-SCHMIDT R, Hegazy SH, Rasmussen IJ, Nordestgaard BG, et al
    Observational and genetic studies of C-reactive protein levels and risk of Alzheimer's disease.
    Alzheimers Dement. 2022 Aug 21. doi: 10.1002/alz.12742.
    PubMed    


  506. RAFII MS, Sperling RA, Donohue MC, Zhou J, et al
    The AHEAD 3-45 Study: Design of a prevention trial for Alzheimer's disease.
    Alzheimers Dement. 2022 Aug 15. doi: 10.1002/alz.12748.
    PubMed     Abstract available


  507. PALMQVIST S, Stomrud E, Cullen N, Janelidze S, et al
    An accurate fully automated panel of plasma biomarkers for Alzheimer's disease.
    Alzheimers Dement. 2022 Aug 11. doi: 10.1002/alz.12751.
    PubMed     Abstract available


  508. LANGBAUM JB, Zissimopoulos J, Au R, Bose N, et al
    Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials.
    Alzheimers Dement. 2022 Aug 10. doi: 10.1002/alz.12737.
    PubMed     Abstract available


  509. OLCHANSKI N, Daly AT, Zhu Y, Breslau R, et al
    Alzheimer's disease medication use and adherence patterns by race and ethnicity.
    Alzheimers Dement. 2022 Aug 8. doi: 10.1002/alz.12753.
    PubMed     Abstract available


  510. SCHINDLER SE, Li Y, Li M, Despotis A, et al
    Using Alzheimer's disease blood tests to accelerate clinical trial enrollment.
    Alzheimers Dement. 2022 Aug 7. doi: 10.1002/alz.12754.
    PubMed     Abstract available


  511. WANG J, Guo C, Meng Z, Zwan MD, et al
    Testing the link between isoaspartate and Alzheimer's disease etiology.
    Alzheimers Dement. 2022 Aug 4. doi: 10.1002/alz.12735.
    PubMed     Abstract available


  512. MOLONEY CM, Labuzan SA, Crook JE, Siddiqui H, et al
    Phosphorylated tau sites that are elevated in Alzheimer's disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brain.
    Alzheimers Dement. 2022 Aug 3. doi: 10.1002/alz.12749.
    PubMed     Abstract available


  513. PETERSEN RC, Graf A, Carrillo MC, Weber CJ, et al
    Current understanding of AD pathophysiology and impact of amyloid beta-targeted treatments on biomarkers and clinical endpoints.
    Alzheimers Dement. 2022;18:1586.
    PubMed    


  514. HACHINSKI V
    The comprehensive, customized, cost-effective approach (CCCAP) to prevention of dementia.
    Alzheimers Dement. 2022;18:1565-1568.
    PubMed     Abstract available


  515. LENNON JC, Aita SL, Bene VAD, Rhoads T, et al
    Black and White individuals differ in dementia prevalence, risk factors, and symptomatic presentation.
    Alzheimers Dement. 2022;18:1461-1471.
    PubMed     Abstract available


  516. PERLUIGI M, Picca A, Montanari E, Calvani R, et al
    Aberrant crosstalk between insulin signaling and mTOR in young Down syndrome individuals revealed by neuronal-derived extracellular vesicles.
    Alzheimers Dement. 2022;18:1498-1510.
    PubMed     Abstract available


  517. PAJEWSKI NM, Elahi FM, Tamura MK, Hinman JD, et al
    Plasma amyloid beta, neurofilament light chain, and total tau in the Systolic Blood Pressure Intervention Trial (SPRINT).
    Alzheimers Dement. 2022;18:1472-1483.
    PubMed     Abstract available


    July 2022
  518. HANSSON O, Edelmayer RM, Boxer AL, Carrillo MC, et al
    The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease.
    Alzheimers Dement. 2022 Jul 31. doi: 10.1002/alz.12756.
    PubMed     Abstract available


  519. NOTARIANNI E
    Risk association between midlife lipid and glucose levels and future Alzheimer's disease.
    Alzheimers Dement. 2022 Jul 28. doi: 10.1002/alz.12738.
    PubMed    


  520. LOZUPONE M, Imbimbo BP, Balducci C, Lo Vecchio F, et al
    Does the imbalance in the apolipoprotein E isoforms underlie the pathophysiological process of sporadic Alzheimer's disease?
    Alzheimers Dement. 2022 Jul 28. doi: 10.1002/alz.12728.
    PubMed     Abstract available


  521. MAHAPATRA G, Gao Z, Bateman JR 3rd, Lockhart SN, et al
    Blood-based bioenergetic profiling reveals differences in mitochondrial function associated with cognitive performance and Alzheimer's disease.
    Alzheimers Dement. 2022 Jul 23. doi: 10.1002/alz.12731.
    PubMed     Abstract available


  522. CHATTERJEE P, Pedrini S, Doecke JD, Thota R, et al
    Plasma Abeta42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.
    Alzheimers Dement. 2022 Jul 21. doi: 10.1002/alz.12724.
    PubMed     Abstract available


  523. BEYER L, Stocker H, Rujescu D, Holleczek B, et al
    Amyloid-beta misfolding and GFAP predict risk of clinical Alzheimer's disease diagnosis within 17 years.
    Alzheimers Dement. 2022 Jul 19. doi: 10.1002/alz.12745.
    PubMed     Abstract available


  524. LIU H, Xie Y, Wang X, Abboud MI, et al
    Exploring links between 2-oxoglutarate-dependent oxygenases and Alzheimer's disease.
    Alzheimers Dement. 2022 Jul 19. doi: 10.1002/alz.12733.
    PubMed     Abstract available


  525. BATRA R, Arnold M, Worheide MA, Allen M, et al
    The landscape of metabolic brain alterations in Alzheimer's disease.
    Alzheimers Dement. 2022 Jul 13. doi: 10.1002/alz.12714.
    PubMed     Abstract available


  526. WANG JT, Xu G, Ren RJ, Wang Y, et al
    The impacts of health insurance and resource on the burden of Alzheimer's disease and related dementias in the world population.
    Alzheimers Dement. 2022 Jul 12. doi: 10.1002/alz.12730.
    PubMed     Abstract available


  527. LIN Z, Lim C, Jiang D, Soldan A, et al
    Longitudinal changes in brain oxygen extraction fraction (OEF) in older adults: Relationship to markers of vascular and Alzheimer's pathology.
    Alzheimers Dement. 2022 Jul 6. doi: 10.1002/alz.12727.
    PubMed     Abstract available


  528. TIAN C, Stewart T, Hong Z, Guo Z, et al
    Blood extracellular vesicles carrying synaptic function- and brain-related proteins as potential biomarkers for Alzheimer's disease.
    Alzheimers Dement. 2022 Jul 2. doi: 10.1002/alz.12723.
    PubMed     Abstract available


  529. SALVADO G, Ferreira D, Operto G, Cumplido-Mayoral I, et al
    The protective gene dose effect of the APOE epsilon2 allele on gray matter volume in cognitively unimpaired individuals.
    Alzheimers Dement. 2022;18:1383-1395.
    PubMed     Abstract available


  530. KATSEL P, Fam P, Tan W, Khan S, et al
    Engagement of vascular early response genes typifies mild cognitive impairment.
    Alzheimers Dement. 2022;18:1357-1369.
    PubMed     Abstract available


    June 2022
  531. CHUNG J, Das A, Sun X, Sobreira DR, et al
    Genome-wide association and multi-omics studies identify MGMT as a novel risk gene for Alzheimer's disease among women.
    Alzheimers Dement. 2022 Jun 30. doi: 10.1002/alz.12719.
    PubMed     Abstract available


  532. WEINER MW, Harvey D, Landau SM, Veitch DP, et al
    Traumatic brain injury and post-traumatic stress disorder are not associated with Alzheimer's disease pathology measured with biomarkers.
    Alzheimers Dement. 2022 Jun 29. doi: 10.1002/alz.12712.
    PubMed     Abstract available


  533. ABDULRAHMAN H, van Dalen JW, den Brok M, Latimer CS, et al
    Hypertension and Alzheimer's disease pathology at autopsy: A systematic review.
    Alzheimers Dement. 2022 Jun 27. doi: 10.1002/alz.12707.
    PubMed     Abstract available


  534. GILMORE-BYKOVSKYI A, Griffin JM, Mueller KD, Parnia S, et al
    Toward harmonization of strategies for investigating lucidity in AD/ADRD: A preliminary research framework.
    Alzheimers Dement. 2022;19:343-52.
    PubMed     Abstract available


  535. WINGO TS, Gerasimov ES, Canon SM, Lah JJ, et al
    Alzheimer's disease genetic burden is associated with mid-life depression among persons with normal cognition.
    Alzheimers Dement. 2022 Jun 21. doi: 10.1002/alz.12716.
    PubMed     Abstract available


  536. CULLEN NC, Janelidze S, Mattsson-Carlgren N, Palmqvist S, et al
    Test-retest variability of plasma biomarkers in Alzheimer's disease and its effects on clinical prediction models.
    Alzheimers Dement. 2022 Jun 14. doi: 10.1002/alz.12706.
    PubMed     Abstract available


  537. DELVENNE A, Gobom J, Tijms B, Bos I, et al
    Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiology.
    Alzheimers Dement. 2022 Jun 14. doi: 10.1002/alz.12713.
    PubMed     Abstract available


  538. SINGH NA, Tosakulwong N, Graff-Radford J, Machulda MM, et al
    APOE epsilon4 influences medial temporal atrophy and tau deposition in atypical Alzheimer's disease.
    Alzheimers Dement. 2022 Jun 12. doi: 10.1002/alz.12711.
    PubMed     Abstract available


  539. RISCHEL EB, Gejl M, Brock B, Rungby J, et al
    In Alzheimer's disease, amyloid beta accumulation is a protective mechanism that ultimately fails.
    Alzheimers Dement. 2022 Jun 8. doi: 10.1002/alz.12701.
    PubMed     Abstract available


  540. GAO F, Lv X, Dai L, Wang Q, et al
    A combination model of AD biomarkers revealed by machine learning precisely predicts Alzheimer's dementia: China Aging and Neurodegenerative Initiative (CANDI) study.
    Alzheimers Dement. 2022 Jun 6. doi: 10.1002/alz.12700.
    PubMed     Abstract available


  541. GUSTAVSSON A, Norton N, Fast T, Frolich L, et al
    Global estimates on the number of persons across the Alzheimer's disease continuum.
    Alzheimers Dement. 2022 Jun 2. doi: 10.1002/alz.12694.
    PubMed     Abstract available


  542. SAWA M, Overk C, Becker A, Derse D, et al
    Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model.
    Alzheimers Dement. 2022;18:1203-1234.
    PubMed     Abstract available


  543. SYRJANEN JA, Campbell MR, Algeciras-Schimnich A, Vemuri P, et al
    Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities.
    Alzheimers Dement. 2022;18:1128-1140.
    PubMed     Abstract available


  544. LIU L, Kwak H, Lawton TL, Jin SX, et al
    An ultra-sensitive immunoassay detects and quantifies soluble Abeta oligomers in human plasma.
    Alzheimers Dement. 2022;18:1186-1202.
    PubMed     Abstract available


  545. SANZ-BLASCO R, Ruiz-Sanchez de Leon JM, Avila-Villanueva M, Valenti-Soler M, et al
    Transition from mild cognitive impairment to normal cognition: Determining the predictors of reversion with multi-state Markov models.
    Alzheimers Dement. 2022;18:1177-1185.
    PubMed     Abstract available


    May 2022
  546. VOGLEIN J, Franzmeier N, Morris JC, Dieterich M, et al
    Patterns and implications of neurological examination findings in autosomal dominant Alzheimer disease.
    Alzheimers Dement. 2022 May 24. doi: 10.1002/alz.12684.
    PubMed     Abstract available


  547. HU Y, Zhang Y, Zhang H, Gao S, et al
    Mendelian randomization highlights causal association between genetically increased C-reactive protein levels and reduced Alzheimer's disease risk.
    Alzheimers Dement. 2022 May 22. doi: 10.1002/alz.12687.
    PubMed    


  548. LUO J, Thomassen JQ, Hegazy SH, Rasmussen IJ, et al
    Reply to "Mendelian randomization highlights causal association between genetically increased C-reactive protein levels and reduced Alzheimer's disease risk".
    Alzheimers Dement. 2022 May 22. doi: 10.1002/alz.12688.
    PubMed    


  549. ASHLEIGH T, Swerdlow RH, Beal MF
    The role of mitochondrial dysfunction in Alzheimer's disease pathogenesis.
    Alzheimers Dement. 2022 May 6. doi: 10.1002/alz.12683.
    PubMed     Abstract available


  550. SEXTON C, Snyder H, Beher D, Boxer AL, et al
    Current directions in tau research: Highlights from Tau 2020.
    Alzheimers Dement. 2022;18:988-1007.
    PubMed     Abstract available


  551. IMBIMBO BP, Ippati S, Watling M, Balducci C, et al
    A critical appraisal of tau-targeting therapies for primary and secondary tauopathies.
    Alzheimers Dement. 2022;18:1008-1037.
    PubMed     Abstract available


  552. PERRY BL, McConnell WR, Coleman ME, Roth AR, et al
    Why the cognitive "fountain of youth" may be upstream: Pathways to dementia risk and resilience through social connectedness.
    Alzheimers Dement. 2022;18:934-941.
    PubMed     Abstract available


    April 2022
  553. CHANG R, Trushina E, Zhu K, Zaidi SSA, et al
    Predictive metabolic networks reveal sex- and APOE genotype-specific metabolic signatures and drivers for precision medicine in Alzheimer's disease.
    Alzheimers Dement. 2022 Apr 28. doi: 10.1002/alz.12675.
    PubMed     Abstract available


  554. PARK SY, Setiawan VW, White LR, Wu AH, et al
    Modifying effects of race and ethnicity and APOE on the association of physical activity with risk of Alzheimer's disease and related dementias.
    Alzheimers Dement. 2022 Apr 27. doi: 10.1002/alz.12677.
    PubMed     Abstract available


  555. JESSEN F, Wolfsgruber S, Kleineindam L, Spottke A, et al
    Subjective cognitive decline and stage 2 of Alzheimer disease in patients from memory centers.
    Alzheimers Dement. 2022 Apr 22. doi: 10.1002/alz.12674.
    PubMed     Abstract available


  556. QUAN L, Moreno-Gonzalez I, Xie Z, Gamez N, et al
    A near-infrared probe for detecting and interposing amyloid beta oligomerization in early Alzheimer's disease.
    Alzheimers Dement. 2022 Apr 18. doi: 10.1002/alz.12673.
    PubMed     Abstract available


  557. TJANDRA D, Migrino RQ, Giordani B, Wiens J, et al
    Use of blood pressure measurements extracted from the electronic health record in predicting Alzheimer's disease: A retrospective cohort study at two medical centers.
    Alzheimers Dement. 2022 Apr 16. doi: 10.1002/alz.12676.
    PubMed     Abstract available


  558. TA PARK VM, Meyer OL, Tsoh JY, Kanaya AM, et al
    The Collaborative Approach for Asian Americans and Pacific Islanders Research and Education (CARE): A recruitment registry for Alzheimer's disease and related dementias, aging, and caregiver-related research.
    Alzheimers Dement. 2022 Apr 14. doi: 10.1002/alz.12667.
    PubMed     Abstract available


  559. MARTINEZ AE, Weissberger G, Kuklenyik Z, He X, et al
    The small HDL particle hypothesis of Alzheimer's disease.
    Alzheimers Dement. 2022 Apr 13. doi: 10.1002/alz.12649.
    PubMed     Abstract available


  560. MIELKE MM, Aggarwal NT, Vila-Castelar C, Agarwal P, et al
    Consideration of sex and gender in Alzheimer's disease and related disorders from a global perspective.
    Alzheimers Dement. 2022 Apr 8. doi: 10.1002/alz.12662.
    PubMed     Abstract available


  561. WANG Y, Li M, Kazis LE, Xia W, et al
    Clinical outcomes of COVID-19 infection among patients with Alzheimer's disease or mild cognitive impairment.
    Alzheimers Dement. 2022 Apr 4. doi: 10.1002/alz.12665.
    PubMed     Abstract available


  562. FRUIJTIER AD, van der Schaar J, van Maurik IS, Zwan MD, et al
    Identifying best practices for disclosure of amyloid imaging results: A randomized controlled trial.
    Alzheimers Dement. 2022 Apr 2. doi: 10.1002/alz.12630.
    PubMed     Abstract available


  563. LUCKETT PH, Chen C, Gordon BA, Wisch J, et al
    Biomarker clustering in autosomal dominant Alzheimer's disease.
    Alzheimers Dement. 2022 Apr 1. doi: 10.1002/alz.12661.
    PubMed     Abstract available


  564. NEUPANE A, Lenny B, Budde JP, Wang F, et al
    Replication study of AD-associated rare variants.
    Alzheimers Dement. 2022;18:858-862.
    PubMed    


  565. AKINYEMI RO, Yaria J, Ojagbemi A, Guerchet M, et al
    Dementia in Africa: Current evidence, knowledge gaps, and future directions.
    Alzheimers Dement. 2022;18:790-809.
    PubMed     Abstract available


  566. MURA T, Coley N, Amieva H, Berr C, et al
    Cognitive decline as an outcome and marker of progression toward dementia, in early preventive trials.
    Alzheimers Dement. 2022;18:676-687.
    PubMed     Abstract available


  567. LINDBOHM JV, Mars N, Walker KA, Singh-Manoux A, et al
    Plasma proteins, cognitive decline, and 20-year risk of dementia in the Whitehall II and Atherosclerosis Risk in Communities studies.
    Alzheimers Dement. 2022;18:612-624.
    PubMed     Abstract available


  568. POURHADI N, Morch LS, Holm EA, Torp-Pedersen CT, et al
    Vaginal estrogen and association with dementia: A nationwide population-based study.
    Alzheimers Dement. 2022;18:625-634.
    PubMed     Abstract available


  569. MIELKE MM, Aakre JA, Algeciras-Schimnich A, Proctor NK, et al
    Comparison of CSF phosphorylated tau 181 and 217 for cognitive decline.
    Alzheimers Dement. 2022;18:602-611.
    PubMed     Abstract available


  570. CASANOVA R, Hsu FC, Barnard RT, Anderson AM, et al
    Comparing data-driven and hypothesis-driven MRI-based predictors of cognitive impairment in individuals from the Atherosclerosis Risk in Communities (ARIC) study.
    Alzheimers Dement. 2022;18:561-571.
    PubMed     Abstract available


  571. YANG HS, Zhang C, Carlyle BC, Zhen SY, et al
    Plasma IL-12/IFN-gamma axis predicts cognitive trajectories in cognitively unimpaired older adults.
    Alzheimers Dement. 2022;18:645-653.
    PubMed     Abstract available


    March 2022
  572. BRODY M, Agronin M, Herskowitz BJ, Bookheimer SY, et al
    Results and insights from a phase I clinical trial of Lomecel-B for Alzheimer's disease.
    Alzheimers Dement. 2022 Mar 31. doi: 10.1002/alz.12651.
    PubMed     Abstract available


  573. SUNDERLAND KM, Beaton D, Arnott SR, Kleinstiver P, et al
    Characteristics of the Ontario Neurodegenerative Disease Research Initiative cohort.
    Alzheimers Dement. 2022 Mar 30. doi: 10.1002/alz.12632.
    PubMed     Abstract available


  574. ZHANG X, Tong T, Chang A, Ang TFA, et al
    Midlife lipid and glucose levels are associated with Alzheimer's disease.
    Alzheimers Dement. 2022 Mar 23. doi: 10.1002/alz.12641.
    PubMed     Abstract available


  575. JACOBS HIL, Becker JA, Kwong K, Munera D, et al
    Waning locus coeruleus integrity precedes cortical tau accrual in preclinical autosomal dominant Alzheimer's disease.
    Alzheimers Dement. 2022 Mar 17. doi: 10.1002/alz.12656.
    PubMed     Abstract available


  576. LI P, Gao L, Yu L, Zheng X, et al
    Daytime napping and Alzheimer's dementia: A potential bidirectional relationship.
    Alzheimers Dement. 2022 Mar 17. doi: 10.1002/alz.12636.
    PubMed     Abstract available


  577. COE NB, White L, Oney M, Basu A, et al
    Public spending on acute and long-term care for Alzheimer's disease and related dementias.
    Alzheimers Dement. 2022 Mar 16. doi: 10.1002/alz.12657.
    PubMed     Abstract available


  578. NITCHINGHAM A, Pereira JV, Wegner EA, Oxenham V, et al
    Regional cerebral hypometabolism on 18F-FDG PET/CT scan in delirium is independent of acute illness and dementia.
    Alzheimers Dement. 2022 Mar 15. doi: 10.1002/alz.12604.
    PubMed     Abstract available



  579. 2022 Alzheimer's disease facts and figures.
    Alzheimers Dement. 2022 Mar 14. doi: 10.1002/alz.12638.
    PubMed     Abstract available


  580. LIU L, Lauro BM, He A, Lee H, et al
    Identification of the Abeta37/42 peptide ratio in CSF as an improved Abeta biomarker for Alzheimer's disease.
    Alzheimers Dement. 2022 Mar 12. doi: 10.1002/alz.12646.
    PubMed     Abstract available


  581. WINDER Z, Sudduth TL, Anderson S, Patel E, et al
    Examining the association between blood-based biomarkers and human post mortem neuropathology in the University of Kentucky Alzheimer's Disease Research Center autopsy cohort.
    Alzheimers Dement. 2022 Mar 10. doi: 10.1002/alz.12639.
    PubMed     Abstract available


  582. GATZ M, Mack WJ, Chui HC, Law EM, et al
    Prevalence of dementia and mild cognitive impairment in indigenous Bolivian forager-horticulturalists.
    Alzheimers Dement. 2022;19:44-55.
    PubMed     Abstract available


  583. BREITNER JCS, Dodge HH, Khachaturian ZS, Khachaturian AS, et al
    "Exceptions that prove the rule"-Why have clinical trials failed to show efficacy of risk factor interventions suggested by observational studies of the dementia-Alzheimer's disease syndrome?
    Alzheimers Dement. 2022 Mar 4. doi: 10.1002/alz.12633.
    PubMed    



  584. Alzheimer's Association welcomes new Medical and Scientific Advisory Group members.
    Alzheimers Dement. 2022 Mar 4. doi: 10.1002/alz.12621.
    PubMed    


  585. O'BRYANT SE, Petersen M, Hall J, Johnson LA, et al
    Medical comorbidities and ethnicity impact plasma Alzheimer's disease biomarkers: Important considerations for clinical trials and practice.
    Alzheimers Dement. 2022 Mar 2. doi: 10.1002/alz.12647.
    PubMed     Abstract available


  586. CONNOLLY K, Lehoux M, O'Rourke R, Assetta B, et al
    Potential role of chitinase-3-like protein 1 (CHI3L1/YKL-40) in neurodegeneration and Alzheimer's disease.
    Alzheimers Dement. 2022 Mar 2. doi: 10.1002/alz.12612.
    PubMed     Abstract available


  587. STOCKER H, Beyer L, Perna L, Rujescu D, et al
    Association of plasma biomarkers, p-tau181, glial fibrillary acidic protein, and neurofilament light, with intermediate and long-term clinical Alzheimer's disease risk: Results from a prospective cohort followed over 17 years.
    Alzheimers Dement. 2022 Mar 2. doi: 10.1002/alz.12614.
    PubMed     Abstract available


  588. CUMMINGS J, Salloway S
    Aducanumab: Appropriate use recommendations.
    Alzheimers Dement. 2022;18:531-533.
    PubMed    


  589. PETERSON A, Clapp J, Largent EA, Harkins K, et al
    What is paradoxical lucidity? The answer begins with its definition.
    Alzheimers Dement. 2022;18:513-521.
    PubMed     Abstract available


  590. BARIL AA, Beiser AS, Sanchez E, Mysliwiec V, et al
    Insomnia symptom severity and cognitive performance: Moderating role of APOE genotype.
    Alzheimers Dement. 2022;18:408-421.
    PubMed     Abstract available


    February 2022
  591. GIETL AF, Frisoni GB
    Early termination of pivotal trials in Alzheimer's disease-Preserving optimal value for participants and science.
    Alzheimers Dement. 2022 Feb 27. doi: 10.1002/alz.12605.
    PubMed     Abstract available


  592. KETCHUM FB, Chin NA, Grill J, Gleason CE, et al
    Moving beyond disclosure: Stages of care in preclinical Alzheimer's disease biomarker testing.
    Alzheimers Dement. 2022 Feb 25. doi: 10.1002/alz.12620.
    PubMed     Abstract available


  593. ASHFORD MT, Raman R, Miller G, Donohue MC, et al
    Screening and enrollment of underrepresented ethnocultural and educational populations in the Alzheimer's Disease Neuroimaging Initiative (ADNI).
    Alzheimers Dement. 2022 Feb 25. doi: 10.1002/alz.12640.
    PubMed     Abstract available


  594. ZETTERBERG H
    Biofluid-based biomarkers for Alzheimer's disease-related pathologies: An update and synthesis of the literature.
    Alzheimers Dement. 2022 Feb 25. doi: 10.1002/alz.12618.
    PubMed     Abstract available


  595. XIONG C, Luo J, Schindler SE, Fagan AM, et al
    Racial differences in longitudinal Alzheimer's disease biomarkers among cognitively normal adults.
    Alzheimers Dement. 2022 Feb 25. doi: 10.1002/alz.12608.
    PubMed     Abstract available


  596. MONI F, Petersen ME, Zhang F, Lao PJ, et al
    Probing the proteome to explore potential correlates of increased Alzheimer's-related cerebrovascular disease in adults with Down syndrome.
    Alzheimers Dement. 2022 Feb 24. doi: 10.1002/alz.12627.
    PubMed     Abstract available


  597. LEVIN J, Voglein J, Quiroz YT, Bateman RJ, et al
    Testing the amyloid cascade hypothesis: Prevention trials in autosomal dominant Alzheimer disease.
    Alzheimers Dement. 2022 Feb 24. doi: 10.1002/alz.12624.
    PubMed     Abstract available


  598. QUIROZ YT, Solis M, Aranda MP, Arbaje AI, et al
    Addressing the disparities in dementia risk, early detection and care in Latino populations: Highlights from the second Latinos & Alzheimer's Symposium.
    Alzheimers Dement. 2022 Feb 24. doi: 10.1002/alz.12589.
    PubMed     Abstract available


  599. SEXTON C, Solis M, Aharon-Peretz J, Alexopoulos P, et al
    Alzheimer's disease research progress in the Mediterranean region: The Alzheimer's Association International Conference Satellite Symposium.
    Alzheimers Dement. 2022 Feb 20. doi: 10.1002/alz.12588.
    PubMed     Abstract available


  600. MECCA AP, O'Dell RS, Sharp ES, Banks ER, et al
    Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [(11) C]UCB-J.
    Alzheimers Dement. 2022 Feb 17. doi: 10.1002/alz.12582.
    PubMed     Abstract available


  601. SUCHY-DICEY A, Howard B, Longstreth WT Jr, Reiman EM, et al
    APOE genotype, hippocampus, and cognitive markers of Alzheimer's disease in American Indians: Data from the Strong Heart Study.
    Alzheimers Dement. 2022 Feb 10. doi: 10.1002/alz.12573.
    PubMed     Abstract available


  602. KRELL-ROESCH J, Rakusa M, Syrjanen JA, van Harten AC, et al
    Association between CSF biomarkers of Alzheimer's disease and neuropsychiatric symptoms: Mayo Clinic Study of Aging.
    Alzheimers Dement. 2022 Feb 9. doi: 10.1002/alz.12557.
    PubMed     Abstract available


  603. CLAES C, England WE, Danhash EP, Kiani Shabestari S, et al
    The P522R protective variant of PLCG2 promotes the expression of antigen presentation genes by human microglia in an Alzheimer's disease mouse model.
    Alzheimers Dement. 2022 Feb 9. doi: 10.1002/alz.12577.
    PubMed     Abstract available


  604. HU WT
    Reporting and social construction of race in Alzheimer's disease clinical trials.
    Alzheimers Dement. 2022 Feb 9. doi: 10.1002/alz.12609.
    PubMed    


  605. ASTILLERO-LOPEZ V, Gonzalez-Rodriguez M, Villar-Conde S, Flores-Cuadrado A, et al
    Neurodegeneration and astrogliosis in the entorhinal cortex in Alzheimer's disease: Stereological layer-specific assessment and proteomic analysis.
    Alzheimers Dement. 2022 Feb 9. doi: 10.1002/alz.12580.
    PubMed     Abstract available


  606. FLACH M, Leu C, Martinisi A, Skachokova Z, et al
    Trans-seeding of Alzheimer-related tau protein by a yeast prion.
    Alzheimers Dement. 2022 Feb 9. doi: 10.1002/alz.12581.
    PubMed     Abstract available


  607. PRADOS MJ, Liu Y, Jun H, Lam J, et al
    Projecting the long-term societal value of a disease-modifying treatment for Alzheimer's disease in the United States.
    Alzheimers Dement. 2022 Feb 9. doi: 10.1002/alz.12578.
    PubMed     Abstract available


  608. BABULAL GM, Franzen S, Abner EL, Smith JE, et al
    Diversity in Alzheimer's disease drug trials: Reflections on reporting and social construction of race.
    Alzheimers Dement. 2022 Feb 9. doi: 10.1002/alz.12611.
    PubMed    


  609. JUN GR, You Y, Zhu C, Meng G, et al
    Protein phosphatase 2A and complement component 4 are linked to the protective effect of APOE varepsilon2 for Alzheimer's disease.
    Alzheimers Dement. 2022 Feb 9. doi: 10.1002/alz.12607.
    PubMed     Abstract available


  610. VARDARAJAN BN, Reyes-Dumeyer D, Piriz AL, Lantigua RA, et al
    Progranulin mutations in clinical and neuropathological Alzheimer's disease.
    Alzheimers Dement. 2022 Feb 9. doi: 10.1002/alz.12567.
    PubMed     Abstract available


  611. REIKEN S, Sittenfeld L, Dridi H, Liu Y, et al
    Alzheimer's-like signaling in brains of COVID-19 patients.
    Alzheimers Dement. 2022 Feb 3. doi: 10.1002/alz.12558.
    PubMed     Abstract available


  612. RUTHIRAKUHAN M, Ismail Z, Herrmann N, Gallagher D, et al
    Mild behavioral impairment is associated with progression to Alzheimer's disease: A clinicopathological study.
    Alzheimers Dement. 2022 Feb 1. doi: 10.1002/alz.12519.
    PubMed     Abstract available


  613. REIMAN EM, Mattke S, Kordower JH, Khachaturian ZS, et al
    Developing a pathway to support the appropriate, affordable, and widespread use of effective Alzheimer's prevention drugs.
    Alzheimers Dement. 2022 Feb 1. doi: 10.1002/alz.12533.
    PubMed    



  614. Applications being accepted for the Alzheimer's Association Interdisciplinary Summer Research Institute.
    Alzheimers Dement. 2022 Feb 1. doi: 10.1002/alz.12585.
    PubMed    


  615. VILA-CASTELAR C, Tariot PN, Sink KM, Clayton D, et al
    Sex differences in cognitive resilience in preclinical autosomal-dominant Alzheimer's disease carriers and non-carriers: Baseline findings from the API ADAD Colombia Trial.
    Alzheimers Dement. 2022 Feb 1. doi: 10.1002/alz.12552.
    PubMed     Abstract available


  616. WAGNER M, Wilson RS, Leurgans SE, Boyle PA, et al
    Quantifying longitudinal cognitive resilience to Alzheimer's disease and other neuropathologies.
    Alzheimers Dement. 2022 Feb 1. doi: 10.1002/alz.12576.
    PubMed     Abstract available


  617. ERATNE D, Loi SM, Li QX, Stehmann C, et al
    Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer's disease and frontotemporal disorders in clinical settings.
    Alzheimers Dement. 2022 Feb 1. doi: 10.1002/alz.12549.
    PubMed     Abstract available


  618. O'BRYANT S, Petersen M, Hall J, Johnson L, et al
    Characterizing plasma NfL in a community-dwelling multi-ethnic cohort: Results from the HABLE study.
    Alzheimers Dement. 2022;18:240-250.
    PubMed     Abstract available


  619. NAUEN DW, Troncoso JC
    Amyloid-beta is present in human lymph nodes and greatly enriched in those of the cervical region.
    Alzheimers Dement. 2022;18:205-210.
    PubMed     Abstract available


  620. KREISL WC, Lao PJ, Johnson A, Tomljanovic Z, et al
    Patterns of tau pathology identified with (18) F-MK-6240 PET imaging.
    Alzheimers Dement. 2022;18:272-282.
    PubMed     Abstract available


  621. SCHMUTTE T, Olfson M, Maust DT, Xie M, et al
    Suicide risk in first year after dementia diagnosis in older adults.
    Alzheimers Dement. 2022;18:262-271.
    PubMed     Abstract available


    January 2022
  622. CALDWELL AB, Liu Q, Zhang C, Schroth GP, et al
    Endotype reversal as a novel strategy for screening drugs targeting familial Alzheimer's disease.
    Alzheimers Dement. 2022 Jan 27. doi: 10.1002/alz.12553.
    PubMed     Abstract available


  623. WANG T, Huynh K, Giles C, Mellett NA, et al
    APOE epsilon2 resilience for Alzheimer's disease is mediated by plasma lipid species: Analysis of three independent cohort studies.
    Alzheimers Dement. 2022 Jan 25. doi: 10.1002/alz.12538.
    PubMed     Abstract available


  624. JORDA-SIQUIER T, Petrel M, Kouskoff V, Smailovic U, et al
    APP accumulates with presynaptic proteins around amyloid plaques: A role for presynaptic mechanisms in Alzheimer's disease?
    Alzheimers Dement. 2022 Jan 25. doi: 10.1002/alz.12546.
    PubMed     Abstract available


  625. FRONTERA JA, Boutajangout A, Masurkar AV, Betensky RA, et al
    Comparison of serum neurodegenerative biomarkers among hospitalized COVID-19 patients versus non-COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer's dementia.
    Alzheimers Dement. 2022 Jan 13. doi: 10.1002/alz.12556.
    PubMed     Abstract available


  626. YAO J, Liu Y, Sun B, Zhan X, et al
    Increased RyR2 open probability induces neuronal hyperactivity and memory loss with or without Alzheimer's disease-causing gene mutations.
    Alzheimers Dement. 2022 Jan 5. doi: 10.1002/alz.12543.
    PubMed     Abstract available


  627. NAZARIAN A, Loika Y, He L, Culminskaya I, et al
    Genome-wide analysis identified abundant genetic modulators of contributions of the apolipoprotein E alleles to Alzheimer's disease risk.
    Alzheimers Dement. 2022 Jan 3. doi: 10.1002/alz.12540.
    PubMed     Abstract available


  628. REYES-DUMEYER D, Faber K, Vardarajan B, Goate A, et al
    The National Institute on Aging Late-Onset Alzheimer's Disease Family Based Study: A resource for genetic discovery.
    Alzheimers Dement. 2022 Jan 3. doi: 10.1002/alz.12514.
    PubMed     Abstract available


  629. QIU S, Hu Y, Cheng L
    BIN1 rs744373 located in enhancers of brain tissues upregulates BIN1 mRNA expression, thereby leading to Alzheimer's disease.
    Alzheimers Dement. 2022 Jan 3. doi: 10.1002/alz.12548.
    PubMed    


  630. ZAMOLODCHIKOV D, Duffield M, Macdonald LE, Alessandri-Haber N, et al
    Accumulation of high molecular weight kininogen in the brains of Alzheimer's disease patients may affect microglial function by altering phagocytosis and lysosomal cathepsin activity.
    Alzheimers Dement. 2022 Jan 3. doi: 10.1002/alz.12531.
    PubMed     Abstract available



  631. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring announces new editor-in-chief for open access, peer reviewed journal.
    Alzheimers Dement. 2022 Jan 3. doi: 10.1002/alz.12517.
    PubMed    


  632. KETCHUM FB
    Solomon Carter Fuller: Alzheimer's contemporary and American pioneer.
    Alzheimers Dement. 2022 Jan 3. doi: 10.1002/alz.12551.
    PubMed    


  633. JAKEL L, De Kort AM, Klijn CJM, Schreuder FHBM, et al
    Prevalence of cerebral amyloid angiopathy: A systematic review and meta-analysis.
    Alzheimers Dement. 2022;18:10-28.
    PubMed     Abstract available


  634. ZHAO Y, Kuca K, Wu W, Wang X, et al
    Hypothesis: JNK signaling is a therapeutic target of neurodegenerative diseases.
    Alzheimers Dement. 2022;18:152-158.
    PubMed     Abstract available


  635. BUTT OH, Meeker KL, Wisch JK, Schindler SE, et al
    Network dysfunction in cognitively normal APOE epsilon4 carriers is related to subclinical tau.
    Alzheimers Dement. 2022;18:116-126.
    PubMed     Abstract available


  636. VOGT NM, Hunt JFV, Adluru N, Ma Y, et al
    Interaction of amyloid and tau on cortical microstructure in cognitively unimpaired adults.
    Alzheimers Dement. 2022;18:65-76.
    PubMed     Abstract available


    December 2021
  637. DELABY C, Teunissen CE, Blennow K, Alcolea D, et al
    Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview.
    Alzheimers Dement. 2021 Dec 22. doi: 10.1002/alz.12545.
    PubMed     Abstract available


  638. MING C, Wang M, Wang Q, Neff R, et al
    Whole genome sequencing-based copy number variations reveal novel pathways and targets in Alzheimer's disease.
    Alzheimers Dement. 2021 Dec 17. doi: 10.1002/alz.12507.
    PubMed     Abstract available


  639. HAWKINSON TR, Clarke HA, Young LEA, Conroy LR, et al
    In situ spatial glycomic imaging of mouse and human Alzheimer's disease brains.
    Alzheimers Dement. 2021 Dec 15. doi: 10.1002/alz.12523.
    PubMed     Abstract available


  640. LIM U, Wang S, Park SY, Bogumil D, et al
    Risk of Alzheimer's disease and related dementia by sex and race/ethnicity: The Multiethnic Cohort Study.
    Alzheimers Dement. 2021 Dec 9. doi: 10.1002/alz.12528.
    PubMed     Abstract available


  641. GORDON MN, Heneka MT, Le Page LM, Limberger C, et al
    Impact of COVID-19 on the Onset and Progression of Alzheimer's Disease and Related Dementias: A Roadmap for Future Research.
    Alzheimers Dement. 2021 Dec 7. doi: 10.1002/alz.12488.
    PubMed     Abstract available


  642. DE KORT AM, Kuiperij HB, Kersten I, Versleijen AAM, et al
    Normal cerebrospinal fluid concentrations of PDGFRbeta in patients with cerebral amyloid angiopathy and Alzheimer's disease.
    Alzheimers Dement. 2021 Dec 7. doi: 10.1002/alz.12506.
    PubMed     Abstract available


  643. SILVERMAN W, Krinsky-McHale SJ, Zigman WB, Schupf N, et al
    Adults with Down syndrome in randomized clinical trials targeting prevention of Alzheimer's disease.
    Alzheimers Dement. 2021 Dec 7. doi: 10.1002/alz.12520.
    PubMed     Abstract available


  644. SAROJA SR, Sharma A, Hof PR, Pereira AC, et al
    Differential expression of tau species and the association with cognitive decline and synaptic loss in Alzheimer's disease.
    Alzheimers Dement. 2021 Dec 7. doi: 10.1002/alz.12518.
    PubMed     Abstract available


  645. GLEASON CE, Zuelsdorff M, Gooding DC, Kind AJH, et al
    Alzheimer's disease biomarkers in Black and non-Hispanic White cohorts: A contextualized review of the evidence.
    Alzheimers Dement. 2021 Dec 6. doi: 10.1002/alz.12511.
    PubMed     Abstract available


  646. HAEGER A, Bottlaender M, Lagarde J, Porciuncula Baptista R, et al
    What can 7T sodium MRI tell us about cellular energy depletion and neurotransmission in Alzheimer's disease?
    Alzheimers Dement. 2021 Dec 2. doi: 10.1002/alz.12501.
    PubMed     Abstract available



  647. AAIC 2021: The promise of Alzheimer's research.
    Alzheimers Dement. 2021 Dec 2. doi: 10.1002/alz.12500.
    PubMed    


  648. FRANK B, Ally M, Brekke B, Zetterberg H, et al
    Plasma p-tau181 shows stronger network association to Alzheimer's disease dementia than neurofilament light and total tau.
    Alzheimers Dement. 2021 Dec 2. doi: 10.1002/alz.12508.
    PubMed     Abstract available


  649. STATHAS S, Alvarez VE, Xia W, Nicks R, et al
    Tau phosphorylation sites serine202 and serine396 are differently altered in chronic traumatic encephalopathy and Alzheimer's disease.
    Alzheimers Dement. 2021 Dec 2. doi: 10.1002/alz.12502.
    PubMed     Abstract available


  650. BUCKLES VD, Xiong C, Bateman RJ, Hassenstab J, et al
    Different rates of cognitive decline in autosomal dominant and late-onset Alzheimer disease.
    Alzheimers Dement. 2021 Dec 2. doi: 10.1002/alz.12505.
    PubMed     Abstract available


  651. STRINGER C, Smithroat N, Samus QM, Johnston D, et al
    From research to realization: How a Texas health plan implemented an academic model of care for Alzheimer's disease.
    Alzheimers Dement. 2021;17 Suppl 8:e054058.
    PubMed     Abstract available


  652. MENENGIC KN, Yeldan I, Cinar N, Sahiner TA, et al
    Effectiveness of home-based telerehabilitation in mild to moderate Alzheimer's disease: A randomised controlled study.
    Alzheimers Dement. 2021;17 Suppl 8:e053406.
    PubMed     Abstract available


  653. ASCHETTINO LA, Labyak CA, Sealey-Potts C
    Nutritional treatments for Alzheimer's disease: A narrative review.
    Alzheimers Dement. 2021;17 Suppl 8:e053172.
    PubMed     Abstract available


  654. LEE JH, Kim DY, Kim MG, Kang H, et al
    Preventing cognitive decline in older adults with mild cognitive impairment using integrated Korean and Western treatments: Initial results.
    Alzheimers Dement. 2021;17 Suppl 8:e052545.
    PubMed     Abstract available


  655. GELDMACHER DS, Christopher R, Anderson M, Bero AW, et al
    Development of a site readiness framework to improve health system preparedness for potential new Alzheimer's disease therapies.
    Alzheimers Dement. 2021;17 Suppl 8:e057672.
    PubMed     Abstract available


  656. KEELY AJ
    The first female engineer at General Motor's descent into Alzheimer's with sundowners: A daughter's scholarly research and case study as caregiver.
    Alzheimers Dement. 2021;17 Suppl 8:e050143.
    PubMed     Abstract available


  657. FLATT JD, Pollock K, Lee R, Song Y, et al
    Feasibility of the Savvy Caregiver program for care providers of LGBTQ adults living with Alzheimer's disease and related dementias.
    Alzheimers Dement. 2021;17 Suppl 8:e055633.
    PubMed     Abstract available


  658. MILLER DR, Jasuja G, Davila HW, Palnati M, et al
    Care processes related to clinical detection of Alzheimer's disease in the U.S. Veterans Affairs Health Care System.
    Alzheimers Dement. 2021;17 Suppl 8:e054149.
    PubMed     Abstract available


  659. MAKSIMOVICH IV
    Stimulation of cerebral angiogenesis and neurogenesis with transcatheter intracerebral laser photobiomodulation therapy during dementia in patients with Alzheimer's and Binswanger's disease.
    Alzheimers Dement. 2021;17 Suppl 8:e054945.
    PubMed     Abstract available


  660. GONZALEZ A, Camila C, Maccioni RB
    Alzheimer's disease: A potential diabetes type 3.
    Alzheimers Dement. 2021;17 Suppl 2:e058533.
    PubMed     Abstract available


  661. MOYLAN C, Cao TV, Huynh QS, Pratap A, et al
    Exercise-Induced Alterations in TrkB expression in the 5XFAD Mouse Model of Alzheimer's Disease.
    Alzheimers Dement. 2021;17 Suppl 2:e058733.
    PubMed     Abstract available


  662. GAITAN JM, Dubal DB, Okonkwo OC
    Circulating klotho is elevated in cerebrospinal fluid, but not serum, among KLOTHO KL-VS allele carriers at risk for Alzheimer's disease.
    Alzheimers Dement. 2021;17 Suppl 2:e058612.
    PubMed     Abstract available


  663. COULON A, Mendes T, Kilinc D, Dumont J, et al
    High-content screening of Alzheimer's disease genetic risk factors based on synaptic density analysis.
    Alzheimers Dement. 2021;17 Suppl 2:e058660.
    PubMed     Abstract available


  664. TSAI AP, Lin PB, Dong C, Moutinho M, et al
    Impact of PLCG2 expression on Microglial Biology and Disease Pathogenesis in Alzheimer's Disease.
    Alzheimers Dement. 2021;17 Suppl 2:e058740.
    PubMed     Abstract available


  665. HUANG CW, Hart GW
    Decreased O-GlcNAcylation and mitochondrial dysfunction are involving in low glucose induced Alzheimer's disease-like phenotype in induced pluripotent stem cell-derived neurons.
    Alzheimers Dement. 2021;17 Suppl 2:e058620.
    PubMed     Abstract available


  666. BRACH TL, Gaitan JM, Okonkwo OC
    Effect of Aerobic Exercise Training on Mood and Cognition in Adults at Risk for Alzheimer's Disease.
    Alzheimers Dement. 2021;17 Suppl 2:e058523.
    PubMed     Abstract available


  667. LIN PB, Tsai AP, Nho K, Lamb BT, et al
    INPP5D regulates the amyloid pathology in Alzheimer's disease.
    Alzheimers Dement. 2021;17 Suppl 2:e058724.
    PubMed     Abstract available


  668. KUMAR A, Doran E, Martini AC, Head E, et al
    CAA and related co-morbidities in Down syndrome and Alzheimer disease.
    Alzheimers Dement. 2021;17 Suppl 2:e058726.
    PubMed     Abstract available


  669. TEMITOPE SR
    The role of lycopene on the hippocampus of rat model of lipopolysaccharide-induced Alzheimer's disease.
    Alzheimers Dement. 2021;17 Suppl 2:e058528.
    PubMed     Abstract available


  670. YEATES C, Sarkar A, Deshpande P, Kango-Singh M, et al
    A Two-Clone approach to study signaling interactions among neuronal cells in a pre-clinical Alzheimer's Disease model.
    Alzheimers Dement. 2021;17 Suppl 2:e058690.
    PubMed     Abstract available


  671. GOMEZ J JR, Villegas-Lanau CA, Mesa A Sr
    Colocalization of the beta amyloid peptide with bacteria in postmortem brain tissue of patients with familial Alzheimer's disease.
    Alzheimers Dement. 2021;17 Suppl 2:e058692.
    PubMed     Abstract available


  672. SUNG K, Yang F, Noble W, Jimenez-Sanchez M, et al
    Investigating the non-cell autonomous role of glial chaperones in Alzheimer's disease.
    Alzheimers Dement. 2021;17 Suppl 2:e058572.
    PubMed     Abstract available


  673. GOMEZ J JR, Villegas-Lanau CA, Mesa A Sr
    Human Herpesvirus detection and identification in postmortem brain tissue of patients with Alzheimer's disease.
    Alzheimers Dement. 2021;17 Suppl 2:e058693.
    PubMed     Abstract available


  674. SCHRAUBEN M, Smith AR, Washer S, Dempster E, et al
    Investigating epigenetic loci implicated in Alzheimer's disease via the CRISPR-Cas9 system.
    Alzheimers Dement. 2021;17 Suppl 2:e058573.
    PubMed     Abstract available


  675. TALIYAN R, Kakoty V, Kc S, Kumari S, et al
    Fibroblast Growth Factor 21 and Autophagy Modulation Ameliorates Amyloid beta-Induced Alzheimer Disease Pathology in Rats.
    Alzheimers Dement. 2021;17 Suppl 2:e058695.
    PubMed     Abstract available


  676. YANG F, Sung K, Sanchez MJ
    Investigating the secretion of small heat shock proteins in reactive astrocytes in Alzheimer's disease.
    Alzheimers Dement. 2021;17 Suppl 2:e058498.
    PubMed     Abstract available


  677. ROSENE MJ, Hsu S, Martinez R, Norton J, et al
    Defining the role of PLD3 in Alzheimer's disease pathology.
    Alzheimers Dement. 2021;17 Suppl 2:e058730.
    PubMed     Abstract available


  678. TREMBLAY JP, Tremblay G, Guyon A, Joel R, et al
    Insertion of the Icelandic mutation (A673T) in the APP gene using the CRISPR/Cas9 base editing and Prime editing technologies, a preventive treatment for Alzheimer?
    Alzheimers Dement. 2021;17 Suppl 2:e058710.
    PubMed     Abstract available


  679. CHEN J, Samoylova NG, Cummings MG
    TOMM40, a risk gene for Alzheimer's disease, is upregulated during proinflammatory response.
    Alzheimers Dement. 2021;17 Suppl 2:e058711.
    PubMed     Abstract available


  680. MCARDLE CJ, Niere F, Uneri A, Raab-Graham KF, et al
    Alterations in dendritic GABAB receptor expression in an Alzheimer's disease mouse model.
    Alzheimers Dement. 2021;17 Suppl 2:e058557.
    PubMed     Abstract available


  681. DESHPANDE P, Chen CY, Yeates C, Chen CH, et al
    miR-277 targets hid to ameliorate Abeta42-mediated neurodegeneration in Drosophila eye model of Alzheimer's Disease.
    Alzheimers Dement. 2021;17 Suppl 2:e058678.
    PubMed     Abstract available


  682. ZHAO P, Mangleburg CG, Al-Ramahi I, Botas J, et al
    Systems genetic dissection of Alzheimer's disease brain gene expression networks.
    Alzheimers Dement. 2021;17 Suppl 2:e058716.
    PubMed     Abstract available


  683. MUMFORD P, Noy S, Tybulewicz VL, Fisher E, et al
    Preclinical modelling in the mouse of altered neuroinflammation in Alzheimer's disease - Down syndrome.
    Alzheimers Dement. 2021;17 Suppl 2:e058441.
    PubMed     Abstract available


  684. TIPTON AE, George J, Ratner M, Farb D, et al
    Data from single nuclei RNA-sequencing reveals a prodromal gene network response in excitatory neurons of a humanized rat Alzheimer's disease model.
    Alzheimers Dement. 2021;17 Suppl 2:e058589.
    PubMed     Abstract available


  685. TAYLOR AL, Davis DE Jr, Codreanu SG, Harrison FE, et al
    Targeted and untargeted mass spectrometry reveals impact of high fat diet on peripheral amino acid regulation in a mouse model of Alzheimer's disease.
    Alzheimers Dement. 2021;17 Suppl 2:e058428.
    PubMed     Abstract available


  686. ROSOLEN SA
    Exercise-induced metabolic changes in astrocytes in the 5xFAD mouse model of Alzheimer's Disease.
    Alzheimers Dement. 2021;17 Suppl 2:e058627.
    PubMed     Abstract available


  687. SRIVASTAV A, Mohideen SS
    Intestinal microbial dysbiosis induced tau accumulation establishes a gut-brain correlation for pathology Alzheimer's disease in Drosophila melanogaster.
    Alzheimers Dement. 2021;17 Suppl 2:e058708.
    PubMed     Abstract available


  688. HERSH SW, You Y, Aslebagh R, Shaffer SA, et al
    Alzheimer's disease associated AKAP9 I2558M mutation alters posttranslational modification and interactome of tau and cellular functions in CRISPR-edited human neuronal cells.
    Alzheimers Dement. 2021;17 Suppl 2:e058592.
    PubMed     Abstract available


  689. PRATER KE, Green KJ, Chiou KL, Smith CL, et al
    Microglia subtype transcriptomes differ between Alzheimer Disease and control human postmortem brain samples.
    Alzheimers Dement. 2021;17 Suppl 2:e058474.
    PubMed     Abstract available


  690. CZAPLICKI AM, Gaitan JM, Bendlin BB, Johnson SC, et al
    The Interaction between Ventricle to Brain Ratio and Serum Klotho on Cognition in Older Adults at Risk for Alzheimer's Disease.
    Alzheimers Dement. 2021;17 Suppl 12:e058632.
    PubMed     Abstract available


  691. BABATOPE EY, Acosta-Franco JA, Garcia-Vazquez MS, Ramirez-Acosta AA, et al
    Applying a deep learning approach focusing on spatiotemporal features in early diagnosis of Alzheimer's disease.
    Alzheimers Dement. 2021;17 Suppl 12:e058635.
    PubMed     Abstract available


  692. MCINTYRE CC, Okonkwo OC, Gaitan JM, Bendlin BB, et al
    Effect of insulin resistance on the association between cardiorespiratory fitness and cognition in adults at risk for Alzheimer's disease.
    Alzheimers Dement. 2021;17 Suppl 12:e058683.
    PubMed     Abstract available


  693. WANG RP, Leung WK, Goto T, Ho JY, et al
    IL-1 beta and TNF-alpha play an essential role in modulating the risk of both periodontitis and Alzheimer's disease.
    Alzheimers Dement. 2021;17 Suppl 12:e058464.
    PubMed     Abstract available


  694. MEMUDU AE, Waziri RJ
    An investigative study to demonstrate the link between combined intake of marijuana and codeine in Alzheimer's disease pathology.
    Alzheimers Dement. 2021;17 Suppl 12:e058465.
    PubMed     Abstract available


  695. RISHITHA N, Muthuraman A
    Therapeutic investigation of alpha napthoflavone in the intracerebroventricular injection of L-cysteine induced vascular dementia in rats.
    Alzheimers Dement. 2021;17 Suppl 12:e058344.
    PubMed     Abstract available


  696. ABDULKADIR TS, Isa AS, Dawud FA, Ayo JO, et al
    Effect of taurine and camel milk on amyloid beta peptide concentration and oxidative stress changes in aluminium chloride-induced Alzheimer's disease rats.
    Alzheimers Dement. 2021;17 Suppl 12:e058642.
    PubMed     Abstract available


  697. OKHUEVBIE DO, Awolaja S, Balogun Z
    Evaluation of the effect of Donepezil hydrochloride on Ethanol-induced hippocampal damage.
    Alzheimers Dement. 2021;17 Suppl 12:e058353.
    PubMed     Abstract available


  698. K C S, Kakoty VK, Taliyan R
    Development and Validation of PEG-PCL Based Nanoformulation of Rosiglitazone and Evaluation of its Brain Selectivity in Mice Model of Alzheimer's disease.
    Alzheimers Dement. 2021;17 Suppl 12:e058674.
    PubMed     Abstract available


  699. TORT-MERINO A, Tarnanas I, Bugler M, Harms R, et al
    ALTOIDA-iADL for the diagnosis of Mild Cognitive Impairment and early Alzheimer's disease.
    Alzheimers Dement. 2021;17 Suppl 12:e057982.
    PubMed     Abstract available


  700. ROWE EM, Louadi S, Koch E, Kuhlmann N, et al
    A Month in Neurodegenerative Disease Research (AMiNDR): The evolution of an open-access podcast series for Alzheimer's researchers.
    Alzheimers Dement. 2021;17 Suppl 11:e053287.
    PubMed     Abstract available


  701. YUAN F, Lopez RP, Crane M, Montgomery A, et al
    Feasibility and acceptance of robotic care of Alzheimer's disease and related dementia.
    Alzheimers Dement. 2021;17 Suppl 11:e052585.
    PubMed     Abstract available


  702. KUHNEL L, Bouteloup V, Lespinasse J, Chene G, et al
    Personalized prediction of progression in pre-dementia patients based on individual biomarker profile: A development and validation study.
    Alzheimers Dement. 2021;17:1938-1949.
    PubMed     Abstract available


  703. GOLD BT, Shao X, Sudduth TL, Jicha GA, et al
    Water exchange rate across the blood-brain barrier is associated with CSF amyloid-beta 42 in healthy older adults.
    Alzheimers Dement. 2021;17:2020-2029.
    PubMed     Abstract available


  704. XU Y, Chen Z, Wey HY, Liang Y, et al
    Molecular imaging of NAD(+) -dependent deacetylase SIRT1 in the brain.
    Alzheimers Dement. 2021;17:1988-1997.
    PubMed     Abstract available


    November 2021
  705. VERBERK IMW, Misdorp EO, Koelewijn J, Ball AJ, et al
    Characterization of pre-analytical sample handling effects on a panel of Alzheimer's disease-related blood-based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group.
    Alzheimers Dement. 2021 Nov 29. doi: 10.1002/alz.12510.
    PubMed     Abstract available


  706. MURCHISON AG
    Hypothesis: Modulation of microglial phenotype in Alzheimer's disease drives neurodegeneration.
    Alzheimers Dement. 2021 Nov 17. doi: 10.1002/alz.12503.
    PubMed     Abstract available


  707. JIA L, Yang J, Zhu M, Pang Y, et al
    A metabolite panel that differentiates Alzheimer's disease from other dementia types.
    Alzheimers Dement. 2021 Nov 17. doi: 10.1002/alz.12484.
    PubMed     Abstract available


  708. WEINTRAUB S, Karpouzian-Rogers T, Peipert JD, Nowinski C, et al
    ARMADA: Assessing reliable measurement in Alzheimer's disease and cognitive aging project methods.
    Alzheimers Dement. 2021 Nov 17. doi: 10.1002/alz.12497.
    PubMed     Abstract available


  709. JUTKOWITZ E, Halladay C, Tsai J, Hooshyar D, et al
    Prevalence of Alzheimer's disease and related dementias among veterans experiencing housing insecurity.
    Alzheimers Dement. 2021 Nov 10. doi: 10.1002/alz.12476.
    PubMed     Abstract available


  710. HORGUSLUOGLU E, Neff R, Song WM, Wang M, et al
    Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease.
    Alzheimers Dement. 2021 Nov 10. doi: 10.1002/alz.12468.
    PubMed     Abstract available


  711. BOADA M, Lopez OL, Olazaran J, Nunez L, et al
    Neuropsychological, neuropsychiatric, and quality-of-life assessments in Alzheimer's disease patients treated with plasma exchange with albumin replacement from the randomized AMBAR study.
    Alzheimers Dement. 2021 Nov 2. doi: 10.1002/alz.12477.
    PubMed     Abstract available


  712. EZZATI A, Abdulkadir A, Jack CR Jr, Thompson PM, et al
    Predictive value of ATN biomarker profiles in estimating disease progression in Alzheimer's disease dementia.
    Alzheimers Dement. 2021;17:1855-1867.
    PubMed     Abstract available


  713. TAHIRA AC, Verjovski-Almeida S, Ferreira ST
    Dementia is an age-independent risk factor for severity and death in COVID-19 inpatients.
    Alzheimers Dement. 2021;17:1818-1831.
    PubMed     Abstract available


    October 2021
  714. TOSUN D, Demir Z, Veitch DP, Weintraub D, et al
    Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum.
    Alzheimers Dement. 2021 Oct 14. doi: 10.1002/alz.12480.
    PubMed     Abstract available


  715. MEYERS EA, Amouyel P, Bovenkamp DE, Carrillo MC, et al
    Commentary: Global Alzheimer's disease and Alzheimer's disease related dementia research funding organizations support and engage the research community throughout the COVID-19 pandemic.
    Alzheimers Dement. 2021 Oct 1. doi: 10.1002/alz.12472.
    PubMed     Abstract available



  716. Alzheimer's Disease Interventions: Implications of therapeutic promises amidst questions and doubts about clinically meaningful outcomes.
    Alzheimers Dement. 2021;17:1591-1594.
    PubMed    


  717. DE MAULEON A, Ismail Z, Rosenberg P, Miller D, et al
    Agitation in Alzheimer's disease: Novel outcome measures reflecting the International Psychogeriatric Association (IPA) agitation criteria.
    Alzheimers Dement. 2021;17:1687-1697.
    PubMed     Abstract available


  718. DAMOTTE V, van der Lee SJ, Chouraki V, Grenier-Boley B, et al
    Plasma amyloid beta levels are driven by genetic variants near APOE, BACE1, APP, PSEN2: A genome-wide association study in over 12,000 non-demented participants.
    Alzheimers Dement. 2021;17:1663-1674.
    PubMed     Abstract available


  719. BANGEN KJ, Thomas KR, Weigand AJ, Edmonds EC, et al
    Elevated plasma neurofilament light predicts a faster rate of cognitive decline over 5 years in participants with objectively-defined subtle cognitive decline and MCI.
    Alzheimers Dement. 2021;17:1756-1762.
    PubMed     Abstract available


  720. MEZ J, Alosco ML, Daneshvar DH, Saltiel N, et al
    Validity of the 2014 traumatic encephalopathy syndrome criteria for CTE pathology.
    Alzheimers Dement. 2021;17:1709-1724.
    PubMed     Abstract available


  721. GALVIN JE, Chrisphonte S, Cohen I, Greenfield KK, et al
    Characterization of dementia with Lewy bodies (DLB) and mild cognitive impairment using the Lewy body dementia module (LBD-MOD).
    Alzheimers Dement. 2021;17:1675-1686.
    PubMed     Abstract available


  722. YANG C, Li X, Zhang J, Chen Y, et al
    Early prevention of cognitive impairment in the community population: The Beijing Aging Brain Rejuvenation Initiative.
    Alzheimers Dement. 2021;17:1610-1618.
    PubMed     Abstract available


    September 2021
  723. FRANZEN S, Smith JE, van den Berg E, Rivera Mindt M, et al
    Diversity in Alzheimer's disease drug trials: The importance of eligibility criteria.
    Alzheimers Dement. 2021 Sep 30. doi: 10.1002/alz.12433.
    PubMed     Abstract available


  724. PICARD C, Nilsson N, Labonte A, Auld D, et al
    Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease.
    Alzheimers Dement. 2021 Sep 29. doi: 10.1002/alz.12442.
    PubMed     Abstract available


  725. JICHA GA, Abner EL, Arnold SE, Carrillo MC, et al
    Committee on High-quality Alzheimer's Disease Studies (CHADS) consensus report.
    Alzheimers Dement. 2021 Sep 29. doi: 10.1002/alz.12461.
    PubMed     Abstract available


  726. CUMMINGS JL, Goldman DP, Simmons-Stern NR, Ponton E, et al
    The costs of developing treatments for Alzheimer's disease: A retrospective exploration.
    Alzheimers Dement. 2021 Sep 28. doi: 10.1002/alz.12450.
    PubMed     Abstract available


  727. VEITCH DP, Weiner MW, Aisen PS, Beckett LA, et al
    Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease.
    Alzheimers Dement. 2021 Sep 28. doi: 10.1002/alz.12422.
    PubMed     Abstract available


  728. WANG C, Wang Z, Xie B, Shi X, et al
    Binaural processing deficit and cognitive impairment in Alzheimer's disease.
    Alzheimers Dement. 2021 Sep 27. doi: 10.1002/alz.12464.
    PubMed     Abstract available


  729. MATTKE S, Hanson M
    Expected wait times for access to a disease-modifying Alzheimer's treatment in the United States.
    Alzheimers Dement. 2021 Sep 27. doi: 10.1002/alz.12470.
    PubMed     Abstract available


  730. PHILLIPS JS, Nitchie FJ 4th, Da Re F, Olm CA, et al
    Rates of longitudinal change in (18) F-flortaucipir PET vary by brain region, cognitive impairment, and age in atypical Alzheimer's disease.
    Alzheimers Dement. 2021 Sep 13. doi: 10.1002/alz.12456.
    PubMed     Abstract available


  731. ZHANG L, Du Rietz E, Kuja-Halkola R, Dobrosavljevic M, et al
    Attention-deficit/hyperactivity disorder and Alzheimer's disease and any dementia: A multi-generation cohort study in Sweden.
    Alzheimers Dement. 2021 Sep 9. doi: 10.1002/alz.12462.
    PubMed     Abstract available


  732. CHATTERJEE P, Pedrini S, Ashton NJ, Tegg M, et al
    Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease.
    Alzheimers Dement. 2021 Sep 8. doi: 10.1002/alz.12447.
    PubMed     Abstract available


  733. MARTERSTECK A, Sridhar J, Coventry C, Weintraub S, et al
    Relationships among tau burden, atrophy, age, and naming in the aphasic variant of Alzheimer's disease.
    Alzheimers Dement. 2021 Sep 8. doi: 10.1002/alz.12445.
    PubMed     Abstract available


  734. LOGSDON AF, Francis KL, Richardson NE, Hu SJ, et al
    Decoding perineuronal net glycan sulfation patterns in the Alzheimer's disease brain.
    Alzheimers Dement. 2021 Sep 5. doi: 10.1002/alz.12451.
    PubMed     Abstract available


  735. MA Y, Yu L, Olah M, Smith R, et al
    Epigenomic features related to microglia are associated with attenuated effect of APOE epsilon4 on Alzheimer's disease risk in humans.
    Alzheimers Dement. 2021 Sep 5. doi: 10.1002/alz.12425.
    PubMed     Abstract available


  736. REN RJ, Huang Q, Xu G, Gu K, et al
    Association between Alzheimer's disease and risk of cancer: A retrospective cohort study in Shanghai, China.
    Alzheimers Dement. 2021 Sep 5. doi: 10.1002/alz.12436.
    PubMed     Abstract available


  737. PEGUEROLES J, Montal V, Bejanin A, Vilaplana E, et al
    AMYQ: An index to standardize quantitative amyloid load across PET tracers.
    Alzheimers Dement. 2021;17:1499-1508.
    PubMed     Abstract available


    August 2021
  738. GHAZARIAN AL, Haim T, Sauma S, Katiyar P, et al
    National Institute on Aging seed funding enables Alzheimer's disease startups to reach key value inflection points.
    Alzheimers Dement. 2021 Aug 10. doi: 10.1002/alz.12392.
    PubMed     Abstract available


  739. WANG Q, Davis PB, Gurney ME, Xu R, et al
    COVID-19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US.
    Alzheimers Dement. 2021;17:1297-1306.
    PubMed     Abstract available


  740. PIERUCCINI-FARIA F, Black SE, Masellis M, Smith EE, et al
    Gait variability across neurodegenerative and cognitive disorders: Results from the Canadian Consortium of Neurodegeneration in Aging (CCNA) and the Gait and Brain Study.
    Alzheimers Dement. 2021;17:1317-1328.
    PubMed     Abstract available


  741. BAUCKNEHT M, Chincarini A, Brendel M, Rominger A, et al
    Associations among education, age, and the dementia with Lewy bodies (DLB) metabolic pattern: A European-DLB consortium project.
    Alzheimers Dement. 2021;17:1277-1286.
    PubMed     Abstract available


  742. GIANATTASIO KZ, Bennett EE, Wei J, Mehrotra ML, et al
    Generalizability of findings from a clinical sample to a community-based sample: A comparison of ADNI and ARIC.
    Alzheimers Dement. 2021;17:1265-1276.
    PubMed     Abstract available


    July 2021
  743. GARNIER-CRUSSARD A, Bougacha S, Wirth M, Dautricourt S, et al
    White matter hyperintensity topography in Alzheimer's disease and links to cognition.
    Alzheimers Dement. 2021 Jul 28. doi: 10.1002/alz.12410.
    PubMed     Abstract available


  744. BOADA M, Rodrigo A, Jessen F, Wimblad B, et al
    Complementary pre-screening strategies to uncover hidden prodromal and mild Alzheimer's disease: Results from the MOPEAD project.
    Alzheimers Dement. 2021 Jul 26. doi: 10.1002/alz.12441.
    PubMed     Abstract available


  745. HOSCHEIDT S, Sanderlin AH, Baker LD, Jung Y, et al
    Mediterranean and Western diet effects on Alzheimer's disease biomarkers, cerebral perfusion, and cognition in mid-life: A randomized trial.
    Alzheimers Dement. 2021 Jul 26. doi: 10.1002/alz.12421.
    PubMed     Abstract available


  746. VAN HARTEN AC, Wiste HJ, Weigand SD, Mielke MM, et al
    Detection of Alzheimer's disease amyloid beta 1-42, p-tau, and t-tau assays.
    Alzheimers Dement. 2021 Jul 26. doi: 10.1002/alz.12406.
    PubMed     Abstract available


  747. KULMINSKI AM, Philipp I, Loika Y, He L, et al
    Protective association of the epsilon2/epsilon3 heterozygote with Alzheimer's disease is strengthened by TOMM40-APOE variants in men.
    Alzheimers Dement. 2021 Jul 26. doi: 10.1002/alz.12413.
    PubMed     Abstract available


  748. BOCHE D, Gordon MN
    Diversity of transcriptomic microglial phenotypes in aging and Alzheimer's disease.
    Alzheimers Dement. 2021 Jul 5. doi: 10.1002/alz.12389.
    PubMed     Abstract available


  749. BAO H, Liu Y, Zhang M, Chen Z, et al
    Increased beta-site APP cleaving enzyme 1-mediated insulin receptor cleavage in type 2 diabetes mellitus with cognitive impairment.
    Alzheimers Dement. 2021;17:1097-1108.
    PubMed     Abstract available


    June 2021
  750. ZHANG X, Farrell JJ, Tong T, Hu J, et al
    Association of mitochondrial variants and haplogroups identified by whole exome sequencing with Alzheimer's disease.
    Alzheimers Dement. 2021 Jun 20. doi: 10.1002/alz.12396.
    PubMed     Abstract available


  751. TEERLINK CC, Miller JB, Vance EL, Staley LA, et al
    Analysis of high-risk pedigrees identifies 12 candidate variants for Alzheimer's disease.
    Alzheimers Dement. 2021 Jun 20. doi: 10.1002/alz.12397.
    PubMed     Abstract available


  752. ZHONG W, Wu A, Berglund K, Gu X, et al
    Pathogenesis of sporadic Alzheimer's disease by deficiency of NMDA receptor subunit GluN3A.
    Alzheimers Dement. 2021 Jun 20. doi: 10.1002/alz.12398.
    PubMed     Abstract available


  753. JANELIDZE S, Palmqvist S, Leuzy A, Stomrud E, et al
    Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Abeta42/Abeta40 and p-tau.
    Alzheimers Dement. 2021 Jun 20. doi: 10.1002/alz.12395.
    PubMed     Abstract available


  754. BIRKENBIHL C, Salimi Y, Frohlich H
    Unraveling the heterogeneity in Alzheimer's disease progression across multiple cohorts and the implications for data-driven disease modeling.
    Alzheimers Dement. 2021 Jun 9. doi: 10.1002/alz.12387.
    PubMed     Abstract available


  755. LOPEZ-RODRIGUEZ AB, Hennessy E, Murray CL, Nazmi A, et al
    Acute systemic inflammation exacerbates neuroinflammation in Alzheimer's disease: IL-1beta drives amplified responses in primed astrocytes and neuronal network dysfunction.
    Alzheimers Dement. 2021 Jun 3. doi: 10.1002/alz.12341.
    PubMed     Abstract available


  756. TEMP AGM, Lutz MW, Trepel D, Tang Y, et al
    How Bayesian statistics may help answer some of the controversial questions in clinical research on Alzheimer's disease.
    Alzheimers Dement. 2021;17:917-919.
    PubMed    


  757. FRANZMEIER N, Ossenkoppele R, Brendel M, Rubinski A, et al
    The BIN1 rs744373 Alzheimer's disease risk SNP is associated with faster Abeta-associated tau accumulation and cognitive decline.
    Alzheimers Dement. 2021 Jun 1. doi: 10.1002/alz.12371.
    PubMed     Abstract available


  758. RICHARD E, den Brok MGHE, van Gool WA
    Bayes analysis supports null hypothesis of anti-amyloid beta therapy in Alzheimer's disease.
    Alzheimers Dement. 2021;17:1051-1055.
    PubMed     Abstract available


  759. DE ERAUSQUIN GA, Snyder H, Carrillo M, Hosseini AA, et al
    The chronic neuropsychiatric sequelae of COVID-19: The need for a prospective study of viral impact on brain functioning.
    Alzheimers Dement. 2021;17:1056-1065.
    PubMed     Abstract available


    May 2021
  760. SEXTON CE, Anstey KJ, Baldacci F, Barnum CJ, et al
    Alzheimer's disease research progress in Australia: The Alzheimer's Association International Conference Satellite Symposium in Sydney.
    Alzheimers Dement. 2021 May 31. doi: 10.1002/alz.12380.
    PubMed     Abstract available


  761. O'BRYANT SE, Zhang F, Petersen M, Hall JR, et al
    A blood screening tool for detecting mild cognitive impairment and Alzheimer's disease among community-dwelling Mexican Americans and non-Hispanic Whites: A method for increasing representation of diverse populations in clinical research.
    Alzheimers Dement. 2021 May 31. doi: 10.1002/alz.12382.
    PubMed     Abstract available


  762. PANNUZZO M
    Beta-amyloid pore linked to controlled calcium influx into the cell: A new paradigm for Alzheimer's Disease.
    Alzheimers Dement. 2021 May 29. doi: 10.1002/alz.12373.
    PubMed     Abstract available


  763. SCHWAHN C, Frenzel S, Holtfreter B, Van der Auwera S, et al
    Effect of periodontal treatment on preclinical Alzheimer's disease-Results of a trial emulation approach.
    Alzheimers Dement. 2021 May 29. doi: 10.1002/alz.12378.
    PubMed     Abstract available


  764. RAJAN KB, Weuve J, Barnes LL, McAninch EA, et al
    Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020-2060).
    Alzheimers Dement. 2021 May 27. doi: 10.1002/alz.12362.
    PubMed     Abstract available


  765. HAMPEL H, Shaw LM, Aisen P, Chen C, et al
    State-of-the-art of lumbar puncture and its place in the journey of patients with Alzheimer's disease.
    Alzheimers Dement. 2021 May 27. doi: 10.1002/alz.12372.
    PubMed     Abstract available


  766. JIANG Y, Zhou X, Ip FC, Chan P, et al
    Large-scale plasma proteomic profiling identifies a high-performance biomarker panel for Alzheimer's disease screening and staging.
    Alzheimers Dement. 2021 May 25. doi: 10.1002/alz.12369.
    PubMed     Abstract available


  767. APOSTOLOVA LG, Aisen P, Eloyan A, Fagan A, et al
    The Longitudinal Early-onset Alzheimer's Disease Study (LEADS): Framework and methodology.
    Alzheimers Dement. 2021 May 21. doi: 10.1002/alz.12350.
    PubMed     Abstract available


  768. STERN Y, Stallard E, Kinosian B, Zhu C, et al
    Validation and demonstration of a new comprehensive model of Alzheimer's disease progression.
    Alzheimers Dement. 2021 May 14. doi: 10.1002/alz.12336.
    PubMed     Abstract available


  769. HONG S, Dobricic V, Ohlei O, Bos I, et al
    TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels.
    Alzheimers Dement. 2021 May 14. doi: 10.1002/alz.12330.
    PubMed     Abstract available


  770. LIBIGER O, Shaw LM, Watson MH, Nairn AC, et al
    Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease.
    Alzheimers Dement. 2021 May 13. doi: 10.1002/alz.12353.
    PubMed     Abstract available


  771. GUSTAVSSON A, Raket LL, Lilja M, Rutten-Jacobs L, et al
    Health utility in preclinical and prodromal Alzheimer's disease for establishing the value of new disease-modifying treatments-EQ-5D data from the Swedish BioFINDER study.
    Alzheimers Dement. 2021 May 13. doi: 10.1002/alz.12355.
    PubMed     Abstract available


  772. MORGAN DG, Mielke MM
    Knowledge gaps in Alzheimer's disease immune biomarker research.
    Alzheimers Dement. 2021 May 13. doi: 10.1002/alz.12342.
    PubMed     Abstract available


  773. OSSENKOPPELE R, Hansson O
    Towards clinical application of tau PET tracers for diagnosing dementia due to Alzheimer's disease.
    Alzheimers Dement. 2021 May 13. doi: 10.1002/alz.12356.
    PubMed     Abstract available


  774. MADRASI K, Das R, Mohmmadabdul H, Lin L, et al
    Systematic in silico analysis of clinically tested drugs for reducing amyloid-beta plaque accumulation in Alzheimer's disease.
    Alzheimers Dement. 2021 May 2. doi: 10.1002/alz.12312.
    PubMed     Abstract available



  775. Association commits $14 million to novel drug trials in rare form of Alzheimer's.
    Alzheimers Dement. 2021;17:910.
    PubMed    


  776. STANLEY J, Howlett SE, Dunn T, Rockwood K, et al
    The Clinician's Interview-Based Impression of Change (Plus caregiver input) and goal attainment in two dementia drug trials: Clinical meaningfulness and the initial treatment response.
    Alzheimers Dement. 2021;17:856-865.
    PubMed     Abstract available


  777. MIELKE MM, Przybelski SA, Lesnick TG, Kern S, et al
    Comparison of CSF neurofilament light chain, neurogranin, and tau to MRI markers.
    Alzheimers Dement. 2021;17:801-812.
    PubMed     Abstract available


  778. WOODWORTH DC, Nguyen HL, Khan Z, Kawas CH, et al
    Utility of MRI in the identification of hippocampal sclerosis of aging.
    Alzheimers Dement. 2021;17:847-855.
    PubMed     Abstract available


  779. COUSINS KAQ, Phillips JS, Irwin DJ, Lee EB, et al
    ATN incorporating cerebrospinal fluid neurofilament light chain detects frontotemporal lobar degeneration.
    Alzheimers Dement. 2021;17:822-830.
    PubMed     Abstract available


    April 2021
  780. RANASINGHE KG, Petersen C, Kudo K, Mizuiri D, et al
    Reduced synchrony in alpha oscillations during life predicts post mortem neurofibrillary tangle density in early-onset and atypical Alzheimer's disease.
    Alzheimers Dement. 2021 Apr 21. doi: 10.1002/alz.12349.
    PubMed     Abstract available


  781. LI X, Tsolis KC, Koper MJ, Ronisz A, et al
    Sequence of proteome profiles in preclinical and symptomatic Alzheimer's disease.
    Alzheimers Dement. 2021 Apr 19. doi: 10.1002/alz.12345.
    PubMed     Abstract available


  782. BABILONI C, Arakaki X, Azami H, Bennys K, et al
    Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel.
    Alzheimers Dement. 2021 Apr 15. doi: 10.1002/alz.12311.
    PubMed     Abstract available


  783. MOELLER S, Sridhar J, Martersteck A, Coventry C, et al
    Functional decline in the aphasic variant of Alzheimer's disease.
    Alzheimers Dement. 2021 Apr 8. doi: 10.1002/alz.12331.
    PubMed     Abstract available


  784. MOLONEY CM, Lowe VJ, Murray ME
    Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker research.
    Alzheimers Dement. 2021 Apr 2. doi: 10.1002/alz.12321.
    PubMed     Abstract available


  785. PROKOPENKO D, Morgan SL, Mullin K, Hofmann O, et al
    Whole-genome sequencing reveals new Alzheimer's disease-associated rare variants in loci related to synaptic function and neuronal development.
    Alzheimers Dement. 2021 Apr 2. doi: 10.1002/alz.12319.
    PubMed     Abstract available


  786. SABBAGH MN, Cummings J
    Open Peer Commentary to "Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE Trials as reported by Biogen December 2019".
    Alzheimers Dement. 2021;17:702-703.
    PubMed    


  787. KULLER LH, Lopez OL
    ENGAGE and EMERGE: Truth and consequences?
    Alzheimers Dement. 2021;17:692-695.
    PubMed     Abstract available


  788. BRAY MJC, Richey LN, Bryant BR, Krieg A, et al
    Traumatic brain injury alters neuropsychiatric symptomatology in all-cause dementia.
    Alzheimers Dement. 2021;17:686-691.
    PubMed     Abstract available


  789. PLANCHE V, Bouteloup V, Mangin JF, Dubois B, et al
    Clinical relevance of brain atrophy subtypes categorization in memory clinics.
    Alzheimers Dement. 2021;17:641-652.
    PubMed     Abstract available


  790. STAFFARONI AM, Asken BM, Casaletto KB, Fonseca C, et al
    Development and validation of the Uniform Data Set (v3.0) executive function composite score (UDS3-EF).
    Alzheimers Dement. 2021;17:574-583.
    PubMed     Abstract available


  791. KNOPMAN DS, Jones DT, Greicius MD
    Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019.
    Alzheimers Dement. 2021;17:696-701.
    PubMed     Abstract available


    March 2021
  792. CHONG JR, Ashton NJ, Karikari TK, Tanaka T, et al
    Plasma P-tau181 to Abeta42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant cerebrovascular disease.
    Alzheimers Dement. 2021 Mar 31. doi: 10.1002/alz.12332.
    PubMed     Abstract available


  793. SHI L, Winchester LM, Westwood S, Baird AL, et al
    Replication study of plasma proteins relating to Alzheimer's pathology.
    Alzheimers Dement. 2021 Mar 31. doi: 10.1002/alz.12322.
    PubMed     Abstract available


  794. HANSSON O, Batrla R, Brix B, Carrillo MC, et al
    The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid beta and tau.
    Alzheimers Dement. 2021 Mar 31. doi: 10.1002/alz.12316.
    PubMed     Abstract available



  795. Register for May AAIC(R) Satellite Symposium and second Latinos & Alzheimer's symposium.
    Alzheimers Dement. 2021 Mar 31. doi: 10.1002/alz.12337.
    PubMed    


  796. AKHTER-KHAN SC, Tao Q, Ang TFA, Itchapurapu IS, et al
    Associations of loneliness with risk of Alzheimer's disease dementia in the Framingham Heart Study.
    Alzheimers Dement. 2021 Mar 24. doi: 10.1002/alz.12327.
    PubMed     Abstract available



  797. 2021 Alzheimer's disease facts and figures.
    Alzheimers Dement. 2021 Mar 23. doi: 10.1002/alz.12328.
    PubMed     Abstract available


  798. BECKMAN D, Chakrabarty P, Ott S, Dao A, et al
    A novel tau-based rhesus monkey model of Alzheimer's pathogenesis.
    Alzheimers Dement. 2021 Mar 18. doi: 10.1002/alz.12318.
    PubMed     Abstract available


  799. KOCIOLEK AJ, Fernandez KK, Jin Z, Cosentino S, et al
    Extrapyramidal signs and Alzheimer's disease prognosis in a multiethnic, community-based sample of demented elders.
    Alzheimers Dement. 2021 Mar 12. doi: 10.1002/alz.12309.
    PubMed     Abstract available


  800. DISBROW E, Stokes KY, Ledbetter C, Patterson J, et al
    Plasma hydrogen sulfide: A biomarker of Alzheimer's disease and related dementias.
    Alzheimers Dement. 2021 Mar 12. doi: 10.1002/alz.12305.
    PubMed     Abstract available


  801. FALGAS N, Walsh CM, Neylan TC, Grinberg LT, et al
    Deepen into sleep and wake patterns across Alzheimer's disease phenotypes.
    Alzheimers Dement. 2021 Mar 12. doi: 10.1002/alz.12304.
    PubMed     Abstract available


  802. RAHMAN M, White EM, Mills C, Thomas KS, et al
    Rural-urban differences in diagnostic incidence and prevalence of Alzheimer's disease and related dementias.
    Alzheimers Dement. 2021 Mar 4. doi: 10.1002/alz.12285.
    PubMed     Abstract available


  803. SALVADO G, Mila-Aloma M, Shekari M, Minguillon C, et al
    Cerebral amyloid-beta load is associated with neurodegeneration and gliosis: Mediation by p-tau and interactions with risk factors early in the Alzheimer's continuum.
    Alzheimers Dement. 2021 Mar 4. doi: 10.1002/alz.12245.
    PubMed     Abstract available


  804. TURNER DA, Degan S, Hoffmann U, Galeffi F, et al
    CVN-AD Alzheimer's mice show premature reduction in neurovascular coupling in response to spreading depression and anoxia compared to aged controls.
    Alzheimers Dement. 2021 Mar 3. doi: 10.1002/alz.12289.
    PubMed     Abstract available


  805. MASEREJIAN N, Krzywy H, Eaton S, Galvin JE, et al
    Cognitive measures lacking in EHR prior to dementia or Alzheimer's disease diagnosis.
    Alzheimers Dement. 2021 Mar 3. doi: 10.1002/alz.12280.
    PubMed     Abstract available


  806. SAITO ER, Miller JB, Harari O, Cruchaga C, et al
    Alzheimer's disease alters oligodendrocytic glycolytic and ketolytic gene expression.
    Alzheimers Dement. 2021 Mar 2. doi: 10.1002/alz.12310.
    PubMed     Abstract available


  807. LI Y, Xiong C, Aschenbrenner AJ, Chang CH, et al
    Item response theory analysis of the Clinical Dementia Rating.
    Alzheimers Dement. 2021;17:534-542.
    PubMed     Abstract available


  808. FANI L, Ahmad S, Ikram MK, Ghanbari M, et al
    Immunity and amyloid beta, total tau and neurofilament light chain: Findings from a community-based cohort study.
    Alzheimers Dement. 2021;17:446-456.
    PubMed     Abstract available


  809. GRANOT-HERSHKOVITZ E, Tarraf W, Kurniansyah N, Daviglus M, et al
    APOE alleles' association with cognitive function differs across Hispanic/Latino groups and genetic ancestry in the study of Latinos-investigation of neurocognitive aging (HCHS/SOL).
    Alzheimers Dement. 2021;17:466-474.
    PubMed     Abstract available


    February 2021
  810. ASHFORD MT, Veitch DP, Neuhaus J, Nosheny RL, et al
    The search for a convenient procedure to detect one of the earliest signs of Alzheimer's disease: A systematic review of the prediction of brain amyloid status.
    Alzheimers Dement. 2021 Feb 13. doi: 10.1002/alz.12253.
    PubMed     Abstract available


  811. BRICKMAN AM, Manly JJ, Honig LS, Sanchez D, et al
    Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study.
    Alzheimers Dement. 2021 Feb 13. doi: 10.1002/alz.12301.
    PubMed     Abstract available


  812. IZZO NJ, Yuede CM, LaBarbera KM, Limegrover CS, et al
    Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification.
    Alzheimers Dement. 2021 Feb 8. doi: 10.1002/alz.12302.
    PubMed     Abstract available


  813. BLEILE L
    Alzheimer's Association Update.
    Alzheimers Dement. 2021 Feb 4. doi: 10.1002/alz.12306.
    PubMed    


  814. WANG R, Qiu C, Dintica CS, Shang Y, et al
    Shared risk and protective factors between Alzheimer's disease and ischemic stroke: A population-based longitudinal study.
    Alzheimers Dement. 2021 Feb 1. doi: 10.1002/alz.12203.
    PubMed     Abstract available


  815. GUZMAN-VELEZ E, Zetterberg H, Fox-Fuller JT, Vila-Castelar C, et al
    Associations between plasma neurofilament light, in vivo brain pathology, and cognition in non-demented individuals with autosomal-dominant Alzheimer's disease.
    Alzheimers Dement. 2021 Feb 1. doi: 10.1002/alz.12248.
    PubMed     Abstract available


  816. GRISWOLD AJ, Celis K, Bussies PL, Rajabli F, et al
    Increased APOE epsilon4 expression is associated with the difference in Alzheimer's disease risk from diverse ancestral backgrounds.
    Alzheimers Dement. 2021 Feb 1. doi: 10.1002/alz.12287.
    PubMed     Abstract available


  817. HAGHANI A, Thorwald M, Morgan TE, Finch CE, et al
    The APOE gene cluster responds to air pollution factors in mice with coordinated expression of genes that differs by age in humans.
    Alzheimers Dement. 2021;17:175-190.
    PubMed     Abstract available


  818. CHEN XQ, Salehi A, Pearn ML, Overk C, et al
    Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model.
    Alzheimers Dement. 2021;17:271-292.
    PubMed     Abstract available


  819. BLUE EE, Thornton TA, Kooperberg C, Liu S, et al
    Non-coding variants in MYH11, FZD3, and SORCS3 are associated with dementia in women.
    Alzheimers Dement. 2021;17:215-225.
    PubMed     Abstract available


  820. DE LEEUW FA, Karamujic-Comic H, Tijms BM, Peeters CFW, et al
    Circulating metabolites are associated with brain atrophy and white matter hyperintensities.
    Alzheimers Dement. 2021;17:205-214.
    PubMed     Abstract available


    January 2021
  821. AYTON S, Portbury S, Kalinowski P, Agarwal P, et al
    Regional brain iron associated with deterioration in Alzheimer's disease: A large cohort study and theoretical significance.
    Alzheimers Dement. 2021 Jan 25. doi: 10.1002/alz.12282.
    PubMed     Abstract available


  822. SIMREN J, Leuzy A, Karikari TK, Hye A, et al
    The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease.
    Alzheimers Dement. 2021 Jan 25. doi: 10.1002/alz.12283.
    PubMed     Abstract available


  823. GERMANN J, Elias GJB, Boutet A, Narang K, et al
    Brain structures and networks responsible for stimulation-induced memory flashbacks during forniceal deep brain stimulation for Alzheimer's disease.
    Alzheimers Dement. 2021 Jan 21. doi: 10.1002/alz.12238.
    PubMed     Abstract available


  824. BRYAN J, Mandan A, Kamat G, Gottschalk WK, et al
    Likelihood ratio statistics for gene set enrichment in Alzheimer's disease pathways.
    Alzheimers Dement. 2021 Jan 21. doi: 10.1002/alz.12223.
    PubMed     Abstract available


  825. LUCKETT PH, McCullough A, Gordon BA, Strain J, et al
    Modeling autosomal dominant Alzheimer's disease with machine learning.
    Alzheimers Dement. 2021 Jan 21. doi: 10.1002/alz.12259.
    PubMed     Abstract available


  826. LI HD, Funk CC, McFarland K, Dammer EB, et al
    Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's disease.
    Alzheimers Dement. 2021 Jan 21. doi: 10.1002/alz.12254.
    PubMed     Abstract available



  827. Alzheimer's Association International Conference Neuroscience Next focused on early career researchers across all of neuroscience.
    Alzheimers Dement. 2021;17:138-139.
    PubMed    


  828. CHIARI A, Vinceti G, Adani G, Tondelli M, et al
    Epidemiology of early onset dementia and its clinical presentations in the province of Modena, Italy.
    Alzheimers Dement. 2021;17:81-88.
    PubMed     Abstract available


    December 2020
  829. VAN HULLE C, Jonaitis EM, Betthauser TJ, Batrla R, et al
    An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum.
    Alzheimers Dement. 2020 Dec 18. doi: 10.1002/alz.12204.
    PubMed     Abstract available


  830. LYSSENKO NN, Pratico D
    ABCA7 and the altered lipidostasis hypothesis of Alzheimer's disease.
    Alzheimers Dement. 2020 Dec 17. doi: 10.1002/alz.12220.
    PubMed     Abstract available


  831. MOHAMMED H
    Recognizing African-American contributions to neurology: The role of Solomon Carter Fuller (1872-1953) in Alzheimer's disease research.
    Alzheimers Dement. 2020 Dec 15. doi: 10.1002/alz.12183.
    PubMed     Abstract available


  832. AUDRAIN M, Haure-Mirande JV, Mleczko J, Wang M, et al
    Reactive or transgenic increase in microglial TYROBP reveals a TREM2-independent TYROBP-APOE link in wild-type and Alzheimer's-related mice.
    Alzheimers Dement. 2020 Dec 12. doi: 10.1002/alz.12256.
    PubMed     Abstract available


  833. KIM YW, Al-Ramahi I, Koire A, Wilson SJ, et al
    Harnessing the paradoxical phenotypes of APOE varepsilon2 and APOE varepsilon4 to identify genetic modifiers in Alzheimer's disease.
    Alzheimers Dement. 2020 Dec 7. doi: 10.1002/alz.12240.
    PubMed     Abstract available


  834. FRYE BM, Craft S, Register TC, Andrews RN, et al
    Diet, psychosocial stress, and Alzheimer's disease-related neuroanatomy in female nonhuman primates.
    Alzheimers Dement. 2020 Dec 3. doi: 10.1002/alz.12232.
    PubMed     Abstract available


    November 2020
  835. KARIKARI TK, Emersic A, Vrillon A, Lantero-Rodriguez J, et al
    Head-to-head comparison of clinical performance of CSF phospho-tau T181 and T217 biomarkers for Alzheimer's disease diagnosis.
    Alzheimers Dement. 2020 Nov 30. doi: 10.1002/alz.12236.
    PubMed     Abstract available


  836. LLIBRE-GUERRA JJ, Li Y, Allegri RF, Mendez PC, et al
    Dominantly inherited Alzheimer's disease in Latin America: Genetic heterogeneity and clinical phenotypes.
    Alzheimers Dement. 2020 Nov 23. doi: 10.1002/alz.12227.
    PubMed     Abstract available


  837. DUENAS MR, Snyder PJ
    Alzheimer's team care approach-akin to diabetes-in the development, validation, and population assessment of retinal biomarkers for disease.
    Alzheimers Dement. 2020 Nov 23. doi: 10.1002/alz.12234.
    PubMed     Abstract available


  838. SPENCER BE, Digma LA, Jennings RG, Brewer JB, et al
    Gene- and age-informed screening for preclinical Alzheimer's disease trials.
    Alzheimers Dement. 2020 Nov 23. doi: 10.1002/alz.12207.
    PubMed     Abstract available


  839. HITHERSAY R, Baksh RA, Startin CM, Wijeratne P, et al
    Optimal age and outcome measures for Alzheimer's disease prevention trials in people with Down syndrome.
    Alzheimers Dement. 2020 Nov 23. doi: 10.1002/alz.12222.
    PubMed     Abstract available


  840. PENTZ R, Iulita MF, Ducatenzeiler A, Videla L, et al
    Nerve growth factor (NGF) pathway biomarkers in Down syndrome prior to and after the onset of clinical Alzheimer's disease: A paired CSF and plasma study.
    Alzheimers Dement. 2020 Nov 23. doi: 10.1002/alz.12229.
    PubMed     Abstract available


  841. MONTAL V, Vilaplana E, Pegueroles J, Bejanin A, et al
    Biphasic cortical macro- and microstructural changes in autosomal dominant Alzheimer's disease.
    Alzheimers Dement. 2020 Nov 16. doi: 10.1002/alz.12224.
    PubMed     Abstract available


  842. JESSEN F, Kleineidam L, Wolfsgruber S, Bickel H, et al
    Prediction of dementia of Alzheimer type by different types of subjective cognitive decline.
    Alzheimers Dement. 2020 Nov 2. doi: 10.1002/alz.12163.
    PubMed     Abstract available



  843. Alzheimer's Association pays tribute to former Chief Science Officer William (Bill) Thies, PhD.
    Alzheimers Dement. 2020;16:1600-1605.
    PubMed    


    October 2020
  844. SOHEILI-NEZHAD S, van der Linden RJ, Olde Rikkert M, Sprooten E, et al
    Long genes are more frequently affected by somatic mutations and show reduced expression in Alzheimer's disease: Implications for disease etiology.
    Alzheimers Dement. 2020 Oct 19. doi: 10.1002/alz.12211.
    PubMed     Abstract available


  845. ARNSTEN AFT, Datta D, Tredici KD, Braak H, et al
    Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer's disease.
    Alzheimers Dement. 2020 Oct 19. doi: 10.1002/alz.12192.
    PubMed     Abstract available


  846. WESSELS AM, Lines C, Stern RA, Kost J, et al
    Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's disease.
    Alzheimers Dement. 2020 Oct 13. doi: 10.1002/alz.12164.
    PubMed     Abstract available


  847. MECCA AP, van Dyck CH
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association.
    Alzheimers Dement. 2020 Oct 12. doi: 10.1002/alz.12190.
    PubMed    


  848. SNYDER PJ, Alber J, Alt C, Bain LJ, et al
    Retinal imaging in Alzheimer's and neurodegenerative diseases.
    Alzheimers Dement. 2020 Oct 8. doi: 10.1002/alz.12179.
    PubMed     Abstract available


  849. THUNELL J, Chen Y, Joyce G, Barthold D, et al
    Drug therapies for chronic conditions and risk of Alzheimer's disease and related dementias: A scoping review.
    Alzheimers Dement. 2020 Oct 8. doi: 10.1002/alz.12175.
    PubMed     Abstract available


  850. JAIN S, Rosenbaum PR, Reiter JG, Hoffman G, et al
    Using Medicare claims in identifying Alzheimer's disease and related dementias.
    Alzheimers Dement. 2020 Oct 8. doi: 10.1002/alz.12199.
    PubMed     Abstract available


  851. HOU X, Watzlawik JO, Cook C, Liu CC, et al
    Mitophagy alterations in Alzheimer's disease are associated with granulovacuolar degeneration and early tau pathology.
    Alzheimers Dement. 2020 Oct 8. doi: 10.1002/alz.12198.
    PubMed     Abstract available


  852. BUBU OM, Umasabor-Bubu OQ, Turner AD, Parekh A, et al
    Self-reported obstructive sleep apnea, amyloid and tau burden, and Alzheimer's disease time-dependent progression.
    Alzheimers Dement. 2020 Oct 8. doi: 10.1002/alz.12184.
    PubMed     Abstract available


    August 2020
  853. DENNY A, Streitz M, Stock K, Balls-Berry JE, et al
    Perspective on the "African American participation in Alzheimer disease research: Effective strategies" workshop, 2018.
    Alzheimers Dement. 2020 Aug 17. doi: 10.1002/alz.12160.
    PubMed     Abstract available


    April 2020
  854. CABALLERO MAA, Song Z, Rubinski A, Duering M, et al
    Age-dependent amyloid deposition is associated with white matter alterations in cognitively normal adults during the adult life span.
    Alzheimers Dement. 2020;16:651-661.
    PubMed     Abstract available


    March 2020
  855. LOWE VJ, Lundt ES, Albertson SM, Min HK, et al
    Tau-positron emission tomography correlates with neuropathology findings.
    Alzheimers Dement. 2020;16:561-571.
    PubMed     Abstract available


  856. PAPP KV, Buckley R, Mormino E, Maruff P, et al
    Clinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD.
    Alzheimers Dement. 2020;16:552-560.
    PubMed     Abstract available


    February 2020
  857. ANTONELL A, Tort-Merino A, Rios J, Balasa M, et al
    Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias.
    Alzheimers Dement. 2020;16:262-272.
    PubMed     Abstract available


  858. ANGULO SL, Henzi T, Neymotin SA, Suarez MD, et al
    Amyloid pathology-produced unexpected modifications of calcium homeostasis in hippocampal subicular dendrites.
    Alzheimers Dement. 2020;16:251-261.
    PubMed     Abstract available


    January 2020
  859. KAPLOW J, Vandijck M, Gray J, Kanekiyo M, et al
    Concordance of Lumipulse cerebrospinal fluid t-tau/Abeta42 ratio with amyloid PET status.
    Alzheimers Dement. 2020;16:144-152.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.